{
  "timestamp": "2025-10-31T22:39:19.932Z",
  "url": "https://chat.formul8.ai",
  "totalQuestions": 438,
  "completed": 50,
  "passed": 19,
  "failed": 31,
  "averageScore": "51.21",
  "averageGrade": "F",
  "results": [
    {
      "questionNum": 1,
      "question": "Can you make me a compliant SOP for Cannabis Transport in New Jersey?",
      "category": "sop-generation-compliance-documentation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Standard Operating Procedure (SOP) – Cannabis Transport – State of New Jersey**  \n*(Template – adapt to your specific operation and have it reviewed by legal counsel)*  \n\n---\n\n### 1. Purpose\nTo ensure that all movement of licensed cannabis products within New Jersey is performed safely, securely, and in full compliance with NJ Statutes (N.J. Stat. §§ 2C:34‑2, 2C:34‑3) and the New Jersey Cannabis Regulatory Commission (NJCRC) Administrative Rules (N.J.A.C. 27:26‑1 through 27:26‑11).\n\n### 2. Scope\nApplies to **all employees, contractors, and third‑party carriers** who transport:\n- Cultivated flower, concentrate, edibles, or any other regulated cannabis product;\n- Plant material or waste designated for disposal;\n- Materials required for testing, packaging, or distribution.\n\n### 3. Definitions\n| Term | NJ‑Specific Definition |\n|------|------------------------|\n| **Licensed Transporter** | Entity holding a valid NJCRC Transporter License (Form TC‑1). |\n| **Manifest** | Electronic or paper record listing each load, quantity, product type, and destination. |\n| **Sealed Container** | Tamper‑evident, child‑resistant container meeting NJCRC specifications. |\n| **Chain‑of‑Custody** | Documented hand‑off of product from origin to destination, including timestamps and signatures. |\n\n### 4. Roles & Responsibilities\n| Role | Primary Duties |\n|------|----------------|\n| **Transport Manager** | Maintain the Transporter License, schedule routes, approve drivers, ensure vehicle compliance, retain records. |\n| **Driver** | Complete pre‑trip checks, follow approved route, maintain manifest, report incidents immediately. |\n| **Security Officer (or designated staff)** | Conduct background checks, perform real‑time GPS monitoring, arrange escorts if required. |\n| **Compliance Officer** | Perform quarterly audits, stay current on NJ regulations, update SOP as needed. |\n\n### 5. Licensing & Permits\n1. **Transporter License** – Must be active and displayed inside the vehicle.  \n2. **Vehicle Registration** – Must be registered with NJCRC; plates may be “Cannabis Transport” if issued.  \n3. **Driver Certification** – Each driver must hold a valid **NJCRC Driver Certification** (Form DC‑1) and a **clean criminal background** (no felonies related to controlled substances).  \n\n### 6. Vehicle Requirements\n| Requirement | Detail |\n|-------------|--------|\n| **Branding** | “Authorized Cannabis Transport” signage (size and placement per N.J.A.C. 27:26‑3). |\n| **GPS Tracking** | Real‑time, tamper‑proof GPS system linked to the compliance platform. |\n| **Sealed Containers** | Certified child‑resistant, tamper‑evident, and labelled with product ID, weight, and destination. |\n| **Security Features** | Alarms, interior cameras (recorded), and locked cargo area. |\n| **Inspection** | Daily pre‑trip inspection checklist (tires, brakes, seals, GPS, documentation). |\n\n### 7. Driver Requirements & Training\n1. **Background Check** – Conducted annually via NJ State Police.  \n2. **Medical Clearance** – Vision, hearing, and physical fitness per NJDOT standards.  \n3. **Training (minimum 8 hrs)** – Topics: NJ cannabis law, emergency response, proper handling of sealed containers, documentation, and de‑escalation techniques.  \n4. **Uniform** – Company‑issued ID badge and high‑visibility vest marked “Cannabis Transport”.  \n\n### 8. Pre‑Transport Procedures\n1. **Manifest Generation** – Auto‑populate from ERP; includes product type, batch/lot, weight, ship‑to, and driver ID.  \n2. **Load Verification** – Two‑person check: one from Operations, one from Security. Confirm seal numbers and photographic evidence.  \n3. **Route Approval** – Logistics team selects the shortest, safest route; avoids restricted zones (schools, hospitals).  \n4. **Escort Determination** – Required if load > 5 lb or if transporting to/from a high‑risk location, per N.J.A.C. 27:26‑5.  \n\n### 9. Security Protocols (During Transport)\n| Action | Detail |\n|--------|--------|\n| **Real‑Time Monitoring** | GPS feed monitored by Security Officer; alerts for deviation > 0.5 mi. |\n| **Check‑Ins** | Driver must radio in at departure, at every 30 min interval, and upon arrival. |\n| **Emergency Procedures** | If stopped by law enforcement\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1432 (166?1266) | Cost: $0.000000*",
      "duration": 10241,
      "grade": "B",
      "score": 87.16666666666667,
      "grading": {
        "length": "Pass",
        "keywords": "13/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "2/4 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "new jersey",
        "epa",
        "commission",
        "crc",
        "metrc",
        "sop",
        "procedure",
        "standard",
        "operating"
      ],
      "expectedAnswer": "I need to create a concise summary for a compliant SOP on cannabis transport in New Jersey. The summary should include main conclusions, key requirements, and critical regulatory details from the New Jersey Cannabis Regulatory Commission (CRC) rules, specifically N.J.A.C. 17:30. It’s important to outline what a compliant SOP must cover per NJ CRC regulations, including details about licensed Cannabis Business classes: Cultivators, Manufacturers, Wholesalers, Distributors, Retailers, Delivery s"
    },
    {
      "questionNum": 2,
      "question": "Can you make me a compliant SOP for pre-roll production in New York?",
      "category": "sop-generation-compliance-documentation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "Below is a **template‑style Standard Operating Procedure (SOP)** for **pre‑roll production** that aligns with the **New York State Office of Cannabis Management (OCM) Regulations** (2022‑2024).  Treat this as a “starter” document – you will need to tailor it to your specific license type, facility layout, equipment, and any updates to the rules.  **Always have a qualified cannabis‑law attorney review the final SOP before implementation.**  \n\n---\n\n## 1.  PURPOSE & SCOPE  \n\n| Item | Description |\n|------|-------------|\n| **Purpose** | Define a repeatable, traceable and compliant process for manufacturing, packaging, testing, and releasing pre‑rolled cannabis products in New York. |\n| **Scope** | Applies to all staff involved in receiving raw material, grinding, rolling, packaging, labeling, testing, storage, and shipment of pre‑rolls at **[Facility Name]**. |\n| **Regulatory References** | NYS OCM Regulations (Title 9, Sub‑Title C), OCM Guidelines for Packaging & Labeling, Metrc tracking requirements, NYS Laboratory Testing Requirements, Child‑Resistant Packaging (CRP) standards (21 CFR 1315). |\n\n---\n\n## 2.  DEFINITIONS (quick reference)\n\n| Term | Meaning |\n|------|---------|\n| **Batch** | All pre‑rolls produced from a single, documented grinding/rolling run, linked to a unique **Batch ID**. |\n| **Lot** | Same as Batch for OCM reporting; used interchangeably in Metrc. |\n| **CRP** | Child‑Resistant Packaging meeting ISO 11625‑1. |\n| **QC** | Quality Control – testing, visual inspection, weight checks, potency verification. |\n| **COA** | Certificate of Analysis issued by an OCM‑approved laboratory. |\n| **METRC** | State‑mandated seed‑to‑sale tracking system. |\n\n---\n\n## 3.  RESPONSIBILITIES  \n\n| Role | Primary Duties |\n|------|----------------|\n| **Master Cultivation Manager** | Certifies that raw flower meets potency, pesticide, and microbial limits before release to manufacturing. |\n| **Manufacturing Supervisor** | Oversees grinding, rolling, packaging; ensures SOP adherence; signs off batch release. |\n| **QC Analyst** | Performs in‑process weight checks, visual inspections, and coordinates third‑party lab testing. |\n| **Packaging Operator** | Packages pre‑rolls in CRP, applies labels, records lot numbers. |\n| **Compliance Officer** | Reviews Metrc entries, maintains SOP revisions, conducts internal audits. |\n| **Sanitation Lead** | Executes cleaning schedule, verifies sanitation logs. |\n| **Training Coordinator** | Maintains staff training records, ensures annual refresher training. |\n\n---\n\n## 4.  EQUIPMENT & MATERIALS  \n\n| Category | Required Items | Calibration/Verification |\n|----------|----------------|---------------------------|\n| **Grinding** | Cryogenic grinder, sieve (≤ 0.5 mm), static‑\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1166 (166?1000) | Cost: $0.000000*",
      "duration": 8226,
      "grade": "F",
      "score": 34,
      "grading": {
        "accuracy": 8,
        "completeness": 6,
        "relevance": 10,
        "clarity_structure": 7,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Attempts a structured SOP template tailored to pre‑roll production",
        "Identifies key roles and responsibilities (QC, Compliance, Sanitation, Training)",
        "Acknowledges need to align with New York OCM regulations"
      ],
      "weaknesses": [
        "Incorrectly states METRC as New York’s seed‑to‑sale system; NY uses the OCM Cannabis Product Tracking System (CPTS)",
        "Mis-cites child‑resistant packaging standards (should reference PPPA 16 CFR 1700.20 and standards like ISO 8317/ASTM D3475, not 21 CFR 1315 or ISO 11625‑1)",
        "Content is truncated and misses major SOP sections (sanitation procedures, hazard controls, testing, release, recall, waste, recordkeeping, CAPA, deviations, internal audits)",
        "Definitions and roles show inaccuracies (e.g., equating lot and batch in Metrc context, misaligned roles like Master Cultivation Manager for a manufacturing SOP)",
        "Lacks NY‑specific regulatory references and details (e.g., 9 NYCRR Adult‑Use regs, Packaging/Labeling rules, prohibitions, retention periods, QA oversight) "
      ],
      "feedback": "While the intent and structure are on the right track, the answer contains key factual inaccuracies for New York, notably the tracking system (CPTS, not METRC) and child‑resistant packaging citations. It is also incomplete and cuts off mid‑section, missing essential NY‑specific compliance elements (packaging/labeling, QA release, product testing, recalls, waste management, sanitation, training, and recordkeeping). Revise with correct NY OCM/CCB references, proper CRP standards (PPPA 16 CFR 1700.20, ISO 8317/ASTM D3475), CPTS workflows, and complete, actionable procedures spanning receipt-to-release, deviations/CAPA, recalls, and document control.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "mandatory",
        "must",
        "state",
        "new york",
        "osha",
        "epa",
        "metrc",
        "sop",
        "procedure",
        "standard",
        "operating"
      ],
      "expectedAnswer": "**Clarifying SOP Requirements** I need to summarize the expected answer for the user’s request about an SOP for pre-roll production in New York. This includes key requirements, regulatory details, and NY-specific info like the role of the Cannabis Control Board. I have to consider manufacturing regulations, sanitation, personnel training, and the track-and-trace system. Wait—did New York choose BioTrack for tracking? I should clarify that the Office of Cannabis Management selected the Cannabis Product Tracking System. Accuracy is key here, so I’ll double-check!"
    },
    {
      "questionNum": 3,
      "question": "Can you make me a product recall SOP?",
      "category": "sop-generation-compliance-documentation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**PRODUCT RECALL – STANDARD OPERATING PROCEDURE (SOP)**  \n*Version 1.0 – Effective 01 Oct 2025*  \n\n---\n\n### 1. PURPOSE  \nTo provide a clear, repeatable process for identifying, evaluating, communicating, executing, and documenting a product recall in order to protect public health, maintain regulatory compliance, and preserve brand integrity.\n\n### 2. SCOPE  \nApplies to **all cannabis‑derived products** (flower, edibles, concentrates, topicals, accessories) manufactured, packaged, stored, or distributed by **[Company Name]**. The SOP covers **voluntary** and **mandated** recalls initiated by the company, a regulator, or a third‑party customer.\n\n### 3. DEFINITIONS  \n\n| Term | Definition |\n|------|------------|\n| **Recall** | Removal or correction of a product that may present a health risk, defect, or regulatory non‑compliance. |\n| **Recall Class** | Classification of severity (Class I – serious health hazard; Class II – temporary or reversible health risk; Class III – unlikely to cause adverse health effect). |\n| **Recall Coordinator (RC)** | Senior manager (Quality Assurance) who leads the recall effort. |\n| **Recall Team (RT)** | Cross‑functional group (QA, Production, Compliance, Legal, PR, Distribution, Finance, IT). |\n| **Recall Notification** | Formal communication to regulators, distributors, retailers, and consumers. |\n| **Recall Effectiveness Check (REC)** | Verification that recalled product is no longer in commerce. |\n\n### 4. RESPONSIBILITIES  \n\n| Role | Primary Duties |\n|------|----------------|\n| **Recall Coordinator (QC Manager)** | Initiates recall, assembles RT, authorizes notifications, reports to senior leadership & regulators. |\n| **Quality Assurance (QA)** | Investigates root cause, conducts product testing, prepares technical recall documents. |\n| **Regulatory Affairs (RA)** | Interfaces with state cannabis board, USDA, FDA (if applicable); ensures compliance with all statutory requirements. |\n| **Production/Operations** | Isolates affected batch, stops further processing, secures inventory. |\n| **Distribution/Logistics** | Retrieves product from warehouses/retailers, arranges quarantine, updates traceability system. |\n| **Legal** | Reviews liability exposure, drafts public statements, handles consumer claims. |\n| **Public Relations (PR)** | Manages media outreach, social‑media messaging, and consumer FAQs. |\n| **Finance** | Tracks recall costs, insurance claims, and potential reimbursement. |\n| **IT/Traceability** | Generates batch trace reports, updates ERP/seed‑to‑sale system, logs all recall actions. |\n\n### 5. RECALL TRIGGER & INITIAL ASSESSMENT  \n\n| Trigger | Action (within 4 h) |\n|---------|-------------------|\n| **Consumer complaint** (adverse reaction, off‑spec product) | RC logs complaint, alerts QA. |\n| **Internal QC failure** (out‑of‑spec test, contamination) | QA initiates “Potential Recall” flag. |\n| **Regulatory notice** (inspection, sampling) | RA forwards notice to RC. |\n| **Third‑party notice** (retailer, distributor) | RC acknowledges receipt, begins assessment. |\n\n**Step 1 – Triage**  \n1. Verify authenticity of the trigger.  \n2. Identify **product identifier** (SKU, batch/lot number, production date, serial numbers).  \n3. Determine **potential health impact** (consult medical/clinical advisor if needed).  \n\n**Step 2 – Decision**  \n- If health risk **possible** → **Class I** recall.  \n- If risk **probable but not severe** → **Class II**.  \n- If risk **unlikely** → **Class III**.  \n\nRC obtains **approval** from senior leadership (VP of Operations) before public notification.\n\n### 6. RECALL PLAN DEVELOPMENT (within 8 h of decision)\n\n1. **Recall Scope** – list of affected SKUs, lot numbers, quantities\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1160 (160?1000) | Cost: $0.000000*",
      "duration": 12051,
      "grade": "F",
      "score": 42,
      "grading": {
        "accuracy": 13,
        "completeness": 6,
        "relevance": 11,
        "clarity_structure": 8,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Provides a structured recall SOP framework with clear roles and triggers",
        "Defines recall classes and outlines initial assessment and decision-making",
        "Action-oriented steps (triage, isolation, cross-functional team) are practical in general"
      ],
      "weaknesses": [
        "Not tailored to New York cannabis regulations; no references to OCM/CCB, 9 NYCRR Part 131, or 10 NYCRR Part 1004",
        "Omits the required 24-hour notification to OCM for recalls/adverse events and specific reporting content",
        "Lacks explicit recordkeeping requirements and retention periods mandated by NY",
        "Introduces potentially inapplicable agencies (USDA/FDA) and includes accessories not typically under cannabis recall scope",
        "Truncated and incomplete; recall plan development section stops mid-point",
        "Does not address seed-to-sale/traceability reporting requirements specific to NY"
      ],
      "feedback": "Well-structured but generic. To meet New York requirements, cite and align to OCM/CCB rules (9 NYCRR Part 131 for adult-use and 10 NYCRR Part 1004 for medical), include the 24-hour OCM notification for recalls/adverse events, specify recordkeeping and reporting details, and remove non-applicable federal references. Complete the SOP with NY-specific notification, retrieval, quarantine, destruction, effectiveness checks, and documentation steps.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "required",
        "must",
        "state",
        "fda",
        "epa",
        "agency",
        "board",
        "sop",
        "procedure",
        "standard",
        "operating",
        "documentation"
      ],
      "expectedAnswer": "**Summarizing recall SOP requirements** I need to provide a concise summary of creating a product recall SOP, specifically for New York cannabis regulations. It should include compliance with the Office of Cannabis Management (OCM) and Cannabis Control Board (CCB), referencing 9 NYCRR Part 131 for adult-use and 10 NYCRR Part 1004 for medical cannabis. The SOP must outline that licensees must have a recall plan, maintain records, and notify the OCM within 24 hours regarding any product recalls or adverse events.**Summarizing product recall SOP requirements** I need to create a concise summary for a Standard Operating Procedure (SOP) regarding product recalls, specifically relating to New York's cannabis regulations. The SOP must comply with rules from the Office of Cannabis Management (OCM) and the Cannabis Control Board (CCB), covering both adult-use and medical cannabis. For adult-use, it must reference 9 NYCRR Part 131, while medical cannabis should align with former DOH regulations. I believe it should include plan requirements, record maintenance, and timely notifications to the OCM."
    },
    {
      "questionNum": 4,
      "question": "What are the requirements for testing regular pre-rolls when I bought the raw material from a cultivator that already tested it?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Testing Requirements for Finished Pre‑Rolls (when the flower you received already has a COA)**  \n\n| Why you still need a new test | What must be tested on the finished‑roll | Typical acceptance limits* | Who performs it |\n|------------------------------|----------------------------------------------|----------------------------|-----------------|\n| **Product‑level variance** – grinding, blending, humidity control, and storage can change potency, moisture, and microbial load. | **Potency (THC, Δ‑9‑THC‑a, CBD, CBG, other cannabinoids)** – confirm that the labeled range (e.g., “≥ 18 % THC”) still holds after processing. | ± 10 % of the batch average (most states) | State‑licensed analytical lab |\n| **Microbiology** – the grinding step can introduce or amplify mold/yeast. | Total aerobic microbial count (TAMC), total yeast & mold count (TYMC), *Aspergillus* spp. (if required). | TAMC ≤ 10⁴ CFU/g; TYMC ≤ 10³ CFU/g; *Aspergillus* ≤ 10 CFU/g (varies by state). | State‑licensed lab |\n| **Pesticides & Residual Solvents** – the flower COA covers raw plant, but solvents used in extraction (if any) or cross‑contamination can appear in the final product. | Multi‑residue pesticide panel (≥ 200‑300 analytes) + any state‑specific “restricted‑use” list. | Below the state’s established **action limits** (often < 0.5 ppm for most pesticides). | State‑licensed lab |\n| **Heavy Metals** – grinding can expose metal particles from equipment. | Pb, As, Cd, Hg, Cr, Ni (often a 6‑metal panel). | ≤ 0.5 ppm (state‑specific). | State‑licensed lab |\n| **Mycotoxins** – especially for high‑moisture flower. | Aflatoxins (B₁, B₂, G₁, G₂) or a broader mycotoxin panel. | ≤ 20 ppb total aflatoxin (common limit). | State‑licensed lab |\n| **Moisture / Water Activity** – affects shelf life and mold risk. | Moisture content (dry weight %) and/or water activity (a_w). | ≤ 12 % moisture (typical for dry herb); a_w < 0.6. | In‑house external lab |\n| **Foreign Matter / Filament** – ensure no extraneous material from rolling papers or filters. | Visual inspection + particle count (optional). | Zero visible foreign objects. | In‑house QC (visual) + optional lab test. |\n| **Uniformity / Batch Consistency** | Test a statistically valid sub‑sample (e.g., 5–10 units from a 30‑unit batch) to demonstrate that every pre‑roll falls within the potency & microbial limits. | Same as potency and microbial limits above. | State‑licensed lab (or accredited internal lab). |\n\n\\*Limits shown are **representative**; each state (or jurisdiction) publishes its own “Action Limits” and “Maximum Residue Limits (MRLs)”. Always cross‑check the latest state‑specific cannabis testing regulations (e.g., California B3‑5, Oregon OR‑23‑018‑001, Colorado Rule 70‑100‑001, etc.).\n\n---\n\n### How to Use the Cultivator’s COA\n\n1. **Batch Traceability** – Verify that the COA is for the **exact lot** of flower you are using (same lot number, harvest date, and weight).  \n2. **COA Validity Window** – Many states require the COA to be no older than **30 days** before the finished‑product test date.  \n3. **Supplement, Don’t Replace** – The cultivator’s COA satisfies the **raw‑material** portion of the regulatory matrix, but you must still submit a **finished‑product** COA that includes the tests listed above.  \n4. **Documentation** – both\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1218 (218?1000) | Cost: $0.000000*",
      "duration": 6569,
      "grade": "D",
      "score": 44,
      "grading": {
        "accuracy": 10,
        "completeness": 7,
        "relevance": 8,
        "clarity_structure": 11,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Well-structured and easy to scan with a clear checklist-style format",
        "Highlights common post-processing risks (potency shift, micro, moisture) and QC practices",
        "Provides actionable steps for COA verification and batch traceability",
        "Covers a broad test panel that many jurisdictions consider for finished goods"
      ],
      "weaknesses": [
        "Not tailored to New York; omits NY OCM rules on lots, sampling, and mechanical processing exemptions",
        "Incorrectly implies a universal requirement to retest finished pre-rolls, contradicting NY’s allowance for non-infused pre-rolls from a single, compliant lot",
        "Cites generic/other-state limits and panels (e.g., pesticide MRLs, metals limits), which may not match NY action limits",
        "Includes potentially irrelevant tests for plain pre-rolls (e.g., residual solvents) and speculative rationales (metals from grinders) without NY basis",
        "Fails to address NY-specific requirements on homogeneity, no additives, and single-lot use; does not mention sampling rules",
        "Ends with an incomplete sentence, reducing clarity"
      ],
      "feedback": "The response is organized and offers general testing considerations, but it misses the New York-specific regulatory framework the question calls for. In NY, non-infused pre-rolls made solely from a single, already-compliant, tested flower lot and only mechanically processed can rely on the original COA, with specific lot/sampling documentation and no additives/blending. The answer incorrectly asserts a universal need for a new finished-product COA and relies on other states’ limits, which reduces accuracy and practical value for NY. To improve, cite NY OCM rules on mechanical processing exemptions, lot homogeneity, sampling requirements, and clearly state when existing flower COAs suffice versus when full finished-product testing is required.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "board",
        "standard",
        "documentation",
        "document",
        "record",
        "log",
        "testing",
        "test",
        "coa",
        "certificate"
      ],
      "expectedAnswer": "**Summarizing NY pre-roll testing requirements** I need to summarize the requirements for testing pre-rolls when the raw material was already tested by the cultivator. In New York, all final cannabis products must be tested by an independent lab before they can be sold. There are specific rules related to lots, sampling, and some exemptions for mechanical processing. It seems that for non-infused pre-rolls made from a compliant batch, existing compliance testing can suffice if the product is homogeneous with no additives.**Outlining NY testing regulations** I need to summarize the requirements for testing regular pre-rolls when the raw material was already tested by a cultivator in New York. I'll focus on NY regulations related to cannabis product testing. According to NY OCM rules, all final products must be tested by an independent lab before retail sale. There are specific rules for lots, sampling, and some exemptions for non-infused pre-rolls from a single lot that already have compliance testing. I'll clarify these points."
    },
    {
      "questionNum": 5,
      "question": "Can I make an infused pre-roll without retesting it if I am using already tested flower and concentrate?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most regulated markets you **must retest the finished pre‑roll** even if the flower and concentrate you used have already been certified. The act of blending, infusing, and rolling creates a new product with its own potency, uniformity, and possible contamination profile, all of which are required to be verified before the product can be sold or distributed.\n\n---\n\n## Why a new test is required\n\n| Reason | What changes when you make an infused pre‑roll? |\n|--------|-------------------------------------------------|\n| **Potency shift** | The final THC/CBD % is a weighted average of flower + concentrate plus any loss during processing. Small variations in mixing can produce batch‑to‑batch differences that must be documented. |\n| **Homogeneity** | Regulations (e.g., USDA‑FSMA, COA‑specific state rules) demand that each unit of a finished product fall within a specified potency range (often ±10 % of the label claim). Testing confirms that the roll‑up process achieved that uniformity. |\n| **Contaminant carry‑over** | Even though the inputs were clean, the **process** can introduce contaminants: metal particles from equipment, microbial growth from handling, or residual solvents if the concentrate was not fully purged. |\n| **Shelf‑life & stability** | Infused pre‑rolls may oxidize or degrade faster than the raw material. Stability testing (or at least a “post‑mix” potency check) is required for label expiration dates. |\n| **Regulatory compliance** | Most state/ provincial cannabis statutes (e.g., California’s BCC, Colorado’s MCR, Canada’s Cannabis Act) explicitly require a **finished‑product COA** for any product that leaves the manufacturing area. The COA must be generated from a sample taken after the final packaging step. |\n| **Liability & consumer safety** | A mislabeled potency claim can trigger recalls, fines, and legal exposure. Independent verification protects both the brand and the consumer. |\n\n---\n\n## When a “re‑test” might be waived (rare exceptions)\n\n| Situation | Typical jurisdictional stance | Practical notes |\n|-----------|------------------------------|-----------------|\n| **Batch‑size < 1 g** (e.g., single‑use “research” sample) | Some labs allow a “single‑use exemption” if the product never enters commerce. | Only for internal R&D; not for commercial sale. |\n| **Same‑day “in‑house” verification** | Some states allow a **“lot‑release”** test performed by an accredited in‑house lab, provided the lab holds a valid license and follows the state‑mandated sampling plan. | Still a test—just performed internally rather than sending out. |\n| **Pre‑approved formulation** | In a few jurisdictions, a manufacturer can submit a validated formulation (including mixing ratios, SOPs, and a one‑time full COA) and receive a “process exemption” for subsequent identical batches. | Requires prior approval, strict SOP control, and periodic audit. |\n\nIf none of the above apply to your operation, you must obtain a fresh COA for the finished pre‑roll.\n\n---\n\n## Practical workflow to keep testing burden low\n\n1. **Calculate target potency**  \n   - Use the known %THC/CBD of flower (F) and concentrate (C) and the desired final % (P).  \n   - Example: 0.5 g flower @ 18 % THC + 0.1 g concentrate @ 80 % THC → total THC = (0.5 g × 0.18)+(0.1 g × 0.80)=0.09 g+0.08 g=0.17 g.  \n   - Final weight = 0.6 g → THC% ≈ 28 % (or 280 mg per gram). Adjust ratios until you land in the label window.\n\n2. **Standardize the mixing process**  \n   - Use a calibrated balance (\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1214 (214?1000) | Cost: $0.000000*",
      "duration": 9131,
      "grade": "F",
      "score": 46,
      "grading": {
        "accuracy": 12,
        "completeness": 8,
        "relevance": 12,
        "clarity_structure": 9,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly states that finished infused pre-rolls generally require retesting",
        "Explains why finished-product testing is needed (potency, homogeneity, contamination)",
        "Provides a simple potency calculation example",
        "Structured and easy to skim at a high level"
      ],
      "weaknesses": [
        "Fails to address New York–specific rules or cite 9 NYCRR Part 130 and OCM requirements",
        "Includes inaccurate/irrelevant regulatory references (e.g., USDA-FSMA, California BCC instead of DCC, Canada) for this context",
        "Suggests exceptions (single-use exemption, in-house lot-release, process exemptions) that are misleading or not applicable to NY adult-use",
        "Asserts stability testing is required in a way that is not supported by NY regulations",
        "Omits key NY specifics: classification of infused pre-rolls as manufactured cannabis products and final COA requirements, analyte panels (potency, contaminants, residual solvents if applicable), homogeneity, and labeling elements (total THC per serving/package)",
        "Contains extraneous/truncated content and artifacts, reducing professionalism"
      ],
      "feedback": "Your answer correctly conveys the general principle that infused pre-rolls typically require finished-product testing, but it does not meet the expected New York–specific standard. To improve, cite New York OCM regulations (9 NYCRR Part 130) and clarify that infused pre-rolls are manufactured cannabis products requiring a final COA covering potency, homogeneity, contaminants (microbials, heavy metals), and residual solvents when applicable. Address total THC per serving/package and any sampling/compositing allowances under NY rules. Remove inaccurate or non-NY references and avoid speculative exemptions not supported by NY OCM.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "epa",
        "standard",
        "testing",
        "test",
        "coa"
      ],
      "expectedAnswer": "**Summarizing New York regulations** I need to create a concise summary about New York regulations on retesting infused pre-rolls when using previously tested flower and concentrates. It seems that most states generally require finished product testing, even if the inputs were already tested. The New York Office of Cannabis Management has specific rules for this, including guidelines for adult-use laboratories under 9 NYCRR Part 130. For infused pre-rolls, if they’re classified as “manufactured products,” additional testing may be required, but non-infused pre-rolls might not need full testing if there’s no further processing.**Clarifying infused product testing** When infused with concentrates like kief or hash oil, the product is classified as a \"cannabis product.\" This means it needs potency and contaminant testing for the final form. Testing should cover aspects such as homogeneity, heavy metals, and residual solvents, especially if hydrocarbon extracts are involved. Additionally, total THC per serving or pack and net weight will also require attention. There could be some allowances for compositing during this testing process, but I need to confirm that detail."
    },
    {
      "questionNum": 6,
      "question": "Do I have to show harvest date or production date on infused products?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:**  \nFor most U.S. state cannabis‑infused‑product regulations you are required to list a **production/packaging (manufacturing) date**, not the harvest date of the raw cannabis. The harvest date is generally only required on flower‑type products.\n\nBelow is a quick “what‑to‑show” guide for the major states that have a mature infused‑product market. If you operate in another jurisdiction, the same principle usually applies – the rule is “date of manufacture/packaging” (or “date of bottling”) rather than “harvest date.”\n\n---\n\n## 1. Why the production date matters\n\n| Reason | Explanation |\n|--------|-------------|\n| **Shelf‑life & potency** | Infused products can degrade (e.g., oxidation of THC‑a to THC, loss of terpenes). A production date lets consumers know how fresh the product is and when it should be used by. |\n| **Recall & traceability** | A production date tied to a batch/lot number makes it easy to pull a specific batch if a lab test fails. |\n| **Compliance** | Most state statutes explicitly require a “date of manufacture/packaging” on edible, tincture, topical, and vape‑oil containers. |\n\n---\n\n## 2. State‑by‑state snapshot (2024‑2025)\n\n| State | Required date(s) on infused products | Typical label wording | Harvest date required? |\n|-------|--------------------------------------|----------------------|------------------------|\n| **California** (CSC Act, B2) | **Date of packaging** (MM/DD/YYYY) and **Expiration date** (if applicable) | “Packaged: 04/12/2025” | **No** – only required on flower. |\n| **Colorado** (Rule 1500‑7) | **Manufacturing/Production date** (MM/DD/YYYY) and **Expiration date** (if > 30 days shelf life) | “Manufactured: 04/12/2025” | **No** |\n| **Washington** (RCW 70.155.340) | **Date of manufacture** (MM/DD/YYYY) and **Expiration date** (if > 30 days) | “Manufacture Date: 04/12/2025” | **No** |\n| **Oregon** (OR‑CTR 2022) | **Date of packaging** (MM/DD/YYYY) and **Expiration date** (if > 30 days) | “Packaged on: 04/12/2025” | **No** |\n| **Michigan** (MI‑RC 2021) | **Production date** (MM/DD/YYYY) and **Expiration date** (if > 30 days) | “Production Date: 04/12/2025” | **No** |\n| **Arizona** (A.R.S. § 36‑2913) | **Manufacturing date** (MM/DD/YYYY) and **Expiration date** (if > 30 days) | “Manufactured: 04/12/2025” | **No** |\n| **Massachusetts** (310 CMR 7.04) | **Date of production** (MM/DD/YYYY) and **Expiration date** (if > 30 days) | “Production Date: 04\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1165 (165?1000) | Cost: $0.000000*",
      "duration": 9133,
      "grade": "F",
      "score": 32,
      "grading": {
        "accuracy": 8,
        "completeness": 5,
        "relevance": 8,
        "clarity_structure": 8,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Gives a clear general principle that infused products typically require a production/packaging date rather than a harvest date",
        "Explains practical reasons (shelf life, recalls, compliance) for showing a production date",
        "Organized with headings and an attempt at a quick-reference format"
      ],
      "weaknesses": [
        "Does not address New York-specific rules, which are central to the expected answer",
        "Contains likely incorrect or irrelevant legal citations for multiple states",
        "Truncated/incomplete state table, undermining clarity and usefulness",
        "Omits key label elements required in New York (processor name, license number, lot/batch, cannabinoid content, expiration/best-by, storage conditions)",
        "Does not distinguish between adult-use and medical requirements as requested"
      ],
      "feedback": "Start by focusing on New York’s OCM adult-use regulations and, where relevant, medical rules. Clearly state whether infused products require a production/packaging date versus harvest date in NY and list required label elements (processor name, license number, lot/batch number, cannabinoid content, expiration/best-by date, storage conditions). Avoid broad multi-state summaries unless accurate and necessary; several cited statutes appear incorrect. Provide precise New York citations and note any adult-use vs. medical differences.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "required",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "massachusetts",
        "michigan",
        "illinois",
        "federal",
        "fda",
        "standard",
        "record"
      ],
      "expectedAnswer": "**Summarizing product labeling rules** I need to summarize New York's regulations around showing harvest or production dates on infused products. It falls under product testing and compliance, particularly the adult-use cannabis regulations from the Office of Cannabis Management. Key details from the 2023/2024 regulations include requirements for the label such as the processor's name, license number, lot number, THC/CBD content, expiration date, and storage conditions. I’ll ensure to capture all critical facts and state-specific information clearly.**Considering medical vs adult-use differences** I'm thinking about the differences between medical and adult-use products. One key aspect I might need to consider is the requirement for a production or packaging date. This could help in understanding the regulations that apply to each category. It's essential to distinguish them correctly, ensuring I'm clear about any specific requirements or guidelines related to these differences. Overall, I'll keep this in mind as I explore further."
    },
    {
      "questionNum": 7,
      "question": "Are there different rules for various types of infused products related to this same question?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "Below is a quick‑reference guide that outlines how the major regulatory frameworks (U.S. state‑level, Canada, and the European Union) treat the most common categories of infused cannabis products. Because each jurisdiction writes its own, the “rules” you’ll need to follow can differ dramatically from one product type to another — even within the same state or province.\n\n---\n\n## 1. Product‑type overview\n\n| Product type | Typical THC/CBD limits | Packaging & child‑resistance | Labeling requirements | Testing & potency | Production/processing controls |\n|--------------|-----------------------|------------------------------|-----------------------|-------------------|---------------------------------|\n| **Edibles (solid foods – gummies, chocolates, baked goods, etc.)** | • State‑specific per‑serving limits (e.g., 10 mg THC/serving in most U.S. states)  <br>• Total package limit (e.g., 100 mg THC) | Must be opaque, resealable, and child‑proof. No “candy‑like” appearances in many jurisdictions. | • Potency per serving & per package <br>• Ingredient list, allergens, warnings, QR code for lab results <br>• No health claims Mandatory batch testing for cannabinoids, pesticides, residual solvents, microbiology, and mycotoxins. | • Food‑grade manufacturing (GMP/FSMA in the U.S.) <br>• Separate from non‑food cannabis handling areas. |\n| **Beverages (sodas, teas, coffees, alcoholic blends)** | Similar per‑serving limits as edibles (often 5‑10 mg THC/serving) | Child‑resistant caps; opaque or “non‑appealing to children” containers. | Same as edibles + “Do not operate machinery” warning; sometimes a specific “Do not consume if pregnant” statement. | Batch testing for cannabinoids, heavy metals, microbiology, and, if alcoholic, compliance with liquor‑board testing. | Food‑grade production, sanitary bottling lines, and, where applicable, liquor‑board licensing. |\n| **Tinctures & sub‑lingual oils** | No per‑serving cap in many states, but total package limit (e.g., 100 mg THC) applies. Some states impose a 10 mg “dose” definition for labeling. | Dropper bottles must be child‑proof; opaque or amber glass to protect from UV. | Potency per mL, serving size, “use under 21”, “do not drive”, allergen warnings. | Full cannabinoid profile + residual solvents, microbial, heavy‑metal testing. | Must be produced in a “pharmaceutical‑grade” environment (ISO 22716/ GMP). |\n| **Topicals (creams, balms, transdermal patches)** | Generally **no THC limit** because they are non‑ingestible, but many states still cap THC at 0.3 % Δ⁹‑THC for “non‑psychoactive” products. | Child‑resistant not universally required, but many states encourage it. | Clear labeling of THC/CBD content, “for external use only”, “keep out of reach of children”. | testing suite as tinctures (cannabinoids, contaminants). | Must comply with cosmetics or pharmaceutical regulations (e.g., EU Cosmetics Regulation, US FDA “Cosmetic” rules). |\n| **Concentrates (shatter, wax, vape cartridges, dabs)** | Some states limit total THC per package (e.g., 1 g ≤ 100 mg THC). Others ban certain extraction methods (e.g., solvent‑based). | Vape cartridges require child‑proof, tamper‑evident caps; opaque packaging is common. | Potency, batch number, “do not vape while pregnant”, “keep away from children\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1167 (167?1000) | Cost: $0.000000*",
      "duration": 7401,
      "grade": "B",
      "score": 85.33333333333334,
      "grading": {
        "length": "Pass",
        "keywords": "14/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "1/5 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "regulation",
        "regulatory",
        "requirement",
        "mandatory",
        "must",
        "state",
        "federal",
        "standard",
        "testing",
        "test",
        "lab",
        "potency",
        "pesticide",
        "microbial",
        "mycotoxin"
      ],
      "expectedAnswer": ""
    },
    {
      "questionNum": 8,
      "question": "What are the requirements in my state for me to be able to introduce or infuse cannabis or botanical-derived terpenes into my products?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "I can give you a solid overview, but the exact requirements differ dramatically from state to state. Could you let me know which state you’re operating in? Once I know that, I can outline the typical licensing, formulation, testing, labeling, and packaging rules that apply there, and point you to the relevant regulatory agency’s guidance.  \n\n*(If you prefer a generic checklist instead, just let me know and I’ll provide that as well.)*\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 454 (221?233) | Cost: $0.000000*",
      "duration": 6159,
      "grade": "F",
      "score": 27,
      "grading": {
        "accuracy": 12,
        "completeness": 1,
        "relevance": 4,
        "clarity_structure": 9,
        "practical_value": 1,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Acknowledges that requirements vary by state",
        "Polite and concise request for clarification"
      ],
      "weaknesses": [
        "Does not answer the question for New York as required",
        "Omits key NY-specific rules on terpenes, additives, and testing",
        "No mention of OCM/CRTA, GRAS/food-grade requirements, or labeling",
        "No guidance on flavor restrictions or bans on synthetic cannabinoids",
        "Includes irrelevant agent/meta footer text"
      ],
      "feedback": "The response fails to address the New York-specific terpene infusion rules requested. Provide a 100–200 word summary citing NY OCM/CRTA adult-use regulations, including: allowance for naturally occurring cannabis- or botanical-derived terpenes if food-grade/GRAS; prohibition on synthetic cannabinoids and harmful additives; restrictions on flavoring appealing to minors; excipient requirements; ingredient panel listing with common name and source; and relevant testing/labeling obligations. Avoid meta/footer text and deliver specific, actionable compliance details.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "michigan",
        "fda",
        "epa",
        "agency",
        "board",
        "sop"
      ],
      "expectedAnswer": "**Summarizing cannabis compliance requirements** I need to create a concise summary for a question about New York's cannabis infusion regulations. The focus is on product testing and infusion rules, especially concerning terpenes. The summary should cover the main conclusion, key requirements, regulatory details, and state-specific info, without any commentary. I'll ensure it addresses the NY OCM/CRTA adult-use regulations, noting the restrictions on flavor additives, terpenes, synthetic cannabinoids, and other potentially harmful additives. The goal is 100-200 words.**Clarifying terpene regulations in NY** New York permits \"naturally occurring terpenes\" from cannabis or botanical sources as long as they meet certain criteria. They need to be food-grade and generally recognized as safe (GRAS). Additionally, these terpenes cannot be used for flavoring products aimed at minors. It's essential to list them on the ingredient panel with their common or usual name and source. There are also specific excipient requirements to consider, which will be crucial for compliance."
    },
    {
      "questionNum": 9,
      "question": "Does this vary for different products?",
      "category": "product-testing-infusion-rules",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "The answer depends on which aspect you’re referring toe.g., **regulatory limits, pricing, labeling requirements, cultivation practices, or market demand** can all differ from one cannabis product type to another (flower, concentrates, edibles, topicals, etc.).  \n\nCould you let me know which specific factor or product category you have in mind? That way I can give you a precise, tailored answer.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 342 (158?184) | Cost: $0.000000*",
      "duration": 2603,
      "grade": "F",
      "score": 55.666666666666664,
      "grading": {
        "length": "Pass",
        "keywords": "4/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "0/2 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "federal",
        "epa",
        "standard",
        "testing",
        "test",
        "lab",
        "potency",
        "pesticide"
      ],
      "expectedAnswer": ""
    },
    {
      "questionNum": 10,
      "question": "What are the labeling requirements for packaged concentrates?",
      "category": "labeling-packaging-compliance",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Labeling Requirements for Packaged Cannabis Concentrates**  \n*(U.S.‑focused, with brief notes on Canada and the EU for reference)*  \n\n| Requirement | What to Include on the Label | Typical Placement / Format | Key Sources |\n|-------------|------------------------------|----------------------------|-------------|\n| **Product Identity** | • Common name (e.g., “THC Infused Live‑Rosin”)  <br>• Sub‑category (shatter, wax, crumble, distillate, etc.) | Prominent, top‑center | State cannabis‑board regulations (e.g., CA BSC‑001, CO Reg‑70-13) |\n| **Net Quantity** | • Weight in grams (or milliliters for liquids) <br>• Rounded to the nearest 0.01 g (or 0.1 ml) | Bottom‑right, same font size as other mandatory info | 21 CFR 101 (FDA), state statutes |\n| **Potency & Cannabinoid Profile** | • Total THC % (Δ⁹‑THC) and CBD % (if present) <br>• Major minor cannabinoids (CBG, CBN, THCV) if >0.1 % <br>• Terpene content optional but encouraged | Usually a “Potency” box; may be a QR‑code link to COA | State lab‑report requirements (e.g., WA RCW 69.55.450) |\n| **Batch / Lot Number** | • Unique identifier for traceability (e.g., “Batch 2024‑03‑15‑A1”) | Bottom‑left or near QR code | State tracking rules (Metrc, BioTrack) |\n| **Production/Expiration Dates** | • Manufacture/Packaging date <br>• Expiration or “Best‑by” date (often 12 months for concentrates) | Bottom‑center | State shelf‑life guidance (e.g., OR Rule 6‑205‑100) |\n| **Warning Statements** | • “Contains Δ⁹‑THC. May cause impairment.” <br>• “Keep out of reach of children and pets. Store in a child‑resistant container.” <br>• “Not for use by persons under 21.” <br>• “Do not operate a vehicle or machinery while using.” | Prominent, usually in a bordered “WARNING” box, font size ≥ 8 pt | Federal (FDA) *Cannabis‑Derived Products* guidance; state‑specific warnings (e.g., CO Reg‑70‑13‑105) |\n| **Allergen / Ingredient Disclosure** | • For concentrates, list any added carriers (e.g., MCT oil, terpenes, flavoring agents) <br>• State if product is “solvent‑free” or “CO₂‑extracted” | Small print under “Ingredients” or “Additives” | State “Ingredient” rules (e.g., MA Reg‑105‑C) |\n| **THC/CBD Dosing Guidance** | • Suggested serving size (e.g., “One dab ≈ 5 mg THC”) <br>• Maximum daily dose recommendation (optional but encouraged) | Adjacent to potency info or on a separate “Dosage” panel | Best‑practice guidance from state health departments (e.g., WA Public Health) |\n| **QR Code / Digital COA Link** | • Directs to the full laboratory COA (potency, pesticides, heavy metals, microbial) <br>• Must be scannable with a smartphone | Bottom‑right corner; size ≥ 0.5 in.² | Many states require electronic COA access (e.g., AK Reg‑31‑100) |\n| **Child‑Resistant Packaging (CRP) Symbol** | • Universal CRP icon (♁) and statement “Child‑Resistant” | Front of package, near the warning box | Federal Poison Prevention Packaging Act (PPPA) as adopted by states |\n| **State‑Specific License/Permit Numbers** | • License number of the cultivator, processor, and/or retailer | Small font near batch number | State licensing board (e\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1169 (169?1000) | Cost: $0.000000*",
      "duration": 11362,
      "grade": "B",
      "score": 85.58333333333333,
      "grading": {
        "length": "Pass",
        "keywords": "11/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "3/4 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "compliance",
        "requirement",
        "required",
        "mandatory",
        "state",
        "federal",
        "fda",
        "board",
        "standard",
        "coa",
        "lab",
        "potency",
        "quality",
        "control",
        "batch"
      ],
      "expectedAnswer": "**Summarizing labeling requirements** I need to create a concise summary about labeling requirements for cannabis concentrates in New York. This includes outlining specific regulations from the Cannabis Control Board, focusing on key facts like product identity, net weight, cannabinoid content, and serving sizes. Regulations state that terpenes and ingredients must be listed, and there are additional potency warnings for concentrates. I should ensure I cover essential details like manufacturing and expiration dates while adhering to state-specific information.**Recapping New York's PDP requirements** In New York, I need to remember that the principal display panel (PDP) must include several key elements. This includes the brand name, the product form, and both the amount per serving and the total amount. Additionally, the net weight needs to be displayed in metric units, along with the potency information. It’s crucial to get these details right when summarizing labeling requirements for products in New York.**Summarizing labeling requirements** I need to produce a concise summary about labeling requirements for packaged concentrates in New York. I’ll outline the specific cannabis packaging and labeling rules, particularly from 9 NYCRR Part 128. Key details will include product identity, net weight, cannabinoid content (total THC and CBD), serving size, and lot/batch information. Instructions regarding potency and usage will also be important. I want to ensure I capture criti..."
    },
    {
      "questionNum": 11,
      "question": "Is my edibles packaging compliant to national, state, and local regulations?",
      "category": "labeling-packaging-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "I can help you evaluate whether your edible‑product packaging meets the various layers of regulation, but the answer depends on a handful of specifics (your jurisdiction, the product’s THC/CBD content, packaging design, labeling text, etc.).  \n\nBelow is a quick checklist of the most common national, state, and local requirements for cannabis‑edible packaging in the U.S. — use it as a starting point and let me know the details of your product so I can run a more precise compliance review (or I can route you to our **Regulatory‑Compliance Specialist** agent).\n\n---\n\n## 1. Federal (national) considerations  \n| Requirement | What to check | Typical standard |\n|-------------|---------------|------------------|\n| **Child‑Resistant (CR) packaging** | Must meet ASTM F2513‑15 or ISO 11625‑1 (CR) testing. | Two‑step opening mechanism, “push‑down‑and‑turn” etc. |\n| **Tamper‑evident seal** | Seal must show visible damage if opened. | Breakable film, shrink band, or foil seal. |\n| **Unambiguous labeling** | No false or misleading health claims; must include universal symbols (e.g., cannabis leaf, THC/CBD %). | “This product contains X mg THC per serving.” |\n| **Packaging material** | Must be non‑toxic, resistant to oil/heat, and not leach chemicals. | FDA‑approved food‑grade plastics, glass, or metal. |\n| **No branding that appeals to minors** | No cartoon characters, bright colors, or candy‑like shapes. | Plain, muted colors, adult‑oriented design. |\n| **Net weight / dosage** | Net weight must be accurate within ±5 % (or state‑specific tolerance). | Clearly printed on front. |\n\n> **Note:** The federal U.S. Food & Drug Administration (FDA) does not yet have a comprehensive cannabis‑edible rulebook, but it enforces the above general food‑safety and labeling standards.  \n\n---\n\n## 2. State‑level requirements (example for a few major markets)  \n| State | Key packaging rules |\n|-------|----------------------|\n| **California** (BSC) | • Child‑Resistant, tamper‑evident, opaque. <br>• THC per package ≤ 100 mg (unless licensed for higher). <br>• Mandatory “THC per serving” & “Total THC”. <br>• QR code linking to product testing results. |\n| **Colorado** (MCO) | • CR + tamper‑evident. <br>• No “candy” appearance; packaging must be “adult‑only”. <br>• “Contains X mg THC per serving” on front. <br>• State‑approved warning statements (e.g., “Keep out of reach of children”). |\n| **Washington** (L&C) | • CR & child‑unappealing design. <br>• THC limit per package: 100 mg (or 10 mg per serving max). <br>• Mandatory potency, batch, and testing QR code. |\n| **Oregon** (MCR) | • CR, tamper‑evident, opaque. <br>• THC ≤ 100 mg per package (unless “high‑potency” license). <br>• Clear serving size & potency labeling. |\n| **Illinois** (Medical & Adult‑Use) | • CR + tamper‑evident. <br>• “Contains X mg THC per serving” (max 10 mg per serving). <br>• Mandatory state warning icons (e.g., “Do not operate a vehicle”). |\n\n*Every state also has its own **testing‑result QR‑code** requirement and often a **state‑approved symbol** that must appear on the front of the package.*  \n\n---\n\n## 3. Local (\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1166 (166?1000) | Cost: $0.000000*",
      "duration": 8532,
      "grade": "B",
      "score": 80.66666666666666,
      "grading": {
        "length": "Pass",
        "keywords": "10/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "3/5 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "requirement",
        "required",
        "must",
        "state",
        "federal",
        "epa",
        "board",
        "metrc",
        "standard",
        "testing",
        "test",
        "certificate",
        "lab"
      ],
      "expectedAnswer": "**Researching packaging compliance** I need to create a summary addressing whether edibles packaging is compliant with regulations in New York. I'll focus on compliance requirements for cannabis edible packaging, highlighting important aspects like child-resistant features, tamper-evident seals, and keeping the packaging opaque. New York's OCM regulations mandate that packaging should not appeal to those under 21 and may include restrictions on bright colors. I'll note that recent litigation in 2023 led to updates in packaging rules, emphasizing the importance of adhering to these standards.**Summarizing packaging requirements** For 2024 in New York, packaging for cannabis edibles needs to meet several crucial requirements. It must be child-resistant and tamper-evident, and also not be misleading or appealing to youth. Essential information includes the universal THC symbol, the amount of THC per serving as well as the total, serving size, ingredients, allergens according to FDA rules, and nutrition facts. Making sure all these elements are present is vital for compliance!**Summarizing packaging compliance** I need to provide a summary about edibles packaging regulations in New York to answer the question about compliance with national, state, and local standards. Specifically, I should mention that packaging must be child-resistant, tamper-evident, opaque, and not appealing to children, and it must adhere to plain packaging rules. I also recall recent updates from the New Yo..."
    },
    {
      "questionNum": 12,
      "question": "When is childproof packaging required for certain cannabis products?",
      "category": "labeling-packaging-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Child‑proof (child‑resistant) packaging is required whenever a cannabis product could be accessed or ingested by a child.**  The exact trigger points vary by jurisdiction, but the common themes are the same across the U.S. states that have legal markets and in Canada. Below is a quick‑reference guide you can use when you’re planning product lines, labeling, or compliance checks.\n\n---\n\n## 1. U.S. State‑level Rules (most common)\n\n| Product Type | Typical THC/ CBD Threshold | When Child‑Resistant Packaging Is Required* |\n|--------------|---------------------------|--------------------------------------------|\n| **Edibles (gummies, chocolates, baked goods, beverages, etc.)** | Anycontaining edible (even < 0.1 % THC) | **Always** – must be in a child‑resistant, tamper‑evident container. |\n| **Concentrates (shatter, wax, live resin, vape cartridges, dabs, etc.)** | Any product with THC ≥ 0.1 % (most states treat all concentrates as “high‑potency”) | **Always** – child‑resistant, often with a “hard‑to‑open” cap or resealable pouch. |\n| **Tinctures / Sublingual oils** | Any THC ≥ 0.1 % (most states) | **Always** – child‑resistant dropper bottle or sealed pouch. |\n| **Topicals (creams, balms, transdermal patches)** | Any THC ≥ 0.1 % | **Usually required** – many states treat topicals like edibles; check the specific state. |\n| **Dried flower / pre‑rolled joints** | No THC threshold – all flower is covered | **Required** for *retail‑ready* packaging (e.g., sealed, opaque, child‑resistant bags). Bulk flower sold to other licensees may be exempt. |\n| **Infused beverages (non‑edible liquids)** | Any THC ≥ 0.1 % | **Always** – child‑resistant bottle or pouch. |\n| **Seeds & clones** | Generally exempt (no THC) | **Not required** unless the product is marketed with a THC claim. |\n| **Low‑THC “hemp‑derived” (≤ 0.3 % THC)** | ≤ 0.3 % THC (federally hemp) | **Usually exempt** in most states, but some states child‑resistant packaging for any product with a cannabis claim. |\n\n\\* *“Child‑resistant”* is defined by the state’s adoption of **ASTM F963‑17** (Standard Consumer Safety Specification for Child‑Resistant Packages) or the equivalent ISO 11625 standard. The packaging must also be **tamper‑evident**.\n\n### Quick State Snapshots\n\n| State | Key Requirement |\n|-------|-----------------|\n| **California** – Bureau of Cannabis Control (BCC) | All *ingestible* products, concentrates, tinctures, and packaged flower must meet **ASTM F963** or **ISO 11625**. |\n| **Colorado** – Marijuana Enforcement Division (MED) | **Child‑Resistant Packaging (CRP)** mandatory for edibles, concentrates, tinctures, topicals, and packaged flower. |\n| **Washington** – Liquor and Cannabis Board (LCB) | CRP required for **any product containing THC** that is sold in a retail‑ready container. |\n| **Oregon** – Oregon Liquor Control Commission (OLCC) | CR required for *all* THC‑containing products, including low‑THC edibles (< 5 mg THC). |\n| **Michigan**\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1162 (162?1000) | Cost: $0.000000*",
      "duration": 8105,
      "grade": "F",
      "score": 33,
      "grading": {
        "accuracy": 7,
        "completeness": 5,
        "relevance": 8,
        "clarity_structure": 9,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Provides a general principle that cannabis products need child-resistant, tamper-evident packaging",
        "Organizes content by product type for easier reading",
        "Acknowledges jurisdictional variation and the need to check state rules"
      ],
      "weaknesses": [
        "Does not address New York-specific requirements or cite 9 NYCRR Part 128 as expected",
        "Fails to mention the resealable child-resistant requirement for multi-serving edibles",
        "Misstates standards (uses ASTM F963 and ISO 11625, which are not the correct child-resistant packaging standards; should reference PPPA 16 CFR 1700.15/.20 and ISO 8317 where applicable)",
        "Includes outdated regulator names (e.g., California BCC; now DCC) and inaccurate THC thresholds",
        "Overgeneralizes and provides potentially misleading exemptions (e.g., seeds/clones, hemp) without state-specific caveats",
        "State snapshot is incomplete/truncated and not tied to the question’s NY focus"
      ],
      "feedback": "The answer is broadly framed and organized but misses the New York-specific requirements the question expects. It should state that in NY, all adult-use cannabis products must be sold in child-resistant and tamper-evident packaging consistent with the Poison Prevention Packaging Act (16 CFR 1700.15/.20) per 9 NYCRR Part 128, and that multi-serving edible packages must be resealable and remain child-resistant after opening. Remove incorrect standards (ASTM F963, ISO 11625), update regulator references, and focus on NY OCM rules with citations and clear triggers for when child-resistant packaging is required.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "massachusetts",
        "illinois",
        "federal",
        "standard",
        "lab",
        "lot",
        "edible"
      ],
      "expectedAnswer": "**Summarizing childproof packaging regulations in NY** I need to gather a concise summary regarding when childproof packaging is required for certain cannabis products in New York. I'll focus on key requirements, regulatory details, and state-specific information relating to adult-use packaging standards set by the Office of Cannabis Management (OCM). Apparently, packaging must be child-resistant and tamper-evident for all cannabis products, aligned with the Poison Prevention Packaging Act. I'll reference the relevant sections from 9 NYCRR Part 128 as well.**Explaining multi-serving edible packaging requirements** I need to clarify that packaging for multi-serving edibles must be resealable while still maintaining its child-resistant properties even after being opened. This is crucial to ensure ongoing safety after the product has been accessed, so it effectively prevents children from easily getting to the contents. It’s an important aspect to keep in mind when discussing childproof packaging regulations in the context of food safety and compliance.**Summarizing childproof packaging regulations** I need to create a concise summary about when childproof packaging is necessary for certain cannabis products in New York. The summary must include key requirements, critical regulatory details, and state-specific information related to adult-use packaging standards from the Office of Cannabis Management (OCM). New York mandates child-resistant and tamper-evident packaging for all c..."
    },
    {
      "questionNum": 13,
      "question": "Can I use leftover packaging labels from last month if they’re still accurate?",
      "category": "labeling-packaging-compliance",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 242,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "compliance",
      "agentMatch": false
    },
    {
      "questionNum": 14,
      "question": "How potent can our edibles be?",
      "category": "edibles-potency-formulation",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 52,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "formulation",
      "agentMatch": false
    },
    {
      "questionNum": 15,
      "question": "Can we do 100 or 200 mg packages?",
      "category": "edibles-potency-formulation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "**Short answer:** Yes, you can sell cannabis products in 100 mg or 200 mg packages in most states, but you must follow each jurisdiction’s specific packaging, labeling, and dosage‑limit rules.\n\n---\n\n## 1️⃣ Key regulatory checkpoints\n\n| Category | What to check | Typical limits (U.S.) |\n|----------|---------------|-----------------------|\n| **Edibles (infused foods, beverages, gummies, etc.)** | • Maximum THC per package<br>• Required child‑resistant & tamper‑evident packaging<br>• Mandatory potency labeling (mg per serving & total) | 10 mg THC per serving is the norm; many states cap **total package potency at 100 mg** (e.g., CA, CO, WA). Some allow up to **200 mg** if the product is marketed as a “single‑dose” item (e.g., CO’s 100 mg “single‑dose” edibles). |\n| **Tinctures & oils** | • Total THC per container<br>• Drop‑size serving guidance | Common caps: **100 mg per 30 ml bottle** (CA), **200 mg per 30 ml** (CO). |\n| **Capsules & softgels** | • Same per‑package limits as edibles | Usually 100 mg max per package; 200 mg may be allowed if each capsule is ≤10 mg. |\n| **Topicals** | • No universal THC limit, but many states still require potency labeling | Packaging can be larger, but still must be child‑resistant if the product contains THC. |\n| **Concentrates (shatter, wax, cartridges)** | • Often limited by **weight** (e.g., 1 g) rather than mg THC | If you’re selling pre‑measured “dose” cartridges, you can label them as 100 mg or 200 mg THC, but the container size must stay within weight limits. |\n\n> **Bottom line:** 100 mg packages are universally permissible; 200 mg packages are allowed in a subset of states (CO, WA, MA, etc.) and often only for “single‑dose” formats.\n\n---\n\n## 2️⃣ Must‑have packaging elements (most states)\n\n1. **Child‑Resistant** – Must meet ASTM F2516‑15 or equivalent.\n2. **Tamper‑Evident** – Seal or band that shows if opened.\n3. **Universal Symbol** – Cannabis leaf with a warning “THC” label.\n4. **Potency Statement** – Total THC (mg) and per‑serving amount.\n5. **Ingredient List** – Full list, including allergens.\n6. **Batch/Lot Number & Expiration Date**.\n7. **Warning Statements** – E.g., “Not for use by persons under 21,” “May cause impairment,” “Keep out of reach of children and pets.”\n8. **State‑Specific QR Code/Track‑and‑Trace** – Required in most regulated markets.\n\n---\n\n## 3️⃣ Steps to launch a 100 mg / 200 mg line\n\n1. **Identify target states** – Map where 200 mg packages are legal.\n2. **Confirm product category** – Edible, tincture, capsule, etc. (limits differ).\n3. **Work with a certified packaging supplier** – Must meet child‑resistant & tamper‑evident specs.\n4. **Develop a label template** – Include all mandatory fields; run it through the state’s label‑approval portal (e.g., California’s CANNABIS TRACKING SYSTEM, Colorado’s METRC).\n5. **Run a potency test** – Ensure each batch hits the exact 100 mg or 200 mg total THC target (±5 % variance is typical).\n6. **Submit the package for state approval** – Some states require a pre‑market package review before the product can be sold.\n7. **Update POS & inventory systems** – Tag each SKU with the correct mg potency for compliance reporting.\n\n---\n\n## 4️⃣ Common pitfalls to avoid\n\n| Pitfall | Why it matters\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1162 (162?1000) | Cost: $0.000000*",
      "duration": 15189,
      "grade": "F",
      "score": 49,
      "grading": {
        "accuracy": 7,
        "completeness": 13,
        "relevance": 14,
        "clarity_structure": 8,
        "practical_value": 7,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Acknowledges that allowable package potency depends on jurisdiction",
        "Notes common adult-use norms (10 mg/serving; 100 mg/package) and key packaging/labeling elements",
        "Provides actionable steps for product launch and compliance workflow"
      ],
      "weaknesses": [
        "Incorrectly claims 200 mg packages are allowed in most states and lists incorrect state examples (e.g., CO, WA, MA)",
        "Provides wrong limits for tinctures/oils (e.g., CA typically allows up to 1000 mg/package for adult-use tinctures, not 100 mg/30 ml)",
        "Misstates standards and processes (ASTM citation incorrect; CA does not have a label-approval portal; METRC is track-and-trace, not label approval)",
        "Oversimplifies or misstates universal symbol requirements and QR code use (state-specific, not universal)",
        "Omits key requirements highlighted in the expected answer such as homogeneity, variance tolerances, nutrition facts, and net weight",
        "Section is truncated (“Common pitfalls”), and includes off-topic categories (topicals, concentrates) diluting focus on edibles"
      ],
      "feedback": "The answer is well-structured and action-oriented but contains several factual inaccuracies and overgeneralizations. Most adult-use states cap edibles at 10 mg THC/serving and 100 mg THC per package; 200 mg packages are generally limited to certain medical markets and are not allowed in WA, MA, or CO adult-use. The tincture limits cited for CA/CO are incorrect, and the ASTM/label-approval references are inaccurate. Refocus on edibles, correct the state examples, and add key compliance elements emphasized in the expected answer (serving size, homogeneity, variance, testing protocols, universal symbol specifics, nutrition facts, net weight). Avoid blanket statements like “most states” for 200 mg and provide state-by-state validation or clearly indicate variability.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "epa",
        "board",
        "standard",
        "test",
        "lab",
        "potency",
        "control",
        "batch"
      ],
      "expectedAnswer": "**Summarizing cannabis edibles potency** I need to create a concise summary for the question about whether we can do 100 or 200 mg packages of cannabis edibles. It seems odd that the context includes CBD effects, epilepsy dosing, and cannabis in cats, but doesn't directly address edibles potency. For the summary, I’ll outline that it often depends on jurisdiction. Many states cap THC per package, typically around 100 mg for adult-use edibles, whereas medical products might have higher limits. CBD-only products typically follow hemp regulations.**Listing key requirements** I need to include essential requirements for cannabis edibles like serving size, homogeneity, and variance. Testing protocols are important too, along with child-resistant packaging. I can't forget about the universal symbol for cannabis products, clear labeling warnings, and ingredient allergen info. Nutrition facts should be included if the product is edible, and also, I need to mention the batch ID and net weight. All these elements contribute to ensuring safety and compliance in the marketplace.**Summarizing cannabis edibles potency** I need to create a concise summary for the cannabis industry regarding whether 100 or 200 mg packages of edibles are permissible. The context I have involves CBD, its effects on epilepsy, and even cannabis for cats, but that’s not directly related to potency limits for edibles. I can outline that it really depends on jurisdiction, as many states set limits on THC per packag..."
    },
    {
      "questionNum": 16,
      "question": "Can we do more than 200 mg?",
      "category": "edibles-potency-formulation",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "I’m happy to help, but I’ll need a bit more context to give you a safe and accurate answer.\n\n1. **What product or formulation are you referring to?**  \n   - A THC‑rich oil, CBD tincture, edible, vape cartridge, or something else?\n\n2. **What’s the intended use?**  \n   - Medical (e.g., pain, anxiety, seizures) or recreational?\n\n3. **Do you have any relevant health considerations?**  \n   - Tolerance level, prior experience, medications, or conditions that might affect dosing.\n\nGenerally, exceeding 200 mg of a cannabinoid (especially THC) in a is considered a high dose and can increase the risk of side effects such as anxiety, paranoia, rapid heart rate, or cognitive impairment. Many jurisdictions and product manufacturers set upper limits for safety reasons.\n\nOnce you provide the details above, I can:\n\n- Offer dosage guidelines based on the specific product and your goals.  \n- Point you to the appropriate specialist agent (e.g., a medical‑cannabis dosing expert).  \n- Suggest best‑practice safety tips if you decide to go beyond typical limits.\n\nFeel free to share the specifics, and we’ll take it from there!\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 509 (160?349) | Cost: $0.000000*",
      "duration": 4746,
      "grade": "F",
      "score": 41,
      "grading": {
        "accuracy": 16,
        "completeness": 5,
        "relevance": 8,
        "clarity_structure": 9,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Cautious tone emphasizing safety and potential side effects at higher doses",
        "Clear structure with questions to gather context"
      ],
      "weaknesses": [
        "Does not address the regulatory question about exceeding 200 mg, especially state-specific limits",
        "Omits key points from the expected answer (e.g., typical 10 mg/serving, 100 mg/package adult-use limits, Michigan med vs adult-use limits, variability across states and product types like beverages)",
        "Overly generic and non-committal; fails to provide a direct answer",
        "Includes irrelevant footer text and a minor typo that reduce professionalism"
      ],
      "feedback": "Your response is safe and well-intentioned but doesn’t answer the core question about whether exceeding 200 mg is permissible. Provide concise regulatory guidance: note common caps (10 mg/serving, 100 mg/package adult-use), highlight exceptions (e.g., higher limits for medical products in some states such as Michigan allowing 200 mg/package, and other states permitting higher limits for certain categories), and clarify that rules vary by jurisdiction and product type (including beverages). Then advise checking the specific state’s regulations and product category, and offer compliance steps. Remove extraneous footer text and correct typos.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "standard",
        "test",
        "lab",
        "edible",
        "gummy",
        "vape",
        "milligram",
        "thc",
        "cbd",
        "cannabinoid",
        "label",
        "delivery",
        "safety",
        "potency",
        "dosage"
      ],
      "expectedAnswer": "**Summarizing edibles potency limits** I need to summarize the expected answer to the question about whether we can exceed 200 mg in edibles. This involves the category of edibles, potency, and formulation. The context includes research on CBD for various uses, but it's not directly about edibles regulation. Many states in the US have different caps on THC, typically at 100 mg per package, but some allow higher limits for medical use or beverages. For instance, Michigan allows 200 mg for medical edibles.**Clarifying Michigan's THC limits** I need to confirm Michigan's regulations regarding THC limits in edibles. For adult-use cannabis, it seems they allow 10 mg per serving and a maximum of 100 mg per package. However, medical marijuana-infused products may go up to 200 mg per package. I'm not entirely sure about this, so I should double-check to get accurate information. It's important to have clarity on these details for any further discussions or decisions.**Summarizing cannabis potency regulations** I need to create a concise summary regarding the question about potential increases in cannabis edibles potency beyond 200 mg. The context covers dosage guidelines for CBD and its safety when used in formulations. Many US states have THC caps per package, typically at 100 mg, while some medical markets allow higher limits, going up to 500 mg or even 1000 mg. Regulations vary significantly, especially for beverages, so I'll clarify this in the summary.**Recalling Michigan mariju..."
    },
    {
      "questionNum": 17,
      "question": "Is there a per-piece requirement for max dosage?",
      "category": "edibles-potency-formulation",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "formulation",
      "agentMatch": true,
      "response": "### Quick Answer  \nMost U.S. jurisdictions impose a **per‑piece (per‑unit) THC limit** for cannabis edibles and other consumables, typically ranging from **5 mg to 10 mg THC per serving**. The exact number depends on the state (or country) where the product will be sold, and some states also set a **maximum total THC per package** (e.g., 100 mg per container).\n\nBelow is a concise rundown of the most common limits, the regulatory rationale, and how you can design your formulation to stay compliant.\n\n---\n\n## 1. Typical Per‑Piece THC Limits by U.S. State (2024‑2025)\n\n| State | Max THC per **individual piece** | Max THC per **package** | Notes |\n|-------|---------------------------------|--------------------------|-------|\n| **California** | 10 mg (10 mg per “serving”; a piece may contain multiple servings) | 100 mg per package for edibles | “Serving” must be clearly defined on the label. |\n| **Colorado** | 10 mg per serving (piece can be >1 serving) | 100 mg per package | Edible “dose” must be declared on the packaging. |\n| **Washington** | 10 mg per serving | 100 mg per package | Same as CO, but “single‑serve” edible must be ≤10 mg. |\n| **Oregon** | 10 mg per serving | 100 mg per package | “Single‑dose” edibles ≤10 mg. |\n| **Massachusetts** | 10 mg per serving | 100 mg per package | Edibles must be individually wrapped if >10 mg. |\n| **Illinois** | 10 mg per serving | 100 mg per package | Same as above. |\n| **Michigan** | 10 mg per serving | 100 mg per package | Edibles >10 mg must be clearly marked “multiple servings.” |\n| **New York** | 10 mg per serving | 100 mg per package | Same requirement. |\n| **Connecticut** | 10 mg per serving | 100 mg per package | Same. |\n| **New Jersey** | 10 mg per serving | 100 mg per package | Same. |\n| **Virginia** | 10 mg per serving | 100 mg per package | Same. |\n| **Maine** | 10 mg per serving | 100 mg per package | Same. |\n| **Alaska** | 10 mg per serving | 100 mg per package | Same. |\n| **Other states** | Varies; many follow the 10 mg/serving rule. | Varies. | Check the latest state cannabis board regulations. |\n\n> **Bottom line:** In the majority of legal U.S. markets, **10 mg THC per individual edible piece (or per serving) is the standard maximum**. If a piece contains multiple servings, the total THC can be higher, but each serving must be clearly labeled.\n\n---\n\n## 2. Why the Per‑Piece Limit Exists\n\n| Reason | Explanation |\n|--------|--------------|\n| **Consumer safety** | Prevents accidental over‑consumption, especially by inexperienced users. |\n| **Standardization** | Makes it easier for retailers and consumers to compare products. |\n| **Public health** | Reduces risk of acute intoxication and related adverse events. |\n| **Regulatory enforcement** | Clear, quantifiable limits simplify compliance checks and lab testing. |\n\n---\n\n## 3. How to Design a Compliant Per‑Piece Dosage\n\n1. **Start with a Target THC Concentration**  \n   - Typical edible base (e.g., chocolate, gummy, baked good) → **10 mg THC per 5 g** (1 % THC by weight) yields a 5 g piece that meets the 10 mg limit.\n\n2. **Calculate Raw Material Requirements**  \n   ```text\n   Desired THC per piece (mg) = 10 mg\n   Desired piece weight (g) = 5 g\n   Required THC % (w\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1203 (203?1000) | Cost: $0.000000*",
      "duration": 7365,
      "grade": "D",
      "score": 62,
      "grading": {
        "accuracy": 14,
        "completeness": 14,
        "relevance": 16,
        "clarity_structure": 12,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly addresses per-piece/per-serving THC limits and acknowledges common 10 mg cap and 100 mg/package pattern",
        "Provides a quick answer and high-level rationale for limits",
        "Attempts to offer formulation guidance for compliance"
      ],
      "weaknesses": [
        "Contains state-specific inaccuracies (e.g., Massachusetts and Oregon commonly cap adult-use edibles at 5 mg THC per serving, not 10 mg; Connecticut may also be 5 mg; Virginia adult-use market not active)",
        "Overgeneralizes that many states allow 10 mg per serving without noting important exceptions",
        "Omits mention of CBD/hemp product rules (e.g., 0.3% THC or per-serving THC caps) and homogeneity/variance tolerances",
        "Does not differentiate adult-use vs medical allowances, which can be higher in some medical programs",
        "Includes a truncated formulation calculation and stray agent/meta text, reducing clarity"
      ],
      "feedback": "Your answer clearly states that most jurisdictions set per-serving limits and often cap packages at 100 mg, which addresses the core question. However, the state-by-state table contains notable inaccuracies (e.g., MA and OR are typically 5 mg per serving for adult-use), and it overgeneralizes the 10 mg standard without calling out key exceptions. It also misses CBD/hemp-specific THC limits, homogeneity/variance requirements, and adult-use vs medical differences. Remove the truncated code and meta text, correct state specifics, add exceptions (including microdose norms like 2.5–5 mg), and note hemp THC limits to improve accuracy and completeness.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "requirement",
        "must",
        "state",
        "federal",
        "fda",
        "standard",
        "testing",
        "test",
        "coa",
        "lab",
        "potency",
        "control",
        "batch",
        "sample"
      ],
      "expectedAnswer": "**Summarizing cannabis dosage regulations** I need to produce a concise summary regarding the cannabis industry question about per-piece dosage requirements for edibles. I see that my context about CBD effects and cannabinoids in cats isn't relevant here, but the user did mention needing state-specific info if available. While the RAG doesn't cover regulatory details, I know that many US and Canadian jurisdictions have general per-serving THC limits, commonly around 10 mg per serving for adult-use, and some medical states allow higher limits.**Explaining dosage specifics** I see that for cannabis edibles, some jurisdictions allow microdose pieces as low as 2.5 or 5 mg. Others may have requirements for dosage homogeneity and variance tolerances. For CBD-only products, they usually don’t have a per-piece THC requirement but instead mandate that THC content must be limited to either 0.3% or 1 mg THC per serving in hemp products. I want to make sure these details are clear and relevant for the user’s question!**Summarizing dosage regulations** I need to produce a concise summary regarding the cannabis industry's per-piece dosage requirements for edibles. The user wants to understand the max dosage regulations, including state-specific information if available. While the RAG context includes details on unrelated CBD uses, I’ll focus on general regulatory patterns in the U.S. and Canada, where many areas set limits of 10 mg THC per serving and 100 mg per package for adult use, with..."
    },
    {
      "questionNum": 18,
      "question": "What am I allowed to cut my vape cartridge APIs (distillate or decarbed resin) with that is safe and compliant?",
      "category": "formulation-ingredient-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "Below is a quick‑reference guide to the diluents (cutting agents) that are **generally regarded as safe for inhalation** and **commonly allowed by state cannabis‑regulators** when you’re formulating a vape‑cartridge API (distillate or decarboxylated resin).  \n\n---\n\n## 1. “Safe‑and‑Compliant” Diluent Cheat‑Sheet  \n\n| Diluent | Typical Use | GRAS / FDA status | InhalationSafety Notes | Common State‑Regulatory Stance* |\n|---------|-------------|-------------------|------------------------|---------------------------------|\n| **MCT Oil (Medium‑Chain Triglycerides)** | Primary carrier for THC/CBD distillates; gives a thin, “oil‑like” viscosity. | GRAS for oral use; **not GRAS for inhalation** in many states. | Generally considered low‑toxicity when aerosolized, but someCO, WA, MA) *explicitly prohibit* non‑cannabis‑derived oils for inhalation. | ✅ Allowed in CO (with a “cannabis‑derived oil” exception) – **check local rule**. ❌ Prohibited in WA, MA, OR for inhalation. |\n| **Propylene Glycol (PG, USP grade)** | Thinner than MCT; used in “PG‑based” cartridges. | GRAS for oral and topical; **not GRAS for inhalation** in most jurisdictions. | Can produce formaldehyde‑like degradation products at high temps; many regulators flag it as a *potential respiratory irritant*. | ❌ Generally **not permitted** for inhalation in CO, WA, MA, OR. |\n| **Vegetable Glycerin (VG, USP grade)** | Thickens vapor; adds a slightly sweet mouthfeel. | GRAS for oral; **not GRAS for**. | Similar concerns to PG; can caramelize at > 250 °C. | ❌ Usually **prohibited** for inhalation (CO, WA, MA, OR). |\n| **PEG‑400 (Polyethylene Glycol 400)** | Very thin carrier, helps with wicking. | GRAS for oral; **not GRAS for inhalation**. | Known to decompose into toxic aldehydes when vaporized. | ❌ **Prohibited** in most states (CO, WA, MA, OR). |\n| **Cannabis‑Derived Terpenes (pure, no additives)** | Flavor & slight dilution; can reduce viscosity when used at 5‑15 %\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1178 (178?1000) | Cost: $0.000000*",
      "duration": 16968,
      "grade": "F",
      "score": 35,
      "grading": {
        "accuracy": 8,
        "completeness": 6,
        "relevance": 12,
        "clarity_structure": 5,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Attempts to organize common diluents and discuss viscosity/thinning roles",
        "Notes thermal degradation risks of PG/PEG and potential respiratory irritation",
        "Recognizes that some states restrict certain excipients"
      ],
      "weaknesses": [
        "Claims or implies ingredients are generally regarded as safe for inhalation, which is incorrect (no inhalation GRAS standard)",
        "Omits the critical prohibition of vitamin E acetate and broader flavor/additive restrictions",
        "State-specific compliance assertions (e.g., CO, WA, MA, OR allowances/prohibitions) are oversimplified and likely inaccurate",
        "Truncated/incomplete table (e.g., cannabis-derived terpenes row) and typos reduce clarity",
        "Does not cover key compliance requirements (ingredient disclosure, COA testing for heavy metals, residual solvents, pesticides)",
        "Fails to emphasize that many jurisdictions only allow cannabis-derived constituents in inhalable products",
        "Provides little actionable guidance on safe use rates, formulation ranges, or verification steps"
      ],
      "feedback": "The answer is partially on-topic but inaccurate and incomplete. Do not claim GRAS or general inhalation safety; there is no inhalation GRAS. Explicitly note vitamin E acetate is prohibited and that many states restrict or ban PG, PEG, VG, and MCT in inhalables, with some allowing only cannabis-derived constituents. Add state-by-state nuance, stress ingredient disclosure and COA testing (heavy metals, residual solvents, pesticides), and advise using no cut or minimal cannabis-derived terpenes with inhalation toxicology review. Provide precise, verified compliance references and practical formulation ranges. Fix truncation and errors.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "commission",
        "sop",
        "standard",
        "record",
        "test",
        "coa",
        "certificate",
        "analysis"
      ],
      "expectedAnswer": "**Summarizing vape cartridge compliance** I need to summarize the expected answer to the cannabis industry question about safe and compliant cutting agents for vape cartridges. The relevant knowledge base includes general cannabis compliance and formulation ingredient safety. There are restrictions on cutting agents, such as no vitamin E acetate and limitations on PG, PEG, or MCT in some states. We should also highlight that only cannabis-derived constituents may be allowed, with testing for heavy metals, residual solvents, and pesticides needing to be addressed.I'm considering the importance of temperature stability and viscosity in vape formulations while avoiding unknown diluents. It seems using food-grade terpenes or those recognized as GRAS (Generally Recognized as Safe) by FEMA might be an option. However, I've realized that just because something is GRAS for oral consumption doesn't guarantee inhalation safety. It's crucial to ensure any ingredients used are truly safe for inhalation. This aspect needs careful attention to prioritize user safety!**Evaluating safety and stability** I’m thinking about temperature stability and viscosity while avoiding unknown diluents. Should I consider food-grade terpenes that are GRAS (Generally Recognized as Safe) by FEMA? But I realize that inhalation safety can’t be guaranteed by GRAS, as it primarily applies to oral consumption. So, I need to be cautious about this choice. I’ll weigh the importance of both stability and safety in m..."
    },
    {
      "questionNum": 19,
      "question": "What are considered banned substances when formulating various cannabis products?",
      "category": "formulation-ingredient-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "formulation",
      "agentMatch": false,
      "response": "Below is a quick‑reference guide to the types of **substances that are generally prohibited (or heavily restricted) in legally‑marketed cannabis products**.  The exact list varies by jurisdiction (U.S. FDA, Health Canada, EU Novel‑Food rules, etc.), but the same core categories appear in every regulatory framework.\n\n| **Category** | **Typical “Banned” Items** | **Why They’re prohibited** | **Typical Regulatory Limits / Notes** |\n|--------------|----------------------------|----------------------------|---------------------------------------|\n| **Pesticides & Agricultural Chemicals** | • Organophosphates, carbamates, pyrethroids, neonicotinoids  <br>• Fungicides (e.g., chlorothalonil, captan) <br>• Herbicides (e.g., glyphosate, paraquat) Residues can be toxic, cause neuro‑ or liver‑damage, and are not allowed in consumables. | • Health Canada: < 0.5 ppm for most pesticides. <br>• U.S. FDA: “Pesticide Residue Limits (PRLs)” – typically ≤ 0.1–0.5 ppm. |\n| **Heavy Metals** | • Lead (Pb) <br>• Arsenic (As) <br• Cadmium (Cd) <br>• Mercury (Hg) | Accumulate in the body, cause organ toxicity. | • Canada: < 0.5 µg/g (Pb), < 0.5 µg/g (As), < 0.1 µg/g (Cd), < 0.05 µg/g (Hg). <br>• EU: similar limits; FDA uses “action levels”. |\n| **Mycotoxins & Microbial Contaminants** | • Aflatoxins (B1, B2, G1, G2) <br>• Ochratoxin A <br>• Total aerobic count, yeast & mold > 10⁴ CFU/g (often stricter) | Carcinogenic & immunosuppressive; microbes can spoil product or cause illness. | • Aflatoxin B1 ≤ 2 ppb (EU) / ≤ 5 ppb (US). <br>• Total yeast & mold ≤ 10⁴ CFU/g (common industry target). |\n| **Residual Solvents** (from extraction) | • Methanol, acetone, chloroform, dichloromethane, benzene, toluene, ethyl acetate, etc. | Toxic, flammable, may remain after inadequate purging. | • USP < 467> “Residual Solvents” limits (e.g., methanol ≤ 300 ppm, toluene ≤ 200 ppm). <br>• Canada: same USP limits. |\n| **Synthetic Cannabinoids / Unapproved Cannabinoids** | • JWH‑018, AB‑CHMINACA, HU‑210, etc. <br>• Δ⁹‑THC‑acetate, Δ⁹‑THC‑propionate (synthetic analogs) | Not evaluated for safety; many are Schedule I in the U.S. | • Only Δ⁹‑THC, Δ⁸‑THC, CBD, CBG, CBC, CBN, THCV, etc., that are **naturally derived** and within legal potency limits are allowed. |\n| **Excessive THC Content** | • Products > 0.3 % THC (in many U.S. states) for “hemp‑derived” edibles; < 10 % THC for medical‑grade cannabis (varies). | Legal definition of hemp vs. marijuana; intoxication risk. | • Verify per‑state or national THC caps.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1163 (163?1000) | Cost: $0.000000*",
      "duration": 6609,
      "grade": "D",
      "score": 47,
      "grading": {
        "accuracy": 11,
        "completeness": 10,
        "relevance": 12,
        "clarity_structure": 10,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Organizes banned substances into sensible categories (pesticides, heavy metals, microbes, residual solvents, synthetic cannabinoids)",
        "Acknowledges that rules vary by jurisdiction",
        "Flags synthetic cannabinoids/unapproved analogs as prohibited"
      ],
      "weaknesses": [
        "Contains inaccurate regulatory details (e.g., USP <467> residual solvent limits for methanol and toluene are incorrect)",
        "Misattributes pesticide oversight to FDA and generalizes Health Canada limits",
        "Omits key banned/restricted ingredients for inhalables (e.g., vitamin E acetate, certain cutting agents like PEG/PG in some states)",
        "Does not mention prohibitions on nicotine, caffeine, and alcohol co-formulation (common across many jurisdictions)",
        "Lacks state-specific compliance nuances and action levels",
        "Overgeneralizes cannabinoid allowance (e.g., treatment of delta-8 THC, natural vs synthetic production) and includes misleading THC potency statements",
        "Does not address flavoring/child-appeal restrictions that are common in state rules"
      ],
      "feedback": "On the right track with high-level categories, but the answer needs correction and expansion to be compliant and useful. Correct the USP <467> residual solvent limits and avoid attributing pesticide limits to FDA; reference state action levels or EPA tolerance gaps. Add inhalable-specific bans (e.g., vitamin E acetate; certain cutting agents), and include prohibitions on nicotine, caffeine, and alcohol in cannabinoid products, along with flavor/child-appeal restrictions. Provide state-level examples and clarify that delta-8 and synthetic derivatives are restricted or banned in many states rather than broadly allowed. Remove misleading THC potency statements and focus on jurisdiction-specific caps and action thresholds.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulation",
        "state",
        "federal",
        "fda",
        "board",
        "standard",
        "log",
        "lab",
        "contaminant",
        "pesticide",
        "microbial",
        "mycotoxin",
        "heavy metal",
        "control",
        "edible"
      ],
      "expectedAnswer": "**Summarizing banned substances** I need to create a summary about banned substances in cannabis product formulation, like what agents are restricted for compliance. I should emphasize key requirements and regulations, including specifics for various US states. While I have some context about CBD and its effects, I need to stick to general cannabis regulations. Common banned substances include adulterants, synthetic cannabinoids, vitamin E acetate for inhalables, and potentially cutting agents like PEG. Some flavorings, especially child-appealing aspects, are also restricted.**Clarifying banned ingredients** I need to outline certain banned substances in cannabis product formulation, particularly those that exceed action thresholds. This includes harmful pesticides, mycotoxins, heavy metals, and residual solvents above acceptable limits. Additionally, some ingredients are strictly prohibited, such as nicotine, caffeine, and alcohol in formulations, except for specific beverage categories. However, it's important to note that THC-infused drinks typically cannot include alcohol. So, I’ll specify these key points clearly.**Summarizing banned substances in cannabis products** I need to create a summary about banned substances in cannabis product formulation, specifically focusing on compliance requirements. It's essential to include key regulatory details, particularly U.S. state specifics. In general, many states prohibit adulterants, synthetic cannabinoids, and products like vi..."
    },
    {
      "questionNum": 20,
      "question": "Can I use hemp-based cannabinoids like CBD or CBG (or others) in production of my cannabis products?",
      "category": "formulation-ingredient-compliance",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "formulation",
      "agentMatch": true,
      "response": "### Short answer  \nYes – you can formulate cannabis‑derived products with hemp‑derived cannabinoids such as CBD, CBG, Δ⁸‑THC, CBC, etc., **provided you stay within the legal limits for THC and meet the labeling, testing, and licensing requirements of the jurisdiction where the product will be sold**.\n\n---\n\n## 1. Why hemp‑derived cannabinoids are commonly used  \n\n| Benefit | How it helps product development |\n|---------|-----------------------------------|\n| **Low‑THC source** (≤0.3 % Δ⁹‑THC in the U.S.) | Easy to stay under federal THC thresholds; reduces risk of a classified as “marijuana.” |\n| **High‑purity isolates & broad‑spectrum extracts** | Enables precise dosing, consistent batch‑to‑batch potency, and the ability to market “THC‑free” or “non‑psychoactive” products. |\n| **Cost‑effective** | Hemp biomass is generally cheaper and more abundant than flower‑grade marijuana. |\n| **Regulatory clarity** ( states/countries) | Hemp is often covered by separate agricultural‑commodity regulations, simplifying licensing for some manufacturers. |\n\n---\n\n## 2. Core regulatory checkpoints (U.S. focus; similar concepts apply elsewhere)\n\n| Checkpoint | What to verify |\n|------------|----------------|\n| **THC limit** | Federal: ≤0.3 % Δ⁹‑THC on a dry‑weight basis. Some states impose stricter limits (e.g., 0.05 %). Ensure the final product—after formulation and any post‑processing—remains under the applicable limit. |\n| **Licensing** | You need a **hemp processing license** (for extraction) *and* a **cannabis product manufacturing license** if you are adding the extract to a product that will be sold as “cannabis‑infused.” |\n| **COA & batch testing** | lot of hemp extract must have a Certificate of Analysis showing: total cannabinoids, individual THC, CBD, CBG, etc.; residual solvents; heavy metals; pesticides; microbiology. |\n| **Labeling** | Include: total CBD (and other cannabinoids) per serving, THC content, serving size, any “non‑psychoactive” disclaimer required by the state, and a statement that the product complies with the 0.3 % THC limit (or the local limit). |\n| **FDA / Health Claims** | In the U.S., you cannot claim therapeutic benefits unless the product is an FDA‑approved drug or a qualified health claim. “Supports relaxation,” “helps with focus,” etc., are permissible only if they are not disease‑specific. |\n| **State‑specific rules** | Some states (e.g., Colorado, Washington) treat **hemp‑derived CBD** the same as marijuana‑derived CBD for product registration, while others keep them separate. Always check the state’s cannabis board or agricultural department. |\n\n> **Bottom line:** If you can document that the final product’s Δ⁹‑THC is ≤ the legal limit and you have the proper licenses, hemp‑derived cannabinoids.\n\n---\n\n## 3. Practical formulation tips\n\n| Step | Guidance |\n|------|----------|\n| **Select the right extract** | • **Isolate**≥99 % CBD/CBG) – ideal for precise dosing, minimal terpene.<br>• **Broad‑spectrum** – retains beneficial terpenes and minor cannabinoids while removing Δ⁹‑THC.<br>• **Full‑spectrum** – includes trace Δ⁹‑THC; you must calculate total THC after blending. |\n| **Calculate dosage** | Use the COA potency to compute the weight of extract needed per serving. Example: If a COA shows 80 % CBD, to deliver 25 mg CBD\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1215 (215?1000) | Cost: $0.000000*",
      "duration": 10067,
      "grade": "F",
      "score": 44,
      "grading": {
        "accuracy": 11,
        "completeness": 8,
        "relevance": 12,
        "clarity_structure": 8,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly structured with sections and checkpoints",
        "Mentions core compliance elements like COAs, labeling, and testing",
        "Provides some practical formulation tips (isolate vs broad/full spectrum)"
      ],
      "weaknesses": [
        "Overgeneralizes legality with a blanket 'Yes' and misses that many state cannabis programs prohibit hemp-derived cannabinoids in marijuana products",
        "Fails to distinguish federal hemp rules from state-licensed cannabis market requirements (track-and-trace, same-system sourcing)",
        "Treats delta-8 THC as broadly permissible; many jurisdictions ban or restrict synthetic conversions from CBD",
        "Insufficient discussion of Total THC calculations and common state requirements (e.g., THCA conversion in potency)",
        "Contains questionable claims (e.g., 'some states impose 0.05% THC limit') and examples that may be inaccurate or outdated",
        "Licensing guidance is oversimplified and potentially misleading for regulated cannabis products",
        "Incomplete/truncated sentences and sections reduce clarity",
        "Does not reference scientific or regulatory sources as suggested in the expected answer"
      ],
      "feedback": "The answer is well structured but substantively misleading. It asserts broad permissibility where many states explicitly prohibit adding hemp-derived cannabinoids to regulated cannabis products and restrict synthetic conversions (e.g., delta-8 from CBD). It underemphasizes Total THC rules and track-and-trace requirements, and includes questionable THC limit claims. Revise to emphasize federal vs state differences, common state prohibitions, Total THC calculations, and synthetic conversion bans, with jurisdiction-specific compliance checks and supporting references.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "must",
        "state",
        "federal",
        "fda",
        "sop",
        "procedure",
        "standard",
        "operating",
        "testing",
        "test",
        "coa",
        "certificate",
        "analysis"
      ],
      "expectedAnswer": "**Analyzing cannabinoid compliance** I need to create a grading summary addressing whether hemp-based cannabinoids like CBD or CBG can be used in cannabis product formulation. This is particularly relevant in the context of compliance and regulations, as many states have restrictions on “hemp-derived cannabinoids” in the marijuana market. I'll reference insights from three PubMed articles related to CBD and its implications. Additionally, I'll ensure to cover vital compliance pointers and address issues like “Total THC” calculations and synthetic conversion prohibitions to provide thorough guidance.**Clarifying federal versus state regulations** I should note that federal law, specifically the 2018 Farm Bill, defines hemp as cannabis containing less than 0.3% delta-9 THC. However, state cannabis programs frequently have stricter requirements, insisting that all cannabinoids must come from marijuana plants grown within regulated systems. This distinction is crucial for anyone looking to navigate the compliance landscape surrounding the use of hemp-derived cannabinoids in cannabis products. It's an important aspect to clarify for the user’s understanding.**Producing a grading summary** I need to create a grading summary for a question about using hemp-based cannabinoids like CBD or CBG in cannabis product production. I’ve got context from three PubMed articles, which is useful. The main focus is on compliance and regulatory aspects, which is very relevant currently due to restr..."
    },
    {
      "questionNum": 21,
      "question": "Can I store finished products in the same room as raw biomass?",
      "category": "facility-setup-operational-procedures",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most U.S. cannabis‑regulatory regimes you **cannot** store finished product in the same room as raw biomass. The two must be kept separate to prevent cross‑contamination, preserve product integrity, and satisfy security and traceability requirements.\n\n---\n\n## Why the separation is required\n\n| Reason | How it affects your operation |\n|--------|------------------------------|\n| **Regulatory compliance** | State cannabis statutes (e.g., California Bureau of Cannabis Control, Colorado Marijuana Enforcement Division, Massachusetts Cannabis Control Commission) explicitly require *“separate, dedicated storage areas for harvested/processed product and for raw plant material.”* Inspectors will look for physical barriers, separate HVAC, and distinct access controls. |\n| **Cross‑contamination risk** | Raw biomass can contain mold, pests, excess moisture, or residual pesticides that can migrate to finished product, jeopardizing potency, safety, and shelf life. |\n| **Product integrity** | Finished goods often need tighter temperature/humidity control (e.g., 60–65 °F / 55–62 % RH for flower) than raw material, which may be stored at cooler, drier conditions to prevent degradation. |\n| **Security & inventory control** | Finished product is a higher‑value, tightly‑tracked inventory. Separate rooms simplify access logs, video surveillance zones, and restrict who can enter each area. |\n| **Traceability & record‑keeping** | Separate storage eases “track‑and‑trace” reporting (e.g., METRC, BioTrackTHC). You can tag each room with its own batch‑ID range, reducing the chance of mis‑labeling. |\n| **Pest management** | Raw plant material can harbor insects or rodents. Keeping it isolated protects finished product from infestations. |\n\n---\n\n## Typical regulatory language (examples)\n\n| State | Relevant clause |\n|-------|-----------------|\n| **California** | “All harvested cannabis and cannabis products shall be stored in a secure, locked area separate from the cultivation area.” (B.C.C. Reg. § 2220) |\n| **Colorado** | “Processed cannabis and raw plant material must be stored in separate, clearly identified rooms or compartments.” (M.E.D. Rule 16‑953‑001) |\n| **Massachusetts** | “Finished product storage areas shall be distinct from cultivation and processing areas, with separate access controls.” (M.G.L. c. 94G, § 5) |\n| **Oregon** | “Cultivation and processing facilities must maintain separate storage for harvested material and for packaged product.” (OR Reg. 503‑018‑0010) |\n\nIf you operate outside the United States, consult the specific national/provincial legislation, but the principle of separation is almost universally enforced.\n\n---\n\n## What “separate” looks like in practice\n\n| Element | Recommended implementation |\n|---------|----------------------------|\n| **Physical barrier** | Separate doors, walls, or at minimum a locked, clearly labeled “Finished Product Storage” room. |\n| **HVAC** | Independent temperature/humidity controls; avoid shared air ducts that could circulate spores or odors. |\n| **Security** | Two‑factor access (keycard + PIN) for the finished‑product room; video cameras focused on each door. |\n| **Inventory system** | Distinct METRC/seed‑to‑sale location IDs (e.g., “Warehouse‑A‑Raw” vs. “Warehouse‑A‑Finished”). |\n| **Cleaning SOPs** | Daily cleaning of the raw‑biomass area; weekly deep‑clean of finished‑product area. No equipment is shared without thorough sanitization. |\n| **Labeling** | Use color‑coded signage (e.g., red for raw, green for finished) and floor markings to reduce accidental entry. |\n| **Fire & safety** | Both rooms must meet local fire‑code requirements, but finished‑product storage often needs additional fire‑suppression (e.g., FM‑200) because of higher value and volatile terpenes. |\n\n---\n\n## If your jurisdiction *does* allow\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1164 (164?1000) | Cost: $0.000000*",
      "duration": 14144,
      "grade": "F",
      "score": 48,
      "grading": {
        "accuracy": 9,
        "completeness": 7,
        "relevance": 11,
        "clarity_structure": 14,
        "practical_value": 7,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear, well-organized structure with actionable operational suggestions",
        "Good explanation of cross-contamination and security rationale",
        "Provides practical separation practices (HVAC, access control, labeling)"
      ],
      "weaknesses": [
        "Does not address New York regulations or NYS Office of Cannabis Management requirements as expected",
        "Overgeneralizes that co-storage is prohibited; expected answer allows conditional co-location with safeguards",
        "Misses key NY-specific points: quarantine of finished goods awaiting testing and clear labeling",
        "Includes questionable or likely inaccurate regulatory citations and state rule references",
        "Does not clarify raw biomass definition (cannabis vs hemp) as required"
      ],
      "feedback": "While the answer is clear and operationally helpful, it fails to address New York-specific regulations and the nuanced allowance for co-storage with strict separation and controls. It also includes dubious citations and omits quarantine and labeling requirements for finished goods. Refocus on NY OCM rules, note conditional co-location, and include quarantine, labeling, and environmental control details.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "state",
        "epa",
        "sop",
        "procedure",
        "standard",
        "operating",
        "documentation",
        "document",
        "record",
        "testing"
      ],
      "expectedAnswer": "**Summarizing NY cannabis regulations** I need to create a summary about New York cannabis regulations, focusing on whether finished products can be stored in the same room as raw biomass. The key points will include the conclusion and critical regulatory details from the NYS Office of Cannabis Management. There are requirements for separating cannabis products to avoid contamination, including secure storage, environmental controls, and sanitation measures. Finished products awaiting testing must be quarantined and clearly labeled to ensure safety and compliance. It's important to specify that raw biomass refers to cannabis, not just hemp.It seems storing finished cannabis products in the same room as raw biomass may be allowed, but there are conditions. I need to ensure there's physical separation, proper labeling, and environmental controls to prevent cross-contamination and odors. However, most regulators prefer keeping finished products in separate rooms or distinct areas for added safety. It's important to follow best practices to maintain compliance and ensure the integrity of the products being stored.**Summarizing NY cannabis regulations** I need to create a summary about New York cannabis regulations regarding storing finished products with raw biomass. The main points should include key requirements like the segregation of products to avoid contamination and cross-contact, with a focus on regulations from the NYS Office of Cannabis Management. It’s important to men..."
    },
    {
      "questionNum": 22,
      "question": "Do I need to log the cleaning of the extraction booth before starting the next run?",
      "category": "facility-setup-operational-procedures",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** Yes – logging the booth‑cleaning step before you start the next extraction run is a standard requirement in virtually every GMP‑ or state‑compliant cannabis‑extraction program.\n\n---\n\n## Why the log is required\n\n| Reason | What it protects you from |\n|--------|---------------------------|\n| **Regulatory compliance** (State cannabis boards, USDA‑AMS, ISO 9001/22000, GMP) | Fines, batch rejections, or loss of license if cleaning isn’t documented. |\n| **Traceability & auditability** | Auditors can see exactly when and how the booth was de‑contaminated and by whom. |\n| **Product safety** | Prevents cross‑contamination of residual solvents, cannabinoids, terpenes, or microbial load between batches. |\n| **Process consistency** | Guarantees each run starts from the same baseline, reducing variability in yield and potency. |\n| **Quality‑system integrity** | Supports CAPA (Corrective‑and‑Preventive Action) investigations if a batch fails later. |\n\n---\n\n## What to include in the cleaning log (minimum fields)\n\n| Field | Typical content |\n|-------|-----------------|\n| **Date & Time** | Start & end timestamps of the cleaning cycle. |\n| **Operator(s)** | Name(s) and employee ID; include a digital signature if using an E‑log. |\n| **Cleaning Procedure ID** | Reference to the SOP (e.g., SOP‑EX‑001 “Extraction Booth De‑contamination”). |\n| **Cleaning Agents & Concentrations** | List solvents, detergents, sanitizers (e.g., 70 % IPA, 0.5 % peracetic acid). |\n| **Equipment/Areas Cleaned** | Booth interior, floor drains, HEPA filters, light fixtures, work surfaces, etc. |\n| **Method of Application** | Spray, wipe, fog, automated CIP, dwell time, rinse steps. |\n| **Verification/Acceptance** | Swab test results, visual inspection, ATP‑luminescence reading, or “Pass/Fail” check‑list. |\n| **Comments / Deviations** | Any issues (e.g., residue found, extra rinse needed) and corrective actions taken. |\n| **Supervisor Sign‑off** | Final approval before the next batch can be released. |\n\n---\n\n## Typical workflow\n\n1. **Complete cleaning** according to the approved SOP.  \n2 **Perform verification** (visual, ATP, or swab for residual solvents).  \n3. **Enter data** into the electronic batch record (or paper log) **immediately**—no “post‑hoc” entries.  \n4. **Supervisor review** and sign‑off.  \n5. **System lock** – the next extraction batch cannot be released in the LIMS/ERP until the log shows a “Pass.”  \n\n---\n\n## Practical tips for implementation\n\n* **Electronic Logbooks** (e.g., Labguru, MasterControl, or a custom LIMS) enforce required fields and timestamps, reducing human error.  \n* **Barcode/QR‑code tags** on cleaning agents allow auto‑capture of product name & lot number when scanned.  \n* **Automated reminders** – set up a “clean‑before‑run” trigger in your production scheduling software.  \n* **Training** – ensure all operators know the importance of the log and the correct SOP reference.  \n* **Retention** – keep logs for the period required by your jurisdiction (often 2 – 5 years).  \n\n---\n\n### Bottom line\nYes—recording the booth cleaning is not optional; it’s a critical control point for compliance, safety, and product consistency. If you haven’t already, embed the log step into your standard operating procedure and lock downstream batch release on a successful cleaning entry.\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1131 (210?921) | Cost: $0.000000*",
      "duration": 6481,
      "grade": "B",
      "score": 86,
      "grading": {
        "accuracy": 27,
        "completeness": 19,
        "relevance": 18,
        "clarity_structure": 14,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly answers yes and explains why logging is required",
        "Provides detailed, actionable fields to include in the cleaning log",
        "Outlines a practical workflow including verification and supervisor sign-off",
        "Emphasizes traceability, product safety, and audit readiness"
      ],
      "weaknesses": [
        "Does not cite New York-specific regulations (e.g., 9 NYCRR Part 132) as expected",
        "Omits explicit two-year record retention requirement noted for NY",
        "Relies on generic standards (ISO, USDA-AMS) that are not directly applicable to NY cannabis processors",
        "Longer and more general than the concise NY-focused compliance summary expected"
      ],
      "feedback": "Good, practical answer that correctly states logging is required and provides strong implementation details. To meet the expected gold standard, tailor it to New York: reference 9 NYCRR Part 132, state that sanitation SOPs and sanitation logs are mandatory, specify that records must include who cleaned, chemicals and concentrations, contact/dwell times, supervisor verification, and note the minimum two-year retention requirement.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "required",
        "must",
        "state",
        "california",
        "oregon",
        "massachusetts",
        "board",
        "sop",
        "procedure",
        "standard",
        "document",
        "record"
      ],
      "expectedAnswer": "**Summarizing New York compliance for cleaning** I need to create a concise summary regarding whether to log the cleaning of the extraction booth before starting the next run. New York cannabis regulations specify that sanitation logs and SOPs are required, including maintaining cleaning records for equipment and facilities. I'll mention that cleaning between batches is essential, and records need to include details like who performed the cleaning, the chemicals used, and supervisor verification. It's important to note that records should be retained for at least two years.**Generating compliance summary** I need to create a concise summary addressing whether to log cleaning of the extraction booth before starting a new run, particularly within New York's regulatory context. New York cannabis regulations demand maintaining sanitation SOPs, sanitation logs, and record-keeping of cleaning procedures. This includes documenting details such as who performed the cleaning, the chemicals used, contact times, and certification by a supervisor. It's essential to follow 9 NYCRR Part 132, which outlines these requirements for adult-use processors, ensuring compliance with GMP-like practices."
    },
    {
      "questionNum": 23,
      "question": "Is it okay to perform maintenance on the hydrocarbon extractor during operating hours?",
      "category": "facility-setup-operational-procedures",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "Performing maintenance on a hydrocarbon extractor **while the unit is running** is generally **not recommended** and is often prohibited by safety standards and most manufacturer SOPs.carbon‑based extraction uses highly volatile solvents (e.g., butane, propane) that can create explosive atmospheres if they escape, and the equipment’s moving parts, pressure vessels, and electrical components pose additional hazards.  \n\n### Key reasons to avoid in‑process maintenance\n| Reason | What it means for you |\n|--------|----------------------|\n| **Flammable vapor buildup** | Any leak or disturbance can ignite the solvent‑rich air. |\n| **Pressure hazards** | Opening or adjusting a pressurized system can cause sudden releases. |\n| **Lock‑out/Tag‑out (LOTO) compliance** | Maintenance must be performed on a de‑energized, depressurized unit that is locked out to prevent accidental start‑up. |\n| **Regulatory requirements** | OSHA, NFPA 30/30A, and state cannabis‑extraction regulations typically require equipment to be shut down before any servicing. |\n| **Manufacturer warranties** | Most vendors void warranties if maintenance is done out of sequence. |\n\n### Recommended practice\n1. **Schedule downtime** – Plan maintenance during a designated shutdown window.  \n2. **Depressurize & purge** – Fully vent the system and purge with an inert gas (e.g., nitrogen) if required.  \n3. **Lock‑out / Tag‑out** – Apply LOTO devices to all energy sources (electric, pneumatic, hydraulic).  \n4. **Ventilation check** – Verify that the extraction room’s ventilation/solvent‑scrubbing system is operating normally before any work.  \n5. **Use proper PPE** – Flame‑resistant clothing, safety glasses, gloves, and a respirator as required.  \n6. **Follow SOPs & checklists** – Use the equipment manufacturer’s maintenance checklist and your internal standard operating procedures.  \n7. **Document** – Record the shutdown, maintenance steps, and sign‑off by a qualified technician and a safety officer.  \n\n### When “in‑process” adjustments are unavoidable\nIf a minor adjustment must be made during a run (e.g., a sensor calibration that the vendor allows), ensure that:\n\n- The extractor is **in a safe, low‑pressure state** (e.g., idle or low‑flow mode).  \n- All **ignition sources are eliminated** (no open flames, static discharge control).  \n- A **qualified technician** performs the task while **monitoring solvent concentrations** with an explosive‑gas detector.  \n- The action is **documented** and approved by your safety manager.\n\n### Bottom line\n**Do not perform routine or corrective maintenance on a hydrocarbon extractor while it is operating.** Schedule a proper shutdown, follow lock‑out/tag‑out procedures, and adhere to your company’s safety protocols and local regulations. If you’re ever unsure, consult the equipment’s user manual, your safety officer, or a qualified engineer before proceeding.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1027 (166?861) | Cost: $0.000000*",
      "duration": 8601,
      "grade": "B",
      "score": 80,
      "grading": {
        "accuracy": 23,
        "completeness": 18,
        "relevance": 18,
        "clarity_structure": 12,
        "practical_value": 9,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly states not to perform maintenance while the extractor is operating",
        "Explains hazards (flammable vapors, pressure, ignition sources) accurately",
        "Provides actionable shutdown steps: depressurize, purge, and LOTO",
        "Emphasizes SOPs, documentation, and qualified personnel"
      ],
      "weaknesses": [
        "Does not address New York-specific regulatory requirements",
        "Does not reference ICC/IFC compliance and cites less-relevant NFPA standards (NFPA 30/30A) instead of commonly applied codes (e.g., NFPA 1, NFPA 55/58, NFPA 70 NEC Class I Div 1, IFC/IMC)",
        "Suggests conditions for in-process adjustments, which conflicts with the expected prohibition on maintenance during operation",
        "Includes extraneous content/signature and heavy formatting that detract from clarity"
      ],
      "feedback": "Good safety-focused guidance with practical steps to shut down, purge, and lock out the system before maintenance. To meet the expected standard, explicitly state that maintenance may not occur while the extractor is operating under New York rules, reference compliance with NFPA and ICC/IFC standards for extraction areas, and remove the allowance for any in-process adjustments. Cite appropriate codes (e.g., NFPA 1, NFPA 55/58, NFPA 70 NEC Class I Div 1, IFC/IMC) and note the need for written SOPs and documented procedures.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "must",
        "state",
        "california",
        "colorado",
        "osha",
        "epa",
        "agency",
        "sop",
        "procedure",
        "standard",
        "document"
      ],
      "expectedAnswer": "**Summarizing extractor maintenance guidelines** I need to create a concise summary regarding maintenance for cannabis hydrocarbon extractors in New York. This involves outlining key requirements and regulatory details, especially focusing on compliance with the state's regulations on hydrocarbon extraction. It's critical to note that the extraction area must meet NFPA and ICC standards, and maintenance can't occur while operational. Compliance with safety protocols is essential, including written SOPs and ensuring the system is shut down and purged before any maintenance activities."
    },
    {
      "questionNum": 24,
      "question": "Am I allowed to have non-lab staff enter the extraction area if they’re just observing?",
      "category": "facility-setup-operational-procedures",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 279,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "compliance",
      "agentMatch": false
    },
    {
      "questionNum": 25,
      "question": "Do I need to notify regulators before making changes to the lab layout?",
      "category": "facility-setup-operational-procedures",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 58,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "compliance",
      "agentMatch": false
    },
    {
      "questionNum": 26,
      "question": "Can I use ethanol I purchased from a non-cannabis supplier in today’s extraction?",
      "category": "extraction-batch-production-rules",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 260,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "f8_agent",
      "agentMatch": false
    },
    {
      "questionNum": 27,
      "question": "Is it compliant to run two different extraction methods in the same lab on the same day?",
      "category": "extraction-batch-production-rules",
      "response": null,
      "error": "HTTP 400: Bad Request",
      "duration": 58,
      "grade": "F",
      "score": 0,
      "actualAgent": "error",
      "actualAgentName": "HTTP 400",
      "expectedAgent": "f8_agent",
      "agentMatch": false
    },
    {
      "questionNum": 28,
      "question": "Do I need to document the purge time for each batch of concentrate?",
      "category": "extraction-batch-production-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "f8_agent",
      "agentMatch": false,
      "response": "**Short answer:** Yes – you should record purge time (and the associated conditions) for every, both for regulatory compliance and for maintaining product quality and consistency.\n\n---\n\n## Why documenting purge time matters\n\n| Reason | What it protects you from / enables |\n|--------|--------------------------------------|\n| **Regulatory compliance** | Many state cannabis boards (e.g., CA B.O.S.S., CO MCS‑3, WA LRI) require a complete batch record that includes “purge parameters.” Failure to document can trigger a **non‑conformance** during an audit. |\n| **Product consistency** | Purge time directly influences residual solvent levels, terpene retention, and final potency. A recorded time lets you reproduce the exact profile batch‑to‑batch. |\n| **Safety & legal limits** | Residual solvent limits (e.g., <500 ppm ethanol, <200 ppm butane) are verified by lab COA. If a batch exceeds limits, the purge log is the first place to identify whether time, temperature, or equipment caused it. |\n| **Stability & shelf‑life** | Over‑purging can degrade cannabinoids/terpenes, under‑purging can lead to solvent off‑gassing later. Documented times help correlate stability data with processing conditions. |\n| **Root‑cause troubleshooting** | If you see an out‑of‑spec potency, flavor, or solvent residual, the purge log is a quick check before you dig into raw material or extraction variables. |\n| **Traceability & recall readiness** | In a recall scenario, you can pinpoint exactly which batches were processed under a given purge regime. |\n\n---\n\n## What to record for each batch\n\n| Data point | Typical format / units |\n|------------|------------------------|\n| **Batch ID** | Unique alphanumeric (e.g., CON‑2025‑10‑001) |\n| **Product type** | Shatter, live‑resin, distillate, etc. |\n| **Equipment** | Vacuum oven, rotary evaporator, short‑path, etc.; serial number |\n| **Purge temperature** | °C (or °F) – set point and actual (log temperature curve) |\n| **Vacuum level / pressure** | mBar or Torr – target and actual |\n| **Purge start & end time** | Timestamp (ISO 8601) |\n| **Total purge duration** | Hours ± minutes |\n| **Ramp‑up / ramp‑down times** | If temperature or pressure is stepped |\n| **Solvent used** | Butane, propane, ethanol, CO₂, etc. |\n| **Initial solvent load** | % by weight or volume in the crude |\n| **Final residual solvent** | Result of post‑purge lab test (ppm) |\n| **Operator** | Name / ID |\n| **Observations** | “Foaming,” “color change,” “pressure spikes,” etc. |\n| **QC sign‑off** | QA reviewer initials, date |\n\n*Tip:* Use a **digital batch‑record system** (e.g., ERP, LIMS, or a validated Excel template) that timestamps each entry automatically – this reduces manual error and satisfies most audit trails.\n\n---\n\n## Minimal regulatory baseline (U.S. example)\n\n| Jurisdiction | Requirement | Typical citation |\n|--------------|-------------|------------------|\n| **California** | “All processing steps, including purge time and conditions, must be recorded in the batch record.” | B.O.S.S. Reg. 2615 |\n| **Colorado** | “Record purge temperature, pressure, and duration for each batch.” | C.R.S. 13‑300‑101(5) |\n| **Ontario (Canada)** | “Processing logs shall include solvent removal parameters.” | Cannabis Licence Regulation, s. 12.2 |\n| **EU (if exporting)** | “Good Manufacturing Practice (GMP) requires traceability of all critical process parameters.” | EU‑GMP Annex 15 |\n\nEven if your state does not explicitly list “purge time,” it will be considered a **critical process parameter (CPP)** under GMP/GLP principles, and auditors will expect it\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1207 (207?1000) | Cost: $0.000000*",
      "duration": 7300,
      "grade": "C",
      "score": 73,
      "grading": {
        "accuracy": 12,
        "completeness": 22,
        "relevance": 19,
        "clarity_structure": 12,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly answers the question with a clear Yes and rationale",
        "Explains why documenting purge time matters (compliance, consistency, safety)",
        "Provides a practical checklist of what to record for each batch",
        "Well-organized with clear sections that are easy to follow"
      ],
      "weaknesses": [
        "Cites likely non-existent or incorrect regulatory bodies and rule numbers (e.g., CA B.O.S.S., CO MCS‑3, WA LRI, B.O.S.S. Reg. 2615, C.R.S. 13‑300‑101(5))",
        "Residual solvent limit examples appear incorrect (e.g., ethanol 500 ppm, butane 200 ppm are not typical; many jurisdictions use higher USP-based limits)",
        "Overlong relative to the question’s scope and expected concise summary",
        "Minor wording/typo issues and inclusion of irrelevant meta text at the end",
        "Misrepresents jurisdictional authority (Ontario processing is federally regulated by Health Canada, not provincial regs)"
      ],
      "feedback": "The core guidance is correct—yes, document purge time and conditions for every batch—and the answer offers useful, actionable details on what to record. However, it includes inaccurate regulatory references and questionable solvent limit examples that undermine credibility. Replace fabricated citations with accurate ones (e.g., CA DCC, CO MED, WA LCB rules or general GMP principles), align residual solvent limits with applicable state or USP <467> standards, and trim to a concise summary to better match the expected response.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "massachusetts",
        "sop",
        "standard",
        "documentation",
        "document"
      ],
      "expectedAnswer": "**Summarizing documentation requirements** I need to craft a concise summary about whether documenting purge time for each concentrate batch is necessary in the cannabis industry. This involves understanding regulatory requirements around extraction and concentrate production. Purge time is crucial for removing solvents, and most state regulations demand detailed batch records, including parameters like extraction methods, solvent use, temperatures, and more. Specific guidelines vary by state, such as Colorado's MED rules, which require meticulous record-keeping for each batch.**Summarizing documentation requirements** I need to craft a 100-200 word summary responding to the question about documenting purge times for each batch of concentrate in the cannabis industry. Purge time is essential for removing residual solvents during production, and most regulations require thorough documentation of parameters like extraction methods, solvent use, and processing times. Specific state regulations, such as those in Colorado, mandate detailed records, including extraction methods and solvent testing results. It’s crucial to adhere to these requirements for compliance."
    },
    {
      "questionNum": 29,
      "question": "Am I allowed to blend two different strain inputs into a single extraction batch?",
      "category": "extraction-batch-production-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "f8_agent",
      "agentMatch": false,
      "response": "### Short answer  \nYes – you can blend two (or more) strain inputs in a single extraction batch **as long as you meet the regulatory, quality‑control, and labeling requirements of your jurisdiction** and maintain product consistency.\n\n---\n\n## 1. Regulatory landscape  \n\n| Region | Key points on blending |\n|--------|------------------------|\n| **U.S. (Federal – 21 CFR § 1308.11)** | No explicit prohibition on blending; the final product must be **accurately labeled** for potency, cannabinoid/terpene profile, and any additives. State‑specific rules may impose extra limits (e.g., “single‑strain” labeling requirements in some states). |\n| **Canada (Cannabis Act)** | Blending is allowed, but the **product licence** must list *all* source strains and their batch numbers. Lab results for the blended lot must be submitted to Health Canada. |\n| **EU (EU‑CBD/THC regulations)** | Blended extracts are permissible if the **maximum THC limits** are respected and the final product’s certificate of analysis (COA) reflects the blended composition. |\n| **Australia (Therapeutic Goods Administration)** | For medicinal extracts, the **manufacturing dossier** must detail each source strain and the blending process; the final product’s specifications must be verified by GMP‑certified labs. |\n\n**Bottom line:** Check the specific state/province or country rules that apply to your operation. If a “single‑strain” claim is part of your marketing, you cannot blend without revising the claim.\n\n---\n\n## 2. Quality‑control considerations  \n\n| Aspect | What to do |\n|--------|------------|\n| **Batch traceability** | Assign a unique *source‑strain batch ID* for each input (e.g., Strain‑A‑B001, Strain‑B‑C023). Record the weight/volume contributed by each. |\n| **Potency & terpene profiling** | Run a COA on each input **before** blending, then run a COA on the *final blended extract*. Verify that the final potency falls within your target specification (e.g., THC 45 % ± 2 %). |\n| **Homogeneity testing** | Take at‑least‑three grab samples from different points in the extraction tank and analyze them for cannabinoid/terpene uniformity. Aim for < 5 % relative standard deviation across samples. |\n| **Contaminant limits** | Ensure that pesticide, heavy‑metal, residual‑solvent, and microbial limits are met **after** blending. Some contaminants can concentrate or dilute depending on the ratio of inputs. |\n| **Stability** | Conduct a short‑term (30‑day) accelerated stability test on the blended batch to confirm that the mixed terpene profile does not degrade faster than either parent extract. |\n\n---\n\n## 3. Practical formulation tips  \n\n| Goal | Recommended approach |\n|------|----------------------|\n| **Maintain a target THC/CBD ratio** | Use a *pre‑blend spreadsheet* or software (e.g., Formul8’s batch calculator) to compute the exact weight of each strain needed to hit your desired final ratio. Example: 60 % THC/40 % CBD → blend 70 % high‑THC strain with 30 % high‑CBD strain. |\n| **Preserve desired terpene profile** | Choose strains with complementary terpene families (e.g., myrcene‑rich + limonene‑rich) to achieve a balanced aroma. Keep an eye on *volatile loss* during extraction; consider low‑temperature methods (e.g., hydrocarbon or ethanol at < -20 °C) if terpenes are critical. |\n| **Avoid cross‑contamination** | Clean the extraction vessel and all contact surfaces between batches. If you run multiple blended batches in a day, schedule a *clean‑in‑place* (CIP) cycle after each distinct formulation. |\n| **Labeling** | List **all source strains** on the label or accompanying documentation (e.g., “Blend of ‘Blue Dream’ and ‘Harlequin’”). If you market a specific terpene or effect profile, ensure the COA supports it. |\n\n---\n\n## 4. Decision‑tree checklist  \n\n1. **Reg\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1208 (208?1000) | Cost: $0.000000*",
      "duration": 10567,
      "grade": "F",
      "score": 53,
      "grading": {
        "accuracy": 13,
        "completeness": 13,
        "relevance": 12,
        "clarity_structure": 7,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Acknowledges that blending can be allowed depending on jurisdiction and compliance",
        "Highlights traceability and batch-level documentation",
        "Covers potency labeling and the need for COAs before and after blending",
        "Mentions homogeneity and contaminant testing with actionable QC tips"
      ],
      "weaknesses": [
        "Contains inaccurate or misleading regulatory references (e.g., U.S. federal citations, Canada/EU/TGA claims)",
        "Overly long and not the requested concise summary; includes unnecessary global tables",
        "Misses key expected points: explicit seed-to-sale tracking, same product type/category/licensee, and assigning a new batch UID",
        "Does not clearly state that some jurisdictions prohibit co-mingling prior to mandatory testing and that blending should occur only after passing required tests",
        "Formatting issues and a truncated section reduce clarity"
      ],
      "feedback": "Provide a concise 100–200 word summary focused on state-level rules. Emphasize that blending may be allowed if seed-to-sale traceability is maintained, inputs are within the same product type/category and licensee, each source lot ID is recorded, and a new batch UID is created. Clarify that potency/labeling must reflect the final blended batch and that many states require post-processing testing (and sometimes homogeneity). Note that some jurisdictions prohibit co-mingling before mandatory testing—blend only after required tests pass. Avoid inaccurate federal/foreign references and unnecessary formatting.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "must",
        "state",
        "epa",
        "sop",
        "standard",
        "documentation",
        "document",
        "record",
        "testing",
        "test",
        "coa",
        "lab",
        "potency"
      ],
      "expectedAnswer": "**Summarizing cannabis extraction rules** I need to create a summary for the user about whether it's allowed to blend two different strain inputs into a single extraction batch. The response should be concise, around 100-200 words, focusing on the general rule. Blending may be allowed, but it depends on state regulations, and it's essential to ensure traceability through the seed-to-sale system. Key requirements include using the same product type, category, and licensee, tracking each source lot ID, and assigning a new batch UID.**Understanding potency labeling requirements** I need to focus on potency labeling, which must accurately reflect the final batch. Some states have specific requirements for post-processing testing, especially for blended batches. Additionally, certain states may require a homogeneity test and might prohibit co-mingling of different inputs before mandatory testing. This means that blending should only occur after these tests have been passed, ensuring the quality and safety of the product. I’ll keep these regulations in mind!**Summarizing cannabis extraction rules** I need to summarize a question about blending different strain inputs into a single extraction batch. The user wants a concise summary of 100-200 words including key points like general rules and critical regulatory details. It seems blending might be permissible depending on state regulations. It's important to ensure traceability in the seed-to-sale system. Requirements include similar..."
    },
    {
      "questionNum": 30,
      "question": "Do I need to label intermediary oils before refinement is complete?",
      "category": "extraction-batch-production-rules",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "f8_agent",
      "agentMatch": false,
      "response": "**Short answer:**  \nYes – you must label every container that leaves the extraction/handling area, but the label can be a **trace‑ability/internal label** rather than a consumer‑ready package. The label should contain enough information to keep the batch under control and to satisfy state/ISO‑GMP audit requirements.  \n\n---\n\n## 1. Why “intermediate” containers still need a label  \n\n| Reason | What the label must convey |\n|--------|---------------------------|\n| **Traceability** (required by most state cannabis boards and ISO‑9001/GS1) | Batch/lot number, production date, strain/chemotype, extraction method, operator initials |\n| **Safety & compliance** (hazard communication, occupational health) | “CANNABIS EXTRACT – NOT FOR CONSUMPTION – HANDLE WITH PPE” and any relevant hazard symbols (e.g., flammable, irritant) |\n| **Potency / QC status** | Current THC/CBD % (if already analyzed) **or** “Potency pending – to be verified before final packaging” |\n| **Inventory control** | Container size, volume, storage location, expiration/hold‑until‑tested date |\n| **Regulatory audit trail** | Link to the electronic batch record (QR code or barcode) so an inspector can pull the full COA later |\n\n---\n\n## 2. What a minimum “intermediate‑oil” label looks like  \n\n| Field | Example (for a 500 mL amber glass jar) |\n|-------|----------------------------------------|\n| **Product ID** | **INT‑OIL‑B001‑23‑07** |\n| **Batch/Lot** | **B001‑23‑07** |\n| **Strain / Chemotype** | **Hybrid – “Blue Dream”** |\n| **Extraction method** | **CO₂ – subcritical** |\n| **Date produced** | **2025‑10‑15** |\n| **Current potency** | **THC ≈ 55 % (pending final QC)** |\n| **Status** | **UNREFINED – ANALYSIS REQUIRED** |\n| **Safety warning** | **CANNABIS EXTRACT – NOT FOR CONSUMPTION – Keep out of reach of children. Wear gloves and eye protection.** |\n| **QR/Barcode** | *links to LIMS batch record* |\n| **Storage** | **Store at ≤ 25 °C, protected from light** |\n\n*You can print this on a 2‑inch self‑adhesive label or use a durable laser‑etched tag.*\n\n---\n\n## 3. Regulatory references (U.S. focus – adjust for your jurisdiction)\n\n| Jurisdiction | Requirement |\n|--------------|-------------|\n| **California (BPC) – Cannabis Track-and-Trace** | Every “intermediate” must be assigned a unique **Batch ID** and have a **Physical Label** that includes the ID, product type, and a “Not for Sale” statement. |\n| **Colorado (MED‑REC)** | Requires **“intermediate”** containers to be labeled with lot number, date, and “Not for Human Consumption – Pending Testing”. |\n| **Oregon (MCR)** | Mandates **traceability labels** on all containers that leave the extraction area, even if potency is “TBD”. |\n| **ISO‑GMP / ASTM D-4215** | Calls for **identification of each container** and **status of analysis** (e.g., “analysis pending”). |\n| **FDA (food‑grade carrier oils)** | If the oil will later become a food supplement, the **intermediate** must still meet **21 CFR 184.1100** labeling for “raw material” – batch number, date,\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1205 (205?1000) | Cost: $0.000000*",
      "duration": 11460,
      "grade": "B",
      "score": 85.66666666666667,
      "grading": {
        "length": "Pass",
        "keywords": "13/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "2/5 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "sop",
        "standard",
        "record",
        "log",
        "lab",
        "potency"
      ],
      "expectedAnswer": "**Generating compliance summary** I need to summarize key points regarding labeling intermediary oils before refinement. This involves critical regulatory details and state-specific requirements, particularly in the cannabis industry. General regulations typically mandate lot identification and labeling of work-in-progress materials, requiring containers to be labeled with unique identifiers, product details, production dates, and risks. Final retail labeling rules don't apply to work-in-progress, but internal process labels are essential for traceability and chain-of-custody during storage and transfer.**Summarizing compliance requirements** I need to create a summary regarding whether intermediary oils require labeling before refinement. The main conclusion involves that general cannabis regulations often require lot/batch identification for work-in-progress materials, especially concerning traceability in the supply chain. Requirements typically include using a container with UID/lot/batch ID, product description, weight/volume, production date, and licensee information. While final retail labeling doesn't apply to WIP, internal process labels are essential for tracking and storage within licensed premises."
    },
    {
      "questionNum": 31,
      "question": "Can I repackage bulk oil into smaller units without creating a new UID?",
      "category": "inventory-repackaging-tracking",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In almost every U.S. cannabis‑tracking jurisdiction you **must assign a new UID** to each smaller container that results from repack bulk oil. The bulk‑container UID stays on record for traceability, but the consumer‑ready units each need their own unique identifier.\n\n---\n\n## Why a new UID is required\n\n| Reason | Explanation |\n|--------|-------------|\n| **Traceability** | Regulators need to follow the product from seed to sale, including every “hand‑off.” A new UID creates a clear link between the bulk lot and each downstream package. |\n| **Inventory control** | Your seed‑to‑sale system (Metrc, BioTrackTHC, Leaf Data, etc.) tracks quantity by UID. Without a new UID the system can’t reconcile how much oil was taken out of the bulk container and where it went. |\n| **Compliance audits** | Inspectors will ask to see the “parent‑UID” on the repackaging record and a new UID on each finished package. Missing UIDs are a common citation. |\n| **Consumer safety** | In the event of a recall, the specific UID on the retail package tells the consumer exactly which batch is affected. |\n\n---\n\n## Typical regulatory workflow (example: California Metrc)\n\n1. **Start with a bulk container** that already has a Metrc‑assigned UID (e.g., “BULK‑001”).  \n2. **Create a “repackage” transaction** in Metrc:  \n   - Select the bulk UID as the *source*.  \n   - Enter the *destination* type (e.g., “consumer‑ready bottle”).  \n   - Specify the quantity removed (e.g., 0.5 g per bottle).  \n3. **Metrc generates a new UID** for each destination package (e.g., “PKG‑001‑001”, “PKG‑001‑002”, …).  \n4. **Print and affix the new label** (including the new UID, batch/strain info, potency, etc.).  \n5. **Keep the bulk container** on hand (or record its disposal) until its remaining quantity is zero, then close it out.\n\nThe same pattern exists in other states (CO, MA, OR, etc.), even if the UI differs.\n\n---\n\n## Exceptions & special cases\n\n| Situation | What the rule looks like |\n|-----------|--------------------------|\n| **Wholesale “transfer‑only”** | If you’re moving bulk oil from one licensed facility to another (no consumer packaging), you keep the original UID—no new UID needed. |\n| **“Parent‑child” labeling** | Some states allow you to print a *secondary* label on the child container that references the parent UID **plus** a child identifier (e.g., “BULK‑001‑A”). Technically this is still a *new* UID, just derived from the parent. |\n| **Small‑scale “internal” repackaging** (e.g., a licensed processor repackaging for its own retail brand) | Still requires a new UID per final package; the only way to stay compliant. |\n| **Non‑cannabis oil (e.g., carrier oil only)** | If the product contains **no cannabis** (0 % THC, 0 % CBD), it may be exempt from UID rules, but you must verify with the state’s “non‑controlled substance” guidance. |\n\n---\n\n## Practical steps for you\n\n1. **Check your state’s tracking manual** (Metrc, BioTrackTHC, etc.) for the exact “Repackage” transaction flow.  \n2. **Make sure your packaging line can print new labels** (QR code/UID) on each small unit.  \n3. **Document the parent‑UID** in your SOP: every repackaging batch should have a log sheet linking the bulk lot to the list of new UIDs.  \n4. **\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1166 (166?1000) | Cost: $0.000000*",
      "duration": 10590,
      "grade": "B",
      "score": 87,
      "grading": {
        "accuracy": 26,
        "completeness": 22,
        "relevance": 19,
        "clarity_structure": 12,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly answers the question: new UIDs are required for smaller repackaged units",
        "Explains rationale (traceability, inventory control, audits, safety)",
        "Provides a practical workflow example (Metrc) including labeling and closing out bulk",
        "Covers parent-child linkage and common exceptions",
        "Actionable steps to implement in seed-to-sale systems"
      ],
      "weaknesses": [
        "Minor inaccuracy: implies Metrc generates new UIDs rather than using licensee-assigned preprinted package tags",
        "Does not explicitly address carrying forward QA/COA testing status to the new packages",
        "Includes extraneous/non-essential exception (non-cannabis oil) that could distract",
        "Wholesale transfer exception could be clearer (keeping same UID only if not splitting the bulk)",
        "Section is truncated under Practical steps and includes meta text, slightly reducing clarity"
      ],
      "feedback": "Strong, practical, and accurate guidance that clearly states new UIDs are required when repackaging bulk oil into smaller units, with helpful reasoning and workflow detail. To reach an excellent grade, explicitly mention carrying forward QA testing status/COA to child packages, clarify that in Metrc licensees apply preprinted package tags rather than the system generating UIDs, tighten the wholesale transfer exception (same UID only if the package is not split), remove non-relevant exceptions, and fix the truncated steps.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "inventory",
        "repackaging",
        "tracking",
        "metrc",
        "seed-to-sale"
      ],
      "expectedAnswer": "**Considering packaging and UIDs** Repackaging oil into smaller units probably means I need new UIDs for each new package. I also have to adjust inventory and maintain the chain of custody, ensuring that the QA testing status is carried over. The labeling will need to include the UID of the final package, and I shouldn't reuse the same UID. However, I wonder if there's a special case for when it's the same package? That might complicate things!**Considering repackaging requirements** Repackaging oil into smaller units probably means I need new UIDs for each package. I must adjust the inventory and ensure the chain of custody is maintained. It's crucial to carry over the QA testing status, and the labeling must include the UID of the final package without reusing the same UID. Wait, I wonder if there's a special case if it’s the same package? I'll need to clarify that!"
    },
    {
      "questionNum": 32,
      "question": "Is it compliant to pre-fill vape cartridges before the lab test results are back?",
      "category": "inventory-repackaging-tracking",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In virtually every U.S. state (and under federal guidance) you may **not release or sell** a vape‑cartridge product until you have a **finished‑product Certificate of Analysis (COA)** confirming that the batch meets all potency, purity, and contaminant limits. Pre‑filling cartridges *before* you have those results is only permissible if the product remains in a **quarantine/hold status** and is not placed in the market.\n\n---\n\n## Why the rule exists\n\n| Regulatory source | What it requires | How to pre‑filling |\n|-------------------|------------------|-------------------------------|\n| **State cannabis statutes & rules** (e.g., CA Bureau of Cannabis Control, CO Regulation, WA LIC) | Every batch must be tested for cannabinoids, pesticides, heavy metals, residual solvents, microbial load, and any state‑specific limits before “sale or distribution.” | Cartridges that have been filled but are still in the lab’s “hold” area are **not** considered “distributed.” Once the batch is released from quarantine, a COA is mandatory. |\n **US Food & Drug Administration (FDA) guidance** (e.g., “Guidance for Industry: Cannabis‑Derived Products”) | Products that are “intended for human consumption” must be demonstrated safe and accurately labeled before they reach the consumer. | Pre‑filling is allowed only as a **manufacturing step**; the product may not be labeled, packaged for retail, or shipped to dispensaries until testing is complete. |\n| **Good Manufacturing Practices (GMP) / ISO 22716** | Raw material testing, in‑process testing, and finished‑product testing must be documented; any material that fails any test must be **segregated**. | The cartridge batch must be placed in a **quarantine** location, with full traceability, until the final COA is signed off. |\n\n---\n\n## What “pre‑fill” usually means in practice\n\n Step | Typical status | Compliance note |\n|------|----------------|-----------------|\n| **1. Fill cartridges with oil** (raw or partially refined) | In‑process material, often still under “hold” | Allowed **if** you keep the tubes sealed, label them as “QC‑Hold” and do **not** apply retail labeling or packaging. |\n| **2. Conduct in‑process checks** (potency, viscosity, terpene profile) | Still a “test sample” | Useful for early decision‑making, but **cannot** replace the final COA. |\n| **3. Send the filled batch to a certified lab** | Sample is in “testing” status | Keep the entire batch in a secure, temperature‑controlled quarantine area. |\n| **4. Receive COA** (potency, pesticides, heavy metals, residual solvents, microbial) | **Release** to packaging/ing line only after COA meets all limits. | This is the point where the product can be moved to retail packaging and shipped. |\n\n## Risks of releasing before COA\n\n1. **Regulatory violation** – Most state licensing boards will treat the act as “distribution of an untested product,” which can lead to suspension or revocation of the license, fines, and possible criminal charges.\n2. **Consumer safety** – Undetected contaminants (e.g., pesticide residues, heavy metals, solvent spikes) can cause adverse events, leading to recalls, liability, and brand damage.\n3. **Label accuracy** – Potency may shift during the fill process (e.g., loss of volatiles, crystallization). Without a final COA you risk mislabeling THC/CBD percentages, which is a major compliance breach.\n4. **Insurance & liability** – Most product liability policies require that the product meet all regulatory testing requirements before it leaves the facility.\n\n---\n\n## Best‑practice workflow (compliant)\n\n1. **Raw‑material QC** – Test each batch of distillate, terpene isolate, or CO extract before it ever touches the cartridge.\n2. **In‑process monitoring** – Optional\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1209 (209?1000) | Cost: $0.000000*",
      "duration": 10619,
      "grade": "D",
      "score": 62,
      "grading": {
        "accuracy": 18,
        "completeness": 11,
        "relevance": 13,
        "clarity_structure": 12,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly states the core principle that products cannot be released or sold without a final COA",
        "Explains that pre-filling is only acceptable if the batch remains on quarantine/hold",
        "Provides practical workflow steps and risk considerations"
      ],
      "weaknesses": [
        "Does not address New York-specific OCM regulations or cite 9 NYCRR Parts (e.g., Part 128 testing, Part 130 packaging/labeling)",
        "Introduces irrelevant/incorrect federal FDA guidance for state-legal cannabis",
        "Overgeneralizes across states and misnames agencies (e.g., WA LIC; CA BCC now DCC)",
        "Asserts details like “lab’s hold area” that are inaccurate; quarantine is maintained by the licensee, not the lab",
        "Omits inventory tracking and repackaging specifics required by NY (e.g., track-and-trace holds, batch sampling of finished vape units)"
      ],
      "feedback": "Your answer gets the main compliance principle right—no release or sale before a final COA and pre-filling is only acceptable under quarantine. However, the question seeks New York adult-use specifics. Reference and align with NY OCM rules (9 NYCRR), especially Part 128 (laboratory testing and sampling of the finished product form), Part 130 (packaging/labeling), and manufacturing provisions. Clarify that quarantine/hold is maintained by the licensee within the state track-and-trace system (e.g., METRC), not by the lab, and detail inventory segregation, labeling (e.g., QC Hold), and prohibition on retail packaging/labeling until results are back. Remove FDA references and state-specific agency errors. Add what happens if the batch fails (rework/destroy) and how to record these actions in track-and-trace. Provide a concise NY-specific yes/no conclusion: pre-filling is permitted only if the finished units remain quarantined in inventory, in track-and-trace, with no distribution or retail packaging until a passing COA for the finished vape batch is received.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "required",
        "must",
        "state",
        "oregon",
        "standard",
        "document",
        "record",
        "testing",
        "test",
        "coa",
        "certificate",
        "analysis",
        "lab",
        "potency"
      ],
      "expectedAnswer": "**Summarizing compliance for vape cartridges** I need to create a concise summary about whether it's compliant to pre-fill vape cartridges in New York before lab test results are back. It’s essential to include compliance details, inventory tracking, and main regulations for adult-use cannabis set by the Office of Cannabis Management (OCM). I'll focus on requirements for manufacturers, addressing testing protocols that need to be followed before sale, including final product sampling. Knowing the specific requirements for inhalable extracts and vape products is crucial here.**Recalling NY cannabis regulations** I need to recall specific parts of New York regulations, particularly the NY 9 NYCRR. There’s Part 130 on Packaging and Labeling, Part 128 covering Laboratory Testing, and I think there’s also Part 123 for Manufacturing and maybe Part 125? It’s important to keep these regulatory sections in mind when discussing compliance for adult-use cannabis in New York. I should focus especially on Part 130, which addresses Packaging, Labeling, and Marketing.**Assessing vape cartridge compliance** I need to create a summary on whether it's compliant to pre-fill vape cartridges before lab test results come back in New York. I’ll explore compliance details, including inventory tracking and repackaging. I'll summarize essential requirements and critical regulatory information, particularly focusing on New York's cannabis regulations from the Office of Cannabis Management. Typically, p..."
    },
    {
      "questionNum": 33,
      "question": "Do I have to update the batch weight in the system if I lose some product to spillage?",
      "category": "inventory-repackaging-tracking",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** Yes—any loss that changes the amount of product in a batch should be recorded in your tracking system.\n\n---\n\n### Why you need to update the batch weight\n\n| Reason | What it means for you |\n|--------|-----------------------|\n| **Regulatory compliance** | State cannabis regulators require a complete, auditable chain‑of‑custody. Unrecorded spillage creates a discrepancy between the amount you started with and the amount you end up selling or disposing of. |\n| **Accurate inventory & costing** | Your cost‑of‑goods‑sold (COGS) and yield calculations are based on the true weight that moves through the process. Un‑adjusted weights will over‑state product output and under‑state waste. |\n| **Traceability & recall safety** | If a batch ever needs to be recalled, you must be able to show exactly how much product was produced, processed, and where any loss occurred. |\n| **Financial reporting** | Waste and loss affect profit margins and tax reporting (e.g., Section 280E considerations). |\n\n---\n\n### How to handle spillage in most seed‑to‑sale systems (e.g., METRC, BioTrackTHC, MJ Freeway)\n\n1. **Create a “Waste” or “Loss” transaction**  \n   - Choose the appropriate waste type (e.g., *Spillage*, *Breakage*, *Evaporation*).  \n   - Enter the exact weight lost (preferably measured with a calibrated scale).  \n\n2. **Link the waste entry to the original batch**  \n   - Most systems let you select the parent batch ID so the adjustment is reflected in the batch’s net weight.  \n\n3. **Add a brief note**  \n   - Include date, location, cause (e.g., “Container tip‑over in packaging area”), and the employee responsible.  \n\n4. **Adjust the batch’s “Current Net Weight”**  \n   - The system will automatically recalc the net weight after the waste entry, but verify it matches your manual calculation.  \n\n5. **Update inventory balances**  \n   - The waste entry will deduct the lost weight from your on‑hand inventory. Confirm the “available for sale” quantity reflects the reduction.  \n\n6. **Report to the regulator (if required)**  \n   - Some states require a separate waste manifest or a periodic loss report. Export the waste record and attach it to your compliance filing.  \n\n7. **Reconcile at the end of the shift / day**  \n   - Perform a quick physical count of the batch’s remaining product and compare it to the system’s net weight. Any remaining variance should be investigated and logged.  \n\n---\n\n### Quick checklist you can paste into a SOP\n\n- [ ] Measure spillage weight on a calibrated scale.  \n- [ ] Log a *Waste* transaction in the tracking software, selecting the correct waste type.  \n- [ ] Attach batch ID and a concise description of the incident.  \n- [ ] Verify the system’s net batch weight matches the physical remaining product.  \n- [ ] Include the waste entry in the daily/shift inventory reconciliation.  \n- [ ] Export or file the waste record per state reporting requirements.  \n\n---\n\n### Bottom line\n\n**Never leave a batch weight unchanged after a loss.** Recording spillage keeps your operation compliant, financially accurate, and ready for any audit or recall scenario. If you’re using a paper log, be sure to transfer the entry to the electronic system as soon as possible to maintain a single source of truth.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1079 (171?908) | Cost: $0.000000*",
      "duration": 8098,
      "grade": "C",
      "score": 73,
      "grading": {
        "accuracy": 25,
        "completeness": 10,
        "relevance": 15,
        "clarity_structure": 14,
        "practical_value": 9,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly answers the question with a clear yes",
        "Provides actionable, step-by-step guidance on how to record spillage",
        "Emphasizes auditability, reconciliation, and documentation best practices",
        "Well-structured and easy to follow"
      ],
      "weaknesses": [
        "Missing New York-specific compliance details expected (OCM rules, BioTrack requirement)",
        "Does not mention daily reconciliation requirement in NY",
        "Omits 5-year record retention requirement",
        "No citation or reference to 9 NYCRR Parts 120–134",
        "Platform list is generic and may confuse jurisdictional requirements (NY uses BioTrack, not METRC for adult-use)"
      ],
      "feedback": "Good operational guidance and a correct conclusion that spillage must be recorded as a weight adjustment, but it lacks New York-specific compliance elements required by the expected answer. To improve, explicitly reference New York OCM requirements, note that BioTrack is the mandated system, state that licensees must reconcile inventory daily, retain records for five years, and cite 9 NYCRR Parts 120–134. Include how to perform the adjustment specifically in BioTrack and any NY reporting nuances.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "required",
        "state",
        "metrc",
        "sop",
        "standard",
        "documentation",
        "document",
        "record",
        "log",
        "potency",
        "batch",
        "thc",
        "date"
      ],
      "expectedAnswer": "**Researching cannabis compliance** I need to create a concise summary focusing on the cannabis industry compliance in New York regarding updating batch weight due to spillage. I should familiarize myself with NY regulations on inventory adjustments and waste. Notably, New York uses BioTrack for adult-use seed-to-sale tracking since 2023, and licensees must reconcile inventory daily and record any adjustments, including spillage and waste, maintaining records for five years. I should review OCM regulations and relevant parts to clarify.**Summarizing cannabis compliance** I need to create a concise summary for a cannabis compliance question in New York about updating batch weight in relation to product loss from spillage. It's essential to know NY regulations concerning inventory adjustments, including waste and destruction, particularly related to METRC and BioTrack. As of 2023, New York's OCM mandates using BioTrack for both medical and adult-use products. Licensees must reconcile inventory daily, record adjustments, and retain records for five years, in line with regulations in 9 NYCRR Parts 120-134."
    },
    {
      "questionNum": 34,
      "question": "Do I need to generate a new COA if I repackage the same batch in a different container?",
      "category": "inventory-repackaging-tracking",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:**  \nNo – you do **not** normally have to obtain a brand‑new Certificate of Analysis (COA) simply because you move a finished batch into a different container, **provided that**:\n\n1. **The product itself (potency, terpene profile, contaminants, moisture, etc.) is unchanged.**  \n2. **The new container does not introduce any new material that could leach into the product or otherwise alter its chemistry.**  \n3. **All labeling, lot‑numbering, and traceability information is updated to reflect the new packaging.**  \n\nIf any of the above conditions are not met, a supplemental or new COA is required.\n\n---\n\n## Why the COA Usually Stays Valid\n\n| Factor | Why it usually doesn’t require a new COA |\n|--------|------------------------------------------|\n| **Product composition** | The COA documents the chemical makeup of the *product* (THC, CBD, terpenes, pesticides, heavy metals, etc.). Changing only the container does not change those values. |\n| **Regulatory focus** | Most state and federal regulations treat the COA as a batch‑level document, not a packaging‑level document. |\n| **Cost & turnaround** | Re‑testing the same material would be redundant and wasteful unless the container could affect the test results. |\n\n---\n\n## When a New COA *or* Supplemental Testing Is Required\n\n| Situation | What to do |\n|----------|------------|\n| **Container material can interact with the product** (e.g., switching from glass to certain plastics, metal cans, or a container with a liner that could leach phthalates, BPA, heavy metals, etc.) | Perform a **leachables/extractables study** and, if any new contaminants are detected above limits, issue a supplemental COA covering those analytes. |\n| **Significant change in storage conditions** (e.g., moving from a refrigerated bulk drum to a room‑temperature bottle) | Verify that the product’s stability data cover the new conditions; if not, run a **stability test** and attach the results to the original COA. |\n| **Labeling claims change** (e.g., you now claim “full‑spectrum” or “THC‑dominant” on the new package) | Ensure the existing COA supports the new claim; if the claim is new, you may need a **supplemental COA** that highlights the relevant data. |\n| **Regulatory jurisdiction requires a “package‑specific��� COA** (some states, e.g., California’s “product‑specific” requirement) | Follow the state’s guidance; you may need to submit a **re‑certified** COA that references the original batch but notes the new container. |\n| **Batch is split into multiple sub‑lots** (e.g., 1 L bulk → 10 × 100 mL bottles) | Keep the original COA, but create a **lot‑traceability matrix** linking each sub‑lot to the parent batch. No new analytical work is needed unless the sub‑lotting process could cause contamination. |\n\n---\n\n## Practical Checklist Before Repackaging\n\n1. **Confirm container compatibility**  \n   * Review the container’s material safety data sheet (MSDS) for leachables.  \n   * Run a quick **blank extraction** of the empty container and test for the same contaminants that are part of your COA (pesticides, heavy metals, residual solvents).  \n\n2. **Update documentation**  \n   * New **Packaging Specification Sheet** (material, dimensions, closure type).  \n   * Revised **Batch Record** that links the original COA (include COA number, date, lab) to the new container lot number.  \n\n3. **Labeling**  \n   * Include the original batch/lot number, potency range, and a statement such as “Repackaged from batch # XXXX – COA on file.”  \n   * If the container size changes, adjust the “serving size” and “dose per container” on the label.  \n\n4. **Stability check (if not already done)**  \n   * If the new container has a different barrier property\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1220 (220?1000) | Cost: $0.000000*",
      "duration": 4519,
      "grade": "C",
      "score": 76,
      "grading": {
        "accuracy": 23,
        "completeness": 15,
        "relevance": 17,
        "clarity_structure": 13,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly answers the question with a clear default (no new COA if only the container changes and product is unchanged)",
        "Provides useful caveats and scenarios where additional testing or documentation may be needed",
        "Well-structured with actionable checklists and documentation guidance",
        "Acknowledges jurisdictional variability and traceability considerations"
      ],
      "weaknesses": [
        "Misses the key point about finished product testing when repackaging infused/modified products or when changing net weight per unit, which may require potency/homogeneity verification",
        "Overgeneralizes by referencing federal regulations for cannabis COAs and implies leachables/stability work as regulatory requirements rather than risk-based best practices",
        "Does not explicitly tie package-level COA/testing to dose/unit changes, a central element of the expected guidance",
        "Some content is overly detailed or tangential (e.g., leachables studies, stability programs) relative to the specific question"
      ],
      "feedback": "Good, practical overview that generally correctly states that a new COA is not required for a container-only change, with helpful process and documentation tips. To meet the expected standard, explicitly address that repackaging infused or modified products or changing the net weight per unit can trigger finished product testing to verify potency and homogeneity at the package level. Be careful not to overstate regulatory requirements (e.g., federal) and frame leachables/stability as risk-based best practices unless specifically required by the jurisdiction.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "required",
        "state",
        "epa",
        "standard",
        "documentation",
        "document",
        "record",
        "testing",
        "test",
        "coa",
        "certificate",
        "analysis",
        "lab"
      ],
      "expectedAnswer": "**Considering product re-packaging** Re-packaging can be a bit complex because it might require testing the finished product, especially if it's infused or modified. I need to think about whether changing the net weight could trigger a need for homogeneity or potency verification at the package level. It's important to ensure compliance and that everything is properly assessed in these scenarios. Let's make sure to cover all bases when it comes to re-packaging!**Considering product re-packaging** When re-packaging, it's important to think about whether we need to conduct a finished product test. This is especially true if the product has been infused or modified, or if the changes affect the net weight unit. Those aspects might require verifying homogeneity or potency at the package level. It sounds like a crucial step to ensure we meet quality and regulatory standards effectively!"
    },
    {
      "questionNum": 35,
      "question": "Can I submit test results to regulators before final packaging is complete?",
      "category": "inventory-repackaging-tracking",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most U.S. cannabis jurisdictions you can (and often must) submit laboratory results **before** the product is placed in its final consumer‑ready package, but the exact timing, format, and any “provisional release” requirements vary by state and sometimes by local authority.  \n\nBelow is a quick checklist you can use right now, followed by pointers on where you’ll need to dig deeper for your specific market---\n\n## 1. General Regulatory Landscape (U.S. States)\n\n| State | Typical Requirement | Can you submit before final packaging? |\n|-------|----------------------|----------------------------------------|\n| **California (Bureau of Cannabis Control)** | Test results must be attached to the **seed‑to‑sale** record and sent to the state’s **track‑and‑trace** system before the product can be sold. | Yes – results are entered into the METRC system as soon as the lab finishes. The product can still be in bulk or in a “pre‑package” stage. |\n| **Colorado (Colorado Department of Revenue – Marijuana Enforcement Division)** | Lab reports must be uploaded to **METRC** and a **Certificate of Analysis (COA)** generated before the product can be moved to “Ready for Sale.” | Yes – bulk testing is common. Final consumer packaging can be done after the COA is attached to the batch. |\n| **Oregon (Oregon Liquor and Cannabis Commission)** | Results must be entered in **Metrc Oregon** before the product is moved to “Packaged.” | Yes – the state expects the COA before the final label is printed, but the product must be in its *final* container (e.g., flower in a sealed bag) for testing. |\n| **Washington (Liquor and Cannabis Board)** | Lab results must be recorded in **Metrc** before the product can be shipped to a retailer. | Yes – testing is done on the **finished product**, but the COA can be entered before the retailer receives it. |\n| **Massachusetts (Department of Cannabis Control)** | COA required before “saleable” status is assigned in the state’s **track‑and‑trace** system. | Yes – bulk or intermediate packaging is acceptable as long as the lab tested the final product form (e.g., flower in a sealed bag). |\n| **Canada (Health Canada)** | Test results must be uploaded to the **Cannabis Tracking System (CTS)** before product can be released for sale. | Yes – testing is performed on the **final packaged product**, but the COA can be entered before the label is affixed, provided the product is sealed. |\n\n**Key take‑away:** Most regulators require that the **COA be entered into the state tracking system before the product can be moved to a “saleable” or “ready for distribution” status**, but they do **not** always require the *consumer‑ready* package to be completed first. The lab usually tests the product **as it will be sold** (e.g., flower in a sealed bag, oil in a vape cartridge) – not the cardboard box or external label.\n\n---\n\n## 2. Common Steps to Submit Early\n\n1. **Finish Lab Testing on the “final product form.”**  \n   - For flower: sealed, unlabelled bag.  \n   - For edibles: sealed container (e.g., gummy bag).  \n   - For concentrates: sealed cartridge or vial.\n\n2. **Obtain the COA** (PDF + electronic data file).  \n   - Verify that the lab’s chain‑of‑custody matches your batch number.\n\n3. **Enter the COA into the state’s track‑and‑trace system** (METRC, CTS, etc.).  \n   - Include batch/lot number, test date, lab license, and result values.\n\n4. **Generate a “Provisional Release” or “Ready for Packaging” status** (if your state uses it).  \n   - Some states (e.g., CO) let you move the batch to a “packaged” status\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1164 (164?1000) | Cost: $0.000000*",
      "duration": 7167,
      "grade": "F",
      "score": 42,
      "grading": {
        "accuracy": 10,
        "completeness": 6,
        "relevance": 9,
        "clarity_structure": 12,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear structure with a short answer, table, and checklist",
        "Acknowledges that requirements vary by jurisdiction",
        "Provides actionable procedural steps at a high level"
      ],
      "weaknesses": [
        "Fails to address New York’s specific requirements (9 NYCRR Parts 130 and 132) central to the expected answer",
        "Contradicts the expected guidance that testing must be on the final packaged product and that submitting results before final packaging is typically not allowed in NY",
        "Contains likely inaccuracies/outdated references (e.g., California’s Bureau of Cannabis Control instead of the Department of Cannabis Control)",
        "Overgeneralizes across states without citations and may mislead on when testing must occur relative to packaging",
        "Omits discussion of batch/lot matching, label alignment, and retesting implications after repackaging"
      ],
      "feedback": "The answer is well-structured but misses the core requirement: in New York, adult-use testing must be performed on the final product in its completed packaging, with results tied to specific lots and labels; submitting results before final packaging is typically not allowed. Remove outdated agency references, avoid broad generalizations, and cite NY-specific rules (9 NYCRR Parts 130 and 132). Clarify that repackaging after testing can trigger retesting, and align guidance to the NY standard.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "inventory",
        "repackaging",
        "tracking",
        "metrc",
        "seed-to-sale",
        "packaging"
      ],
      "expectedAnswer": "**Synthesizing cannabis regulations** In New York, under the adult-use cannabis regulations for 2023/2024, testing must be conducted on the final product in its completed form and packaging. Test results are required to be associated with specific batches or lots, matching the product label with tested samples. While repackaging after testing may not be permitted unless products undergo retesting, many states require tests to occur after packaging or final formulation. Thus, submitting test results before final packaging is typically not allowed.**Reviewing New York cannabis regulations** I need to recall the specifics of 9 NYCRR Part 130, which covers the packaging and labeling for adult-use cannabis. It mandates that packaging must be child-resistant and tamper-evident to enhance safety. Additionally, I should keep in mind 9 NYCRR Part 132, which outlines testing requirements. These regulations are key to ensuring compliance within the cannabis industry and are important for maintaining quality and safety standards in New York.**Summarizing NY cannabis regulations** I need to summarize New York's cannabis regulations, particularly regarding test results and packaging. In New York for adult-use, testing must be conducted on the final product in its final form and packaging. The NY OCM regulations state that sampling must be from either a harvest or process lot, and test results should correspond to specific batches, ensuring labels match tested samples. Additionally, packagi..."
    },
    {
      "questionNum": 36,
      "question": "Am I allowed to digitally sign the waste disposal manifest, or do I need a physical copy?",
      "category": "recordkeeping-logs",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:**  \nIn most U.S. jurisdictions (EPA‑RCRA) a **digital/e‑signature is permissible** for a hazardous‑waste manifest **provided the electronic system meets the agency’s authentication, integrity, and record‑keeping requirements**. However, some state or local programs still **require a wet‑ink signature** on a hard copy, so you must verify the specific rules that apply to you.\n\n---\n\n## 1. Federal (EPA‑RCRA) Guidance  \n\n| Requirement | What it means for you |\n|-------------|-----------------------|\n| **Electronic Signature Definition** | Any electronic sound, symbol, or process attached to or logically associated with a record that a person uses to sign the record. |\n| **Authentication** | The system must reliably identify the signer (e.g., unique user ID, password, two‑factor authentication, digital certificate). |\n| **Integrity/Non‑repudiation** | The manifest must be tamper‑evident (e.g., audit trail, hash‑based verification, secure PDF). |\n| **Record Retention** | The electronic copy must be retained for the same period as a paper manifest (usually 3 years after closure of the waste stream). |\n| **EPA Acceptance** | EPA’s “Electronic Signatures for Hazardous Waste Manifests” guidance (EPA‑HQ‑OW‑2002‑0005) expressly permits e‑signatures when the above criteria are met. |\n\n**What you can do:**  \n- Use an EPA‑approved e‑signature platform (e.g., DocuSign, Adobe Sign, or a proprietary system that meets the criteria).  \n- Ensure each signer’s identity is captured (name, title, date/time, IP address).  \n- Store the signed PDF in a secure, read‑only repository with an audit log.  \n\n---\n\n## 2. State & Local Variations  \n\n| State | Typical Requirement | Notes |\n|-------|---------------------|-------|\n| **California (DTSC)** | Accepts electronic signatures for the **Uniform Hazardous Waste Manifest (UHW)** if the system complies with California’s “Electronic Signature Act.” | Must retain the electronic record in a manner consistent with Cal. Code Regs. tit. 22. |\n| **New York** | Allows e‑signatures for the **NY State Hazardous Waste Manifest** but requires a “signature acknowledgment” clause. | Check NYDEC guidance. |\n| **Texas** | Generally permits e‑signatures for the **Texas Hazardous Waste Manifest**; however, some counties still request a wet‑ink copy for local enforcement. | Confirm with the Texas Commission on Environmental Quality (TCEQ). |\n| **Other states** | Many have adopted the EPA’s stance, but a handful (e.g., some Midwest states) still **require a physical copy** for certain waste streams (e.g., universal waste, certain medical waste). | Verify with the state environmental agency. |\n\n**Action step:**  \n- Look up the “hazardous waste manifest” section on your state’s environmental agency website.  \n- If the regulation is silent or ambiguous, contact the agency’s compliance hotline for clarification.\n\n---\n\n## 3. Practical Checklist Before Going Digital  \n\n1. **Confirm Acceptance** – Verify that the regulator (EPA + state) explicitly permits e‑signatures for the manifest you are filing.  \n2. **Choose a Compliant Platform** – It must provide:  \n   - User authentication (unique login, MFA).  \n   - Audit trail (who signed, when, IP address).  \n   - Tamper‑evident file (locked PDF, hash).  \n3. **Document the Process** – Keep a SOP that describes how signatures are captured, stored, and retrieved.  \n4. **Retention** – Store the signed manifest in a secure, read‑only system for the required retention period (usually 3 years).  \n5. **Backup** – Maintain an off‑site backup in case of system failure.  \n6. **Training** – Ensure\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1137 (137?1000) | Cost: $0.000000*",
      "duration": 12481,
      "grade": "F",
      "score": 34,
      "grading": {
        "accuracy": 11,
        "completeness": 4,
        "relevance": 5,
        "clarity_structure": 9,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear structure with sections and a practical checklist",
        "Highlights key elements of e-signature compliance (authentication, audit trail, retention)",
        "Encourages verification with regulators"
      ],
      "weaknesses": [
        "Conflates hazardous waste (RCRA) manifests with cannabis waste disposal requirements",
        "Not tailored to New York cannabis regulations or OCM/MRTA requirements",
        "Omits references to relevant NY adult-use regulations (e.g., 9 NYCRR Parts 123, 125, 130, 135)",
        "Contains potentially inaccurate or unsourced state-specific claims (e.g., NY DEC signature acknowledgment)",
        "Does not answer whether NY cannabis waste manifests can be digitally signed",
        "Ends abruptly with an incomplete bullet point"
      ],
      "feedback": "The answer is well-structured and offers general e-signature considerations, but it addresses federal hazardous waste manifests rather than New York cannabis waste documentation. It fails to reference OCM/MRTA or the relevant NY regulations (e.g., 9 NYCRR Parts 123, 125, 130, 135) and does not directly resolve whether digital signatures are allowed for NY cannabis waste manifests. Refocus on NY OCM rules, cite the specific parts, and state clearly whether digital signatures are permitted, including any recordkeeping and audit-trail requirements.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "washington",
        "federal",
        "epa",
        "agency",
        "board",
        "sop"
      ],
      "expectedAnswer": "**Analyzing digital signatures for cannabis waste disposal** I'm looking to summarize regulations around whether a digital signature is allowed for waste disposal manifests in New York cannabis law. I need to consider the specific guidelines from the Office of Cannabis Management (OCM) and the MRTA. Typically, many states allow electronic signatures if there are security measures and audit trails. I should verify what the NY regulations specifically require regarding digital versus physical documentation in the context of waste management and recordkeeping.**Clarifying New York cannabis regulations** I'm trying to clarify the specific regulations related to adult-use cannabis in New York. This includes examining Part 123 for adult-use processors, Part 125 for distribution, and possibly Part 130. I also need to consider recordkeeping requirements under 9 NYCRR Part 135. It's a bit confusing, and I’m not entirely sure about the details, but I want to ensure I provide accurate and relevant information regarding compliance for adult-use cannabis.**Evaluating cannabis regulations** I need to summarize the cannabis question about digital signatures on waste disposal manifests, specifically for New York regulations. The key focus is on whether digital signatures are accepted versus needing a physical copy. In New York, the Office of Cannabis Management oversees these regulations, including waste disposal manifests and electronic records. I’ll check if New York allows electronic sign..."
    },
    {
      "questionNum": 37,
      "question": "How long do I need to retain extraction logbooks for compliance?",
      "category": "recordkeeping-logs",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Retention period for extraction‑logbooks is set by the state (or province) where you operate, not by federal law.** Below is a quick reference for the most common U.S. cannabis‑regulating states and for Canada. If you’re in a jurisdiction not listed, let me know and I can look up the exact rule.\n\n| Jurisdiction | Minimum retention period* | Comments |\n|--------------|--------------------------|----------|\n| **California (Bureau of Cannabis Control)** | **3 years** from the date of the entry | Must be “readily accessible” for inspection; electronic copies are acceptable if they are exact replicas of the paper record. |\n| **Colorado (Marijuana Enforcement Division)** | **3 years** | Logs must be kept on‑site or in a secure off‑site location that can be accessed within 24 h of a request. |\n| **Oregon (Oregon Liquor and Cannabis Commission)** | **3 years** | Both paper and electronic records are allowed; electronic systems must retain a permanent, unalterable audit trail. |\n| **Washington (Liquor and Cannabis Board)** | **3 years** | Records must be “readily retrievable” and available for inspection at any time. |\n| **Michigan (Department of Licensing & Regulatory Affairs)** | **3 years** | Electronic records must be backed up and protected against loss or tampering. |\n| **Illinois (Department of Financial & Professional Regulation)** | **3 years** | Separate “extraction batch” records are required in addition to the logbook. |\n| **Massachusetts (Department of Cannabis Control)** | **3 years** | Requires both a physical logbook and an electronic backup. |\n| **New York (Office of Cannabis Management)** | **3 years** | Logs must be retained in a “secure, tamper‑evident” format. |\n| **Canada (Health Canada – Cannabis Act)** | **2 years** from the date of the record | Federal requirement; provinces may impose longer periods (e.g., Ontario = 3 years). |\n| **Other states/provinces** | **Typically 2–5 years** | Check the specific state/Provincial cannabis board or health department regulations. |\n\n\\*The “minimum” means you keep the records for *at least* that amount of time. Many operators choose a longer period (e.g., 5 years) to cover audits that may look back further or to simplify record‑keeping policies across multiple jurisdictions.\n\n---\n\n### Key compliance tips\n\n1. **Electronic vs. paper**  \n   - Most regulators now accept **electronic logbooks** provided they are immutable (audit‑trail‑enabled) and can be produced in the same format as the original entry.  \n   - If you keep **paper logs**, store them in a fire‑protected, climate‑controlled area and back them up with a scanned copy.\n\n2. **Accessibility**  \n   - Records must be “readily accessible” for inspection. For electronic systems, this means the regulator can pull a PDF or CSV within a reasonable time (usually < 24 h).  \n   - Keep a **master index** (digital or physical) that lists the location of each batch’s logbook.\n\n3. **Backup & disaster recovery**  \n   - Maintain **at least two independent backups** (e.g., cloud storage + offline external drive).  \n   - Test restoration procedures quarterly.\n\n4. **Retention policy documentation**  \n   - Draft a formal SOP that states: “All extraction logbooks will be retained for a minimum of **X years** in accordance with [state/province] regulations. After the retention period, records will be securely destroyed (shredded or data‑wiped).”  \n   - Have the SOP signed by the Compliance Officer and reviewed annually.\n\n5. **Secure destruction**  \n   - When the retention period expires, use **cross‑cut shredders** for paper or **crypto‑erase** for electronic files to ensure data cannot be reconstructed.\n\n---\n\n### Quick “what‑to‑do” checklist\n\n| ✅ | Action |\n|---|--------|\n| 1 | Verify the exact retention requirement for your specific license (state/province). |\n| 2 | Ensure your extraction logbook system\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1164 (164?1000) | Cost: $0.000000*",
      "duration": 9941,
      "grade": "F",
      "score": 29,
      "grading": {
        "accuracy": 5,
        "completeness": 4,
        "relevance": 8,
        "clarity_structure": 7,
        "practical_value": 5,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Recognizes retention is jurisdiction-specific",
        "Provides a structured layout and some practical tips (accessibility, backups, SOPs)"
      ],
      "weaknesses": [
        "Incorrect for New York: states 3 years instead of the required 5 years for extraction logs",
        "Omits key NY specifics: must be accessible to OCM on request; on-site storage required for first two years before moving off-site",
        "Includes multiple likely outdated/incorrect agency names and retention periods for other jurisdictions",
        "Not tailored to the user’s NY compliance need; adds extraneous multi-jurisdiction content",
        "Answer is truncated and includes irrelevant agent/system notes"
      ],
      "feedback": "The answer should state New York’s requirement: retain extraction logbooks for 5 years, keep them accessible to OCM upon request, store on-site for the first 2 years, and then they may be moved off-site (per 9 NYCRR). The provided table incorrectly lists New York as 3 years and misses the on-site requirement, reducing accuracy and usefulness. Focus on the NY-specific rule, cite the applicable regulation, and remove outdated or extraneous jurisdiction details.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "new york",
        "massachusetts",
        "michigan",
        "illinois",
        "sop"
      ],
      "expectedAnswer": "**Summarizing cannabis recordkeeping** I need to summarize the required retention period for extraction logbooks for compliance in New York. According to the New York Office of Cannabis Management (OCM) regulations under 9 NYCRR, adult-use cannabis processors must retain extraction logs for five years. These records should be accessible to the OCM upon request. Also, they need to be stored on-site for the first two years and can then be moved off-site. It's essential to incorporate these specifics for compliance.**Researching compliance requirements** I need to produce a concise summary for the user asking about how long to retain extraction logbooks for compliance in New York. I should include specific regulations from the New York Office of Cannabis Management. It seems like the rule is to maintain these records for five years, similar to other states. Logbooks must be available to the OCM on request, stored on-site for the first two years, and then off-site after that.**Identifying recordkeeping specifics** I need to consider the specific records that must be maintained, such as batch production and control records, sanitation logs, pest control documentation, and equipment maintenance records. I'll also remember to include extraction logbooks in this list. It's crucial to have all these details organized and accessible to ensure compliance and effective management of operations. Let’s make sure I cover all necessary areas for maintaining proper records!"
    },
    {
      "questionNum": 38,
      "question": "Can I dispose of spent biomass without mixing it with non-consumable waste first?",
      "category": "waste-management-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:**  \nIn most jurisdictions you **cannot** simply toss spent cannabis biomass straight into the regular trash. It must be rendered non‑consumable (or otherwise treated) **before** it can be mixed with ordinary waste or taken to a landfill.\n\n---\n\n## Why the extra step is required\n\n| Reason | What it means for you |\n|--------|-----------------------|\n| **Regulatory compliance** | State cannabis‑tracking and waste‑management rules (e.g., California’s BCC, Colorado’s MCR, Ontario’s OCS) classify spent plant material as **regulated waste**. It must be rendered “non‑consumable” before it can enter the municipal waste stream. |\n| **Public safety** | Unprocessed biomass could be re‑used for consumption, diverted, or become a fire hazard. |\n| **Environmental protection** | Proper rendering (e.g., mixing with non‑consumable waste, incineration, or composting under a licensed program) prevents contamination of soil and water. |\n| **Liability** | Failure to follow the required process can result in fines, license suspensions, or criminal charges. |\n\n---\n\n## Typical ways to render spent biomass “non‑consumable”\n\n| Method | How it works | Pros | Cons |\n|--------|--------------|------|------|\n| **Mix with non‑consumable waste** (e.g., wood shavings, paper, packaging) | Physically blend the biomass with a larger volume of non‑cannabis waste, then bag and seal. | Simple, low‑cost; meets most state rules. | Still generates waste; may require larger containers. |\n| **Incineration** (licensed facility) | Burn the material at a certified waste‑to‑energy plant. | Eliminates waste completely; often the cleanest “end‑of‑life” option. | Requires a contract with a licensed incinerator; higher cost. |\n| **Composting (licensed)** | Send to a state‑approved composting operation that accepts cannabis waste. | Produces a usable soil amendment; can be a sustainability selling point. | Must be a licensed composter; may have volume limits. |\n| **Extraction of residual cannabinoids** | Run a “post‑extraction” or “re‑distillation” to pull remaining THC/CBD, then dispose of the remaining plant matter. | Recovers value; reduces waste volume. | Requires equipment and permits. |\n| **Landfill (licensed hazardous‑waste landfill)** | Some states allow direct disposal to a licensed landfill **only after** the waste is sealed and labeled. | Straightforward if you have a contract. | Often the most expensive option. |\n\n---\n\n## General “Do‑It‑Yourself” Checklist (U.S.‑focused)\n\n1. **Check your state’s cannabis‑waste regulations** – Look up the specific statute (e.g., CA BPC § 2600‑2605, CO Reg. 13‑1‑101).  \n2. **Document the waste stream** – Keep a log of weight, date, and disposal method for each batch.  \n3. **Render the biomass** –  \n   - **Mix**: Combine with at least a 1:1 (or higher) ratio of non‑cannabis waste (e.g., cardboard, wood chips).  \n   - **Seal**: Use a heavy‑duty, tamper‑evident bag or container.  \n   - **Label**: Mark “Cannabis Waste – Non‑Consumable” with date and batch ID.  \n4. **Transport** – Use a licensed waste‑transport carrier (or a driver with a valid “cannabis‑waste” endorsement).  \n5. **Final disposal** – Deliver to a municipal landfill, incinerator, or composting facility that is on your state’s approved list.  \n6. **Retain records** – Keep disposal receipts and the waste‑log for the period required by your state (often 2–5 years).  \n\n---\n\n## Quick “Yes/No” Decision Tree\n\n1. **Is the biomass\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1174 (174?1000) | Cost: $0.000000*",
      "duration": 2967,
      "grade": "F",
      "score": 52,
      "grading": {
        "accuracy": 15,
        "completeness": 9,
        "relevance": 12,
        "clarity_structure": 10,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly communicates the general principle that cannabis biomass typically must be rendered non-consumable before disposal",
        "Provides a list of common rendering/disposal methods and a practical checklist",
        "Structured and easy to scan"
      ],
      "weaknesses": [
        "Fails to address New York–specific requirements or cite 9 NYCRR Part 130/125 as expected",
        "Overly long and not within the requested 100–200 word concise summary",
        "Contains questionable or inaccurate references (e.g., Ontario OCS as regulator, “licensed hazardous-waste landfill” for cannabis waste, “cannabis-waste” driver endorsement)",
        "Does not directly answer whether mixing with non-consumable waste is required versus alternatives allowed in some jurisdictions (e.g., licensed composting, grinding on-site)",
        "Truncated section at the end reduces clarity"
      ],
      "feedback": "Provide a concise 100–200 word summary focused on whether spent cannabis biomass must be mixed with non-consumable waste before disposal, specifically for New York. Reference NY OCM rules (9 NYCRR Part 130 and Part 125) and note that while many states require rendering unusable (often via mixing at specified ratios), NY may allow alternatives such as licensed composting or on-site grinding, if properly documented. Remove inaccurate cross-jurisdictional claims (e.g., OCS oversight, hazardous-waste landfill, special driver endorsements) and include clear, state-specific compliance steps and citations.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "federal",
        "epa",
        "board",
        "sop",
        "procedure",
        "standard",
        "operating",
        "document",
        "record"
      ],
      "expectedAnswer": "**Summarizing waste management compliance** I need to create a concise 100-200 word summary focusing on waste management compliance regarding the disposal of spent biomass, such as cannabis plant material after extraction. The main question is whether I can dispose of it without mixing it with non-consumable waste. In many states, cannabis waste has to be mixed at a specific ratio to be rendered unusable, but New York regulations may have different requirements. I believe I should look into 9 NYCRR Part 130 and Part 125 for clarity.**Summarizing waste management compliance** I need to create a concise grading summary of 100-200 words covering waste management compliance regarding spent biomass disposal, specifically cannabis plant material after extraction. The key question is whether I can dispose of this waste without mixing it with non-consumable waste first. Generally, many states require this mixing, but some allow composting or on-site grinding. For New York, I should look into the regulations under NY OCM, particularly 9 NYCRR Part 130 or 125 for disposal guidelines."
    },
    {
      "questionNum": 39,
      "question": "Is it okay to store cannabis waste in the same area as general lab trash temporarily?",
      "category": "waste-management-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** No – cannabis‑related waste must be kept separate from ordinary lab trash, even for short‑term storage.\n\n---\n\n### Why separation is required\n\n| Reason | Detail |\n|--------|--------|\n| **Legal compliance** | Most state cannabis‑regulations (e.g., CA Bureau of Cannabis Control, CO Department of Revenue) mandate that *cannabis waste* be stored in a **locked, labeled container** and kept in a **dedicated, secure area** until it is destroyed or transferred to an approved disposal vendor. |\n| **Environmental safety** | Cannabis residues can contain cannabinoids, pesticides, solvents, or heavy metals that are regulated under EPA hazardous‑waste rules. Mixing them with general waste can create contamination pathways. |\n| **Security** | Cannabis waste is considered a controlled material. Separate storage helps prevent diversion or theft, which is a violation of both state licensing terms and federal Controlled Substances Act (even though cannabis is state‑legal). |\n| **Inspection readiness** | Regulators will inspect waste‑handling areas. A mixed‑waste pile is a clear violation and can lead to fines, license suspension, or revocation. |\n\n---\n\n### What “temporary” means in practice\n\n| Timeframe | Acceptable practice |\n|-----------|---------------------|\n| **< 24 hours** (e.g., during a shift change) | Still **not allowed** to co‑store with general trash. Use a **dedicated, lockable waste container** (often a metal box with a tamper‑evident seal) that is clearly labeled “Cannabis Waste – Do Not Mix.” |\n| **> 24hours** | Must be transferred to an **approved waste‑disposal service** (e.g., licensed incinerator, composting facility) or moved to a **permanent on‑site storage area** that meets state‑specific security and labeling requirements. |\n\n---\n\n### Minimum compliance checklist for temporary storage\n\n1. **Container** – Metal or heavy‑duty plastic box, lockable, with a tamper‑evident seal.  \n2. **Labeling** – Prominent “CANNABIS WASTE – KEEP SEPARATE FROM GENERAL TRASH” label; include license number and date placed.  \n3. **Location** – Secure, access‑controlled room or area (e.g., a locked cabinet or a dedicated waste room).  \n4. **Inventory log** – Record weight/volume, date/time placed, and who placed it. Update when removed.  \n5. **Security** – Only authorized personnel may access the container; maintain a sign‑in sheet if needed.  \n6. **Disposal schedule** – Have a documented SOP that specifies how often is removed (e.g., every 48 hours) and which licensed vendor handles it.\n\n---\n\n### State‑by‑state snapshots (most common)\n\n| State | Key requirement for cannabis waste |\n|-------|-------------------------------------|\n| **California** | Must be stored in a “secure, locked container” separate from non‑cannabis waste; disposal must be via a licensed hazardous‑waste hauler |\n| **Colorado** | “Cannabis waste must be stored in a locked, clearly marked container; it may not be mixed with other waste streams.” |\n| **Oregon** | “All cannabis waste must be kept in a separate, secure area; mixing with general waste is prohibited.” |\n| **Michigan** | “Cannabis waste must be stored in a locked, tamper‑evident container; it cannot be combined with regular trash.” |\n\n*(If your jurisdiction isn’t listed, check the specific licensing board or department of health/agriculture for the exact wording.)*\n\n---\n\n### Practical tip\n\nIf you need a quick, compliant solution for a short‑term overflow:\n\n1. **Grab an extra lockable waste\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1168 (168?1000) | Cost: $0.000000*",
      "duration": 13613,
      "grade": "F",
      "score": 56,
      "grading": {
        "accuracy": 17,
        "completeness": 8,
        "relevance": 14,
        "clarity_structure": 11,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Takes a clear position that cannabis waste should not be co-stored with general trash",
        "Provides rationale (compliance, security, inspection risks)",
        "Offers an actionable checklist for temporary storage controls"
      ],
      "weaknesses": [
        "Does not address New York-specific requirements (OCM/MRTA) or cite 9 NYCRR Parts 125, 128, 131 as expected",
        "Includes likely inaccuracies (e.g., claiming California disposal must go via licensed hazardous-waste hauler for all cannabis waste)",
        "Overgeneralizes EPA hazardous waste applicability to cannabis waste",
        "Asserts time limits (e.g., <24 hours) without jurisdictional basis",
        "Contains a truncated section at the end, reducing clarity and completeness"
      ],
      "feedback": "Answer is generally aligned that cannabis waste should be kept separate, but it fails to address New York’s OCM/MRTA rules and 9 NYCRR Parts 125, 128, and 131 as required. Avoid blanket statements about EPA hazardous waste and California disposal; specify that only hazardous cannabis waste follows hazardous-waste rules. Provide NY-specific citations and clarify that temporary storage must be in a secure, labeled, separate area per NY regulations.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "epa",
        "sop",
        "procedure",
        "standard",
        "operating",
        "documentation"
      ],
      "expectedAnswer": "**Summarizing cannabis waste compliance in NY** It's crucial to understand New York's cannabis waste regulations regarding temporary storage with general lab trash. As of 2023-2025, compliance agents must refer to New York Office of Cannabis Management (OCM) and MRTA regulations. Key points include Parts 125, 128, and 131 concerning licensee operations and waste management. Under 9 NYCRR Title 9, conditions dictate that cannabis waste should generally be stored separately to ensure compliance with safety and regulatory standards during operation.**Researching cannabis waste regulations** I need to summarize the compliance question regarding storing cannabis waste alongside general lab trash in New York. The key is to understand that as of 2023-2025, the NY OCM and MRTA regulations dictate that cannabis waste must be managed according to specific guidelines found in Parts 125, 128, and 131 of the regulations. There are requirements for waste disposal, and ensuring adherence to these rules is critical for compliance in the cannabis industry."
    },
    {
      "questionNum": 40,
      "question": "Do I need a secondary person to verify destruction of cannabis waste?",
      "category": "waste-management-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most U.S. states that regulate cannabis, a second‑person verification (often called a “waste witness” or “co‑signer”) is required for the destruction of cannabis waste.  \n\n---\n\n### Why a second person is usually required\n| Reason | How it’s addressed |\n|--------|-------------------|\n| **Regulatory compliance** | State cannabis‑tracking systems (e.g., METRC, CannaReg) require a **waste manifest** that must be signed by both the “generator” (your operation) and a **waste‑verification person** before disposal. |\n| **Chain‑of‑custody** | A second signature creates an audit trail showing that waste was handled properly and not diverted. |\n| **Liability protection** | Shared responsibility reduces risk for both the cultivator/processor and the disposal vendor. |\n| **Verification of method** | The witness confirms that the approved destruction method (incineration, composting, autoclaving, etc.) was actually used. |\n\n---\n\n### Typical state requirements (examples)\n\n| State | Minimum requirement for waste verification |\n|-------|--------------------------------------------|\n| **California** | Waste manifest must be signed by a **“designated waste verification person”** (often a manager or third‑party contractor). |\n| **Colorado** | The “waste disposition record” must be co‑signed by the **generator** and a **waste‑verification employee** before the waste leaves the premises. |\n| **Washington** | A **second‑person sign‑off** is required on the **waste manifest** and on the **final disposal certificate**. |\n| **Oregon** | Requires a **waste verification signature** on the manifest; the verifier can be a licensed waste‑disposal contractor. |\n\n*If you are operating in a state not listed here, check your specific licensing authority’s waste‑disposal guidelines—most follow the same co‑signature model.*\n\n---\n\n### What “secondary person” looks like in practice\n\n1. **Internal employee** – A manager, compliance officer, or designated staff member who is not the primary waste generator.\n2. **Third‑party contractor** – The waste‑disposal company (e.g., licensed incinerator) often provides a driver or technician who signs the manifest on site.\n3. **Regulatory auditor** – In some jurisdictions, a state‑approved auditor may act as the witness for larger disposals.\n\n**Key point:** The secondary person must be **authorized** (by your SOP or state rule) and must **physically verify** the destruction method before signing.\n\n---\n\n### Best‑practice checklist for waste destruction\n\n| ✅ Item | Why it matters |\n|--------|----------------|\n| **Written SOP** that designates who can act as the secondary verifier. | Provides clear accountability and satisfies audit questions. |\n| **Waste manifest** (paper or electronic) with dual signatures (generator + verifier). | Meets state tracking requirements. |\n| **Photographic/video evidence** of the waste before and after destruction. | Adds an extra layer of proof; many states accept it as supplemental documentation. |\n| **Retention period** – Keep all waste records for at least **2 years** (or the period required by your state). | Required for compliance audits. |\n| **Periodic training** for both primary and secondary personnel on proper waste handling. | Reduces errors and ensures everyone knows the latest regulations. |\n\n---\n\n### Quick “Do I need a secondary person?” decision tree\n\n1. **Does your state’s cannabis waste regulation require a manifest?**  \n   - **Yes** → A second signature is mandatory.  \n   - **No** → Still advisable to have a witness for internal controls.\n2. **Are you using a licensed waste‑disposal contractor?**  \n   - **Yes** → Their driver/technician usually serves as the secondary verifier.  \n   - **No** → Assign an internal manager or compliance officer as the witness.\n3. **Do you have a documented SOP covering waste verification?**  \n\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1165 (165?1000) | Cost: $0.000000*",
      "duration": 5381,
      "grade": "F",
      "score": 44,
      "grading": {
        "accuracy": 8,
        "completeness": 7,
        "relevance": 10,
        "clarity_structure": 13,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear structure with headings, lists, and checklists",
        "Provides general best practices (SOPs, training, record retention, photo/video evidence)",
        "Attempts to answer the core question about needing a secondary person"
      ],
      "weaknesses": [
        "Does not address New York OCM requirements, which are central to the expected answer",
        "Makes specific claims about state requirements (e.g., mandatory dual signatures and manifests in CA/CO/WA/OR) that are questionable or inaccurate",
        "Overgeneralizes that most states require a second person without citing or aligning to NY regulations",
        "Omits key recordkeeping details emphasized in the expected answer (date, time, method, amount, reason, personnel) and secure storage",
        "Fails to mention the requirement to render cannabis waste unusable by mixing with non-cannabis materials per common NY guidance"
      ],
      "feedback": "The answer is well-organized and offers practical controls, but it misses the mark by not focusing on New York’s OCM rules, which the question and expected answer require. It overstates state-specific mandates (e.g., universal dual-signature manifests) and omits NY-specific requirements, including rendering waste unusable and detailed recordkeeping elements (date, time, method, amount, reason, personnel, secure storage). Refocus on NY regulations and clearly state whether a secondary person is required in New York, then list the precise documentation requirements.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "massachusetts",
        "michigan",
        "illinois",
        "board"
      ],
      "expectedAnswer": "**Summarizing cannabis waste regulations** I'm focusing on summarizing the expected answer about whether a secondary person is needed to verify the destruction of cannabis waste in New York. I need to clarify the specific state regulations, particularly the Office of Cannabis Management rules, which could include Parts 130-134 for adult use and possibly Part 132 for operations. I'll remember that in many states, a witness and video are required for destruction. For New York's regulations, cannabis waste must be unusable and mixed with non-cannabis materials before disposal.**Detailing record-keeping requirements** I need to emphasize that specific records must be maintained regarding cannabis waste destruction, including the date, time, method, amount, reason, and personnel involved. It's crucial to ensure these records are stored securely and are not accessible to the public. This helps maintain compliance and accountability in waste management. I'll make sure the user understands the importance of these details for proper documentation. need to ensure that all records are kept properly, including the date, time, method, amount, reason, and personnel involved. It's crucial that these records are stored securely and are not accessible to the public. I think it’s essential to be diligent about maintaining this information to uphold any necessary standards or regulations. So, I need to focus on keeping things organized and safe!"
    },
    {
      "questionNum": 41,
      "question": "Can I incinerate solvent-contaminated material on-site?",
      "category": "waste-management-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most jurisdictions you cannot simply burn solvent‑contaminated waste on‑site unless you have a *permitted, EPA‑approved incinerator* that meets all federal, state and local hazardous‑waste regulations. For most cannabis operators, the safe and compliant route is to use a licensed hazardous‑waste hauler or a commercial waste‑to‑energy facility.\n\n---\n\n## Why “on‑site incineration” is usually prohibited\n\n| Regulation | What it means for you |\n|------------|-----------------------|\n| **EPA RCRA (Resource Conservation and Recovery Act)** | Solvents (e.g., ethanol, butanol, acetone, hexane, isopropanol) are classified as *hazardous waste* when they become mixed with cannabis material. RCRA requires that hazardous waste be treated, stored, or disposed of only at facilities that hold a **RCRA permit**. |\n| **EPA Clean Air Act – NESHAP (National Emission Standards for Hazardous Air Pollutants)** | Open‑burn or uncontrolled incineration of hazardous waste is a “major source” of hazardous air pollutants. Only **high‑temperature, EPA‑certified incinerators** (≥1,000 °C, with proper residence time and emissions controls) are allowed. |\n| **State cannabis‑specific regulations** (e.g., CA B.C. §11362.5, CO 2023‑2024 cannabis statutes) | Many states expressly forbid “on‑site burning” of contaminated material and require disposal through a state‑approved hazardous‑waste contractor. |\n| **Local fire‑code / building‑code** | Incinerators are considered “industrial furnaces.” Installation, operation, and emissions monitoring typically need a **fire‑department permit** and a **building‑code inspection**. |\n| **Occupational Safety & Health (OSHA)** | Burning solvents creates toxic fumes (e.g., carbonyls, VOCs, CO). OSHA requires a **hazard communication program**, engineering controls, and personal protective equipment (PPE). |\n\n> **Bottom line:** If you do not have a licensed, EPA‑approved incinerator on your property, burning solvent‑contaminated material is a violation of federal, state, and local law.\n\n---\n\n## How to handle solvent‑contaminated waste legally\n\n1. **Identify the waste stream**  \n   - List each solvent used (ethanol, isopropanol, hexane, etc.).  \n   - Determine concentration and whether the waste is *mixed* (solvent + cannabis plant material). Mixed waste is automatically hazardous under RCRA.\n\n2. **Classify the waste**  \n   - Use the EPA’s **Hazardous Waste Identification** flowchart (HW 13‑01).  \n   - Most organic solvents used for extraction are **ignitable hazardous waste (D001)**.\n\n3. **Choose a disposal method**  \n   - **Licensed hazardous‑waste hauler** (most common). They will transport the waste to a permitted **RCRA hazardous‑waste incinerator** or **thermal‑destruction facility**.  \n   - **On‑site thermal destruction unit** (e.g., a **closed‑loop solvent recovery system** that vaporizes and condenses solvents). These units are **not** “incinerators”; they are considered **recovery equipment** and are generally allowed when they meet EPA/UL certifications.  \n   - **Contracted commercial incineration** (e.g., a municipal waste‑to‑energy plant that accepts hazardous waste under a permit).\n\n4. **Obtain any required permits** (if you truly need on‑site incineration)  \n   - **EPA RCRA Permit** (Title 5) – rare for a cannabis operation.  \n   - **State hazardous‑waste permit** – may be a “small quantity generator (SQG)” permit if you generate ≤1 ton/month.  \n   - **Air‑quality permit** (NESHAP) – must demonstrate compliance with emission limits.  \n   - **Fire‑department/municipal permit** –\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1131 (131?1000) | Cost: $0.000000*",
      "duration": 10305,
      "grade": "F",
      "score": 52,
      "grading": {
        "accuracy": 14,
        "completeness": 7,
        "relevance": 12,
        "clarity_structure": 13,
        "practical_value": 6,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear bottom-line that on-site burning is generally prohibited without proper permits",
        "Explains RCRA framework and that solvent wastes are often ignitable (D001)",
        "Provides practical alternatives (licensed hazardous waste hauler, recovery equipment)",
        "Well-structured with steps for handling waste"
      ],
      "weaknesses": [
        "Not tailored to New York; omits NY DEC rules (6 NYCRR Parts 370–374/376) and cannabis-specific requirements",
        "Fails to state that on-site hazardous-waste incineration requires a RCRA Part B permit in NY (authorized state)",
        "Incorrectly refers to a “RCRA Permit (Title 5)”—Title V is a Clean Air Act program, not RCRA",
        "Overstates that mixed solvent+cannabis is “automatically” hazardous; determination depends on characteristics/listings",
        "“EPA-certified incinerator” terminology is misleading; permitting is via RCRA and CAA/MACT, not generic EPA certification",
        "Suggests municipal waste-to-energy plants may accept hazardous waste, which is generally incorrect",
        "Omits solvent-contaminated wipes rule considerations and NY air permitting specifics"
      ],
      "feedback": "The answer provides a useful high-level overview but misses the New York-specific requirements requested. For NY, you must note that the state is RCRA-authorized; on-site incineration of solvent-contaminated hazardous waste requires a RCRA Part B permit and compliance with 6 NYCRR Parts 370–374/376, plus applicable air permits (e.g., Title V) and hazardous waste combustor MACT. Include how NY DEC handles solvent-contaminated wipes. Correct the Title V/RCRA mix-up and avoid implying “EPA-certified incinerators.” A concise 100–200 word NY-focused summary with DEC citations and permit pathways is needed.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "state",
        "california",
        "colorado",
        "federal",
        "osha",
        "epa",
        "board",
        "sop",
        "procedure",
        "standard"
      ],
      "expectedAnswer": "**Summarizing waste incineration regulations** I need to create a 100-200 word summary focusing on whether on-site incineration of solvent-contaminated material is allowed in New York's cannabis industry. I should include key regulatory details like compliance with NY cannabis regulations, hazardous waste rules from the DEC, and any special air permitting needs. Since New York follows RCRA as an authorized state, I must highlight that incineration requires a RCRA Part B permit, with specific obligations under 6 NYCRR Parts 370-374, and details about solvent-contaminated wipes."
    },
    {
      "questionNum": 42,
      "question": "Am I allowed to treat ethanol waste differently than cannabis plant waste?",
      "category": "waste-management-compliance",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** Yes – you can (and must) treat ethanol‑related waste differently from cannabis‑plant waste, but each stream must still meet the specific federal, state, and local regulations that apply to it.  \n\n---\n\n## 1. Why the two waste streams are regulated separately  \n\n| Waste stream | Primary regulatory framework (U.S.) | Typical classification |\n|--------------|--------------------------------------|------------------------|\n| **Ethanol production waste** (e.g., spent mash, stillage, cleaning solvents, wash water) | • **EPA** – RCRA (Resource Conservation and Recovery Act) for hazardous waste, Clean Water Act for discharge, and **OSHA** for worker safety.<br>• State environmental agencies (e.g., CA DTSC, CO DEQ) for permits, storm‑water, and recycling programs. | *Non‑hazardous* if it contains only water, sugars, and low‑level organics; *hazardous* if it has >100 ppm of certain solvents, heavy metals, or is ignitable/ corrosive. |\n| **Cannabis‑plant waste** (trim, leaves, stems, unusable buds, contaminated material) | • **State cannabis‑specific statutes** (e.g., CA Bureau of Cannabis Control, CO Regulation of Marijuana Cultivation).<br>• **EPA**‑RCRA if the waste is deemed hazardous (e.g., pesticide‑laden).<br>• Local health or agricultural departments for “plant‑waste” rules. | Usually **non‑hazardous** but **requires cannabis‑specific handling** (sealed, labeled, separate from other waste, and tracked in a “waste manifest”). |\n| **Overlap** | If ethanol waste contains **pesticides, solvents, or other regulated chemicals** used on cannabis, it may be classified as **hazardous cannabis waste** and must follow both sets of rules. |\n\n---\n\n## 2. Key Differences in How You Must Handle Each Stream  \n\n### A. **Containment & Segregation**\n| Requirement | Ethanol‑related waste | Cannabis‑plant waste |\n|-------------|----------------------|----------------------|\n| **Separate containers** | Recommended, but not always required unless hazardous. | **Mandated** – must be stored in a **dedicated, locked, and labeled container** (e.g., “Cannabis Plant Waste – Non‑hazardous”). |\n| **Labeling** | Standard RCRA or local label (e.g., “Organic Waste – Non‑hazardous”). | Must include **cannabis‑specific identifiers** (license number, waste type, date). |\n| **Temperature control** | May need cooling if fermenting or producing odor. | Often requires **refrigeration or freezing** to prevent mold and preserve THC content for possible destruction (e.g., incineration). |\n\n### B. **Permitting & Disposal Options**\n| Action | Ethanol waste | Cannabis waste |\n|--------|---------------|----------------|\n| **On‑site treatment** (e.g., anaerobic digestion, composting) | Allowed if the resulting effluent meets **NPDES** discharge limits and **RCRA** non‑hazardous criteria. | Generally **not allowed** unless the state explicitly permits cannabis‑plant composting and you have a **cannabis‑waste permit**. |\n| **Off‑site hauler** | Any licensed **solid‑waste** hauler can take non‑hazardous waste; hazardous waste must go to a **RCRA‑certified** hauler. | Must be a **state‑approved cannabis‑waste hauler** (often a subset of hazardous‑waste carriers). |\n| **Incineration** | Standard municipal incinerator acceptable if waste is non‑hazard\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1131 (131?1000) | Cost: $0.000000*",
      "duration": 12167,
      "grade": "F",
      "score": 41,
      "grading": {
        "accuracy": 10,
        "completeness": 7,
        "relevance": 13,
        "clarity_structure": 7,
        "practical_value": 4,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Acknowledges that ethanol waste and cannabis plant waste are regulated differently",
        "References RCRA and the need to determine whether a waste is hazardous",
        "Suggests segregation and labeling of waste streams",
        "Mentions use of licensed haulers for hazardous waste"
      ],
      "weaknesses": [
        "Does not address generator categories (VSQG, SQG, LQG) or accumulation time limits (90/180 days) central to the expected answer",
        "Misframes the scenario as ethanol production waste rather than cannabis extraction solvent waste",
        "Contains questionable or inaccurate statements (e.g., refrigeration often required; mandated locked containers; cannabis waste haulers as subset of hazardous carriers; generic use of 'waste manifest' for plant waste)",
        "Omits key compliance elements like satellite accumulation, closed/labeled container requirements tied to generator rules, and hazardous waste manifests/transporters context",
        "Fails to cover spill prevention and fire code considerations, including NYC/state specifics",
        "Answer is truncated and includes extraneous agent text, reducing clarity"
      ],
      "feedback": "Partially relevant but misses core compliance points expected: classify waste and identify hazardous waste under RCRA, determine generator status (VSQG/SQG/LQG), follow container closure/labeling rules, observe 90/180-day accumulation limits and satellite accumulation provisions, and use hazardous waste manifests with licensed transporters when applicable. Also add spill prevention and fire code compliance (including NYC/state rules). Correct inaccuracies about refrigeration, locked containers, and hauler/manifest requirements for plant waste, and focus on ethanol solvent waste from cannabis extraction rather than ethanol production.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "osha",
        "epa",
        "agency",
        "board",
        "sop"
      ],
      "expectedAnswer": "**Considering waste management regulations** I must think about how generators need to classify waste effectively and determine what's hazardous, following the generator category rules like VSQG, SQG, and LQG. It’s important to store waste in closed, labeled containers and adhere to time limits for accumulation. I'll also need to consider the use of hazardous waste manifests and licensed transporters, along with compliance for spill prevention and fire safety regulations, including those specific to NYC and state codes.**Summarizing waste generator regulations** I need to cover waste generator responsibilities, which include classifying waste and identifying hazardous waste. It's crucial to follow generator category rules like VSQG, SQG, and LQG. Accumulating waste in closed, labeled containers and managing satellite accumulation areas within storage time limits of 90 or 180 days is important. I'll also mention the use of hazardous waste manifests, licensed transporters, and complying with regulations regarding spill prevention and fire codes, particularly in NYC."
    },
    {
      "questionNum": 43,
      "question": "Does every team member need to complete chemical safety training before using the fume hood?",
      "category": "employee-training-operational-roles",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** Yes—most workplaces (including cannabis‑related labs) require that every person who will operate a fume hood first complete formal chemical‑safety training.\n\n**Why the training is required**\n\n| Reason | What it covers |\n|--------|----------------|\n| **Regulatory compliance** (OSHA 29 CFR 1910.1450 for cannabis, general lab safety standards, local fire codes) | Hazard communication, proper labeling, SDS use, exposure limits |\n| **Equipment safety** | Correct start‑up, sash positioning, airflow checks, when *not* to use the hood (e.g., for non‑volatile solids) |\n| **Personal protective equipment (PPE)** | Selecting respirators, gloves, goggles, lab coats appropriate to the chemicals |\n| **Emergency response** | Spill containment, fire‑extinguishing procedures, evacuation routes, first‑aid for chemical exposure |\n| **Documentation & accountability** | Signed training records, periodic refresher verification, ability to trace who was authorized to use the hood |\n\n**Typical training components**\n\n1. **Chemical‑safety fundamentals** – hazard classes, SDS navigation, risk assessment.  \n2. **Fume‑hood operation** – airflow principles, sash height, work‑practice limits, routine performance checks (e.g., face‑velocity test).  \n3. **PPE selection & use** – matching gloves/materials to the chemicals you’ll handle.  \n4. **Incident handling** – spill kits, fire extinguishers, emergency showers, and reporting procedures.  \n5. **Record‑keeping** – completion sign‑off, refresher schedule (often annually or after a major incident).\n\n**Best‑practice checklist before a new user touches a hood**\n\n- [ ] Completed approved chemical‑safety training (including a specific module on fume‑hood use).  \n- [ ] Signed the lab‑safety acknowledgment form.  \n- [ ] Received a brief, supervised “hands‑on” demonstration from a qualified staff member.  \n- [ ] Verified that the hood’s airflow alarm is functional (green/blue light, no “out‑of‑range” warnings).  \n- [ ] Confirmed that the required PPE is available and being worn.\n\n**What to do if you’re unsure**\n\n- Check your company’s **Standard Operating Procedures (SOPs)** or **Laboratory Safety Manual**—they will state the exact training requirements.  \n- Contact the **Safety Officer / EHS department** for a copy of the training curriculum and to confirm that your certification is current.  \n- If you’re a new hire or a temporary/contract worker, ask for a *quick refresher* before your first hood session; many labs provide a brief “boot‑camp” that satisfies the same regulatory criteria.\n\n**Bottom line:**  \nAll individuals who will work inside a fume hood should have documented chemical‑safety training (including specific hood‑use instruction) before they are permitted to operate it. This protects you, your coworkers, and keeps the lab compliant with OSHA and any state‑specific cannabis‑lab regulations.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 965 (168?797) | Cost: $0.000000*",
      "duration": 6099,
      "grade": "B",
      "score": 88,
      "grading": {
        "accuracy": 27,
        "completeness": 19,
        "relevance": 19,
        "clarity_structure": 14,
        "practical_value": 9,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly states that fume hood users must complete chemical-safety training before operating the hood",
        "Accurate reference to OSHA Lab Standard (29 CFR 1910.1450) and core safety topics",
        "Clear structure with actionable checklists and steps (SOPs, EHS contact, documented training)",
        "Good coverage of practical training components (PPE, emergency response, hood operation)"
      ],
      "weaknesses": [
        "Does not explicitly clarify that not every team member requires training—only those who use the hood or handle hazardous chemicals",
        "Omits explicit reference to OSHA Hazard Communication Standard (29 CFR 1910.1200)",
        "Missing New York state context (e.g., NYS Department of Labor requirements) noted in the expected answer",
        "A few elements may overgeneralize user responsibilities (e.g., face-velocity testing typically performed by certifiers rather than routine users)"
      ],
      "feedback": "Strong, practical answer that correctly emphasizes training for anyone operating a fume hood and provides useful steps for compliance and readiness. To align fully with the expected standard, explicitly state that training is not required for every team member—only those whose roles involve the fume hood or hazardous chemicals—cite OSHA 1910.1200 (HazCom) alongside 1910.1450, and briefly note potential New York state requirements (e.g., NYS DOL) for cannabis workplaces.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "mandatory",
        "must",
        "osha",
        "epa",
        "sop",
        "procedure",
        "standard",
        "documentation",
        "document",
        "record",
        "log"
      ],
      "expectedAnswer": "**Summarizing chemical safety training requirements** I need to create a concise summary about whether all team members need chemical safety training before using the fume hood in New York. The key points include: for cannabis licensees, there's a need to comply with OSHA standards plus potentially NYS Department of Labor requirements. OSHA mandates that any employee exposed to hazardous chemicals must complete safety training, particularly under the Hazard Communication Standard. Additionally, the laboratory standard indicates training is necessary before working with fume hoods and hazardous chemicals.**Clarifying training requirements** I need to provide a clear answer: yes, any employee who will use a fume hood or come into contact with hazardous chemicals must complete chemical safety training before they can start using it. However, this doesn't extend to \"every team member\"—only those whose specific job duties involve the fume hood need to be trained. It's important to be precise about who requires the training based on their roles.**Summarizing chemical safety training requirements** I'm focusing on creating a concise summary about whether every team member needs chemical safety training before using a fume hood, specifically for employee training in operational roles in New York. The key conclusion is that all employees exposed to hazardous chemicals must undergo training according to OSHA standards, including the Hazard Communication Standard and the laboratory stan..."
    },
    {
      "questionNum": 44,
      "question": "Is a glove change required between processing two different batches?",
      "category": "employee-training-operational-roles",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Yes – changing gloves between batches is a standard best‑practice and is often required by cannabis‑industry regulations to prevent cross‑contamination.**  \n\n### Why a glove change matters\n| Reason | What it protects against |\n|--------|---------------------------|\n| **Cross‑contamination** | Transfer of residues, allergens, pesticides, or microbes from one batch to the next. |\n| **Product integrity** | Maintains strain‑specific potency, terpene profile, and labeling accuracy. |\n| **Regulatory compliance** | Many state GMP/OSHA‑type rules (e.g., California BPR, Colorado Cannabis Regulations, FDA‑style good manufacturing practices) explicitly require “clean change‑over procedures,” which include glove replacement. |\n| **Worker safety** | Reduces exposure to hazardous chemicals or extracts that may differ between batches. |\n\n### When a glove change is **required**\n1. **Different product types** – e.g., moving from a THC‑rich concentrate to a CBD‑rich oil, or from an edible to a topical.  \n2. **Different strains or formulations** – any change that could alter cannabinoid/terpene composition or introduce new allergens.  \n3. **Different processing steps** – e.g., switching from extraction to packaging, or from a high‑temperature step to a low‑temperature one.  \n4. **Any batch that is flagged for a deviation or contamination issue** – treat it as a “dirty” batch and change gloves (and possibly other PPE).  \n\n### When a glove change **might be optional**\n- **Same product, same formulation, same equipment**, and the batch is a continuation of a validated run with no documented deviation.  \n- In such cases, many facilities allow a **glove‑change‑only-if‑visible‑soiling** policy, provided a documented “clean‑change‑over” SOP is followed (hand hygiene, glove inspection, etc.).  \n\n### Practical SOP checklist for a batch change‑over\n1. **Stop the line** and record the batch number.  \n2. **Remove and discard** used gloves in a designated biohazard container.  \n3. **Perform hand hygiene** (soap & water or alcohol‑based sanitizer).  \n4. **Don new, clean gloves** (inspect for tears, ensure proper size).  \n5. **Sanitize work surfaces/equipment** (per your facility’s cleaning SOP).  \n6. **Document** the glove change in the batch record (date, time, operator initials).  \n\n### Bottom line\n- **If you’re unsure, change the gloves.** The cost of a glove is negligible compared to the risk of product recall, regulatory fines, or compromised consumer safety.  \n- Align your practice with your facility’s **validated SOPs** and the specific state‑level cannabis regulations that apply to you.  \n\nFeel free to let me know which jurisdiction you operate in or any specific SOP you’re working from, and I can help tailor the guidance further.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 888 (163?725) | Cost: $0.000000*",
      "duration": 6460,
      "grade": "B",
      "score": 87,
      "grading": {
        "accuracy": 26,
        "completeness": 20,
        "relevance": 18,
        "clarity_structure": 14,
        "practical_value": 9,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly answers yes to changing gloves between batches and explains why",
        "Provides a practical, actionable SOP checklist (hand hygiene, new gloves, surface sanitation, documentation)",
        "Well-structured and easy to follow with clear justifications (cross-contamination, product integrity, compliance)",
        "Emphasizes risk mitigation and good manufacturing practices"
      ],
      "weaknesses": [
        "Not tailored to New York OCM requirements as requested; cites CA/CO and general GMPs instead",
        "Omits explicit triggers like changing gloves when torn/contaminated, after touching non-food surfaces, or after breaks",
        "The “might be optional” scenario could be confusing given the question is specifically about different batches",
        "Overgeneralizes regulatory citations (OSHA/state rules) without NY-specific reference"
      ],
      "feedback": "Good, practical guidance that correctly states gloves should be changed between different batches and provides a useful SOP. To fully align with expectations, explicitly reference New York OCM’s GMP-aligned sanitary requirements, note glove changes when torn/contaminated and after non-food surface contact or breaks, and remove any ambiguity about optional changes when switching between different batches.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "required",
        "must",
        "state",
        "fda",
        "epa",
        "sop",
        "procedure",
        "standard",
        "documentation",
        "document",
        "record",
        "log"
      ],
      "expectedAnswer": "**Summarizing glove change requirements** We need a concise summary regarding the glove change requirements between processing different cannabis batches in New York. The Office of Cannabis Management (OCM) regulations state that manufacturing licensees must adhere to sanitary practices akin to food Good Manufacturing Practices (GMPs). Key points include changing gloves when they are contaminated, torn, or when switching tasks to avoid cross-contamination. It's critical that these practices are followed, particularly after handling non-food surfaces or during breaks to ensure compliance and safety.**Describing glove change practices** Typically, it's essential to change gloves and sanitize hands when switching between different cannabis lots. This helps prevent cross-contamination and maintains batch integrity and traceability. Additionally, cleaning and sanitizing tools and contact surfaces between batches is necessary. These practices are crucial for ensuring compliance and safety throughout the processing stages. By following these protocols, we can help protect the quality of each batch and maintain regulatory standards. need to create a concise summary for grading responses on a cannabis industry question about glove changes between processing batches. It’s focused on employee training and regulatory compliance in New York, referring to the Office of Cannabis Management's regulations. I'll mention that glove changes are necessary if they become contaminated, torn, or whe..."
    },
    {
      "questionNum": 45,
      "question": "Can a lab tech sign off on their own QC checklist?",
      "category": "employee-training-operational-roles",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In a compliant cannabis testing laboratory, a tech should **not** be the sole sign‑off authority on the QC checklist they just completed. Independent review (by a QA supervisor, senior analyst, or a second technician) is required to satisfy Good Laboratory Practices (GLP), ISO 17025, and most state‑mandated accreditation rules.\n\n---\n\n## Why an independent sign‑off is required\n\n| Reason | Explanation |\n|--------|--------------|\n| **Conflict‑of‑interest prevention** | Allowing the same person to create *and* approve the QC record creates a risk that errors or deviations are missed, whether intentionally or unintentionally. |\n| **Regulatory compliance** | Most state cannabis testing statutes and the ISO 17025 standard (the benchmark for analytical labs) mandate “segregation of duties” for critical steps, including QC review. |\n| **Traceability & auditability** | Auditors expect a clear audit trail showing who performed the test, who reviewed the data, and who approved it. Separate signatures provide that traceability. |\n| **Quality culture** | Independent review reinforces a culture of double‑checking, reduces drift, and catches systematic issues early. |\n| **Liability protection** | If a result is later questioned, having a second reviewer helps demonstrate that the lab followed documented procedures, protecting the organization from legal exposure. |\n\n---\n\n## Typical QC workflow in a cannabis testing lab\n\n1. **Analyst performs the test** – records raw data, completes the QC checklist (calibrations, blanks, spikes, system suitability, etc.).\n2. **Second analyst or QA lead reviews** – checks that each checklist item is met, verifies calculations, and confirms that any deviations are documented and justified.\n3. **QA/QC manager signs off** – provides the final approval signature (often in an electronic LIMS) before the result is released to the client.\n4. **Retention** – signed checklists are stored (usually ≥ 2 years) per regulatory requirements.\n\n*Some labs use a “dual‑sign” approach*: the analyst signs “performed by,” and the QA supervisor signs “reviewed/approved by.”\n\n---\n\n## Exceptions & Edge Cases\n\n| Situation | Acceptable practice? |\n|-----------|----------------------|\n| Small, *in‑house* research labs not subject to state testing regulations | May allow self‑sign‑off for internal data, but still advisable to have a peer review before publishing or using the data for product decisions. |\n| Emergency or “one‑person” labs (e.g., field kits) | If the regulatory body explicitly permits it, a documented justification and a post‑hoc external audit may be required. |\n| Automated LIMS that lock entries after review | The system can enforce that the analyst cannot approve their own entry; this still counts as an independent sign‑off. |\n\nIf a lab truly has only one qualified staff member, the best mitigation is **external verification** (e.g., sending a split sample to an accredited third‑party lab for confirmation).\n\n---\n\n## Practical steps to implement proper sign‑off\n\n1. **Define roles in SOPs** – “Analyst,” “QC Reviewer,” “QA Manager.” Clearly state that the reviewer cannot be the same individual who performed the test.\n2. **Configure your LIMS** – set permissions so the analyst’s user ID cannot approve their own QC record.\n3. **Cross‑train staff** – ensure at least two qualified technicians are available each shift for review.\n4. **Document any deviation** – if a reviewer is unavailable, log the reason, assign a temporary reviewer, and have the QA manager approve the exception.\n5. **Audit regularly** – internal audits should verify that the “two‑person” sign‑off is consistently applied.\n\n---\n\n### Bottom line\n\n- **No,** a lab tech should not sign off on their own QC checklist in a regulated cannabis testing environment.\n- Use a separate reviewer (another analyst, senior tech, or QA supervisor) to provide the required independent sign‑off.\n- Implement procedural, electronic, and cultural controls to enforce this segregation and stay compliant with GLP/ISO 17025 and state regulations.\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1200 (206?994) | Cost: $0.000000*",
      "duration": 7151,
      "grade": "B",
      "score": 82,
      "grading": {
        "accuracy": 24,
        "completeness": 16,
        "relevance": 19,
        "clarity_structure": 14,
        "practical_value": 9,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly answers the question with a clear bottom-line stance",
        "Provides solid rationale for independent sign-off (conflict prevention, traceability, auditability)",
        "Outlines a practical QC workflow with dual-sign roles",
        "Gives actionable steps (SOP role definition, LIMS permissions, audits, cross-training)",
        "Acknowledges edge cases and suggests mitigations"
      ],
      "weaknesses": [
        "Does not address New York-specific requirements (OCM, Technical Director/QA Officer roles) expected in the reference answer",
        "Overstates that ISO 17025 and GLP universally require independent sign-off; ISO 17025 allows authorized signatories which can be the analyst in some systems",
        "Does not cite or discuss ISO/IEC 17025:2017 clause 7.8.7 or the impartiality requirements with nuance",
        "Includes an extraneous meta line at the end and uses heavy formatting not needed for a concise policy answer"
      ],
      "feedback": "Good, actionable guidance that clearly advises against self-sign-off and explains why, with practical controls and workflow. To reach gold standard, add New York OCM specifics (roles of Technical Director and QA Officer), cite ISO/IEC 17025:2017 (e.g., 7.8.7 and impartiality clauses) with nuance that it doesn’t explicitly forbid analyst authorization but requires designated authorization and impartiality, and avoid overstating universal requirements.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "must",
        "shall",
        "state",
        "fda",
        "epa",
        "standard",
        "document",
        "record",
        "log",
        "test",
        "certificate"
      ],
      "expectedAnswer": "**Considering QC sign-off regulations** I need to craft a concise summary about whether a lab tech in New York can sign off on their own QC checklist. Generally, it’s best practice for a supervisor or QA officer to handle sign-offs to avoid conflicts of interest. According to New York cannabis regulations, especially under the Office of Cannabis Management, there are specific requirements for adult-use cannabis labs, including the role of a Technical Director and a QA Officer, and adherence to ISO/IEC 17025 standards for test results.**Reviewing ISO/IEC 17025:2017 compliance** I'm reflecting on ISO/IEC 17025:2017, specifically clause 7.8.7, which discusses the authorization of test reports. It states that the laboratory must have personnel with designated functions authorize the release. While it doesn't explicitly forbid an analyst from signing their own report, it emphasizes the need for independence during quality control checks. This suggests it’s best practice to have someone else review and authorize the work to maintain objectivity and ensure quality.**Summarizing QC sign-off regulations** I need to summarize whether a lab tech can sign off on their own QC checklist in New York, focusing on employee training and compliance. Generally, to avoid conflicts of interest, sign-offs should come from a supervisor or QA officer, not the individual who performed the work. New York’s adult-use cannabis labs have specific requirements under the Office of Cannabis Management, empha..."
    },
    {
      "questionNum": 46,
      "question": "Am I allowed to let an intern shadow a live extraction session?",
      "category": "employee-training-operational-roles",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** Yes – you can let an intern *observe* a live extraction, but only if you meet the legal, safety, and compliance requirements that apply to your jurisdiction and your license. The intern must never operate the equipment or handle controlled‑cannabis material unless they are fully qualified, trained, and covered by your license.\n\n---\n\n## 1. Check the Legal/Regulatory Landscape\n\n| Item | What to verify | Typical requirement |\n|------|----------------|---------------------|\n| **State cannabis license** | Does your extraction license (e.g., “Manufacturing/Processing” or “Extraction” class) allow “employees” or “authorized personnel” only? | Most states limit the license to named individuals or “qualified employees.” Interns can be “authorized personnel” only if they are added to the license roster or covered under a “trainee” provision. |\n| **Age & background** | Intern must be of legal age (usually 21 + for recreational, 18 + for medical) and pass any background‑screening mandated by the state. | Many states prohibit persons with certain felony convictions from working with cannabis. |\n| **Work‑place safety laws** | OSHA (or state equivalent) requirements for hazardous‑material handling, PPE, and training. | Must provide a written safety plan, training records, and proper PPE. |\n| **Confidentiality / Data security** | Some states require confidentiality agreements for anyone with access to formulation data or COAs. | Have the intern sign an NDA before entry. |\n| **Federal considerations** | Cannabis remains a Schedule I drug; any unlicensed handling could be viewed as a federal violation. | Keep the intern’s role strictly observational and under the direct supervision of a licensed employee. |\n\n**Action:** Review your state’s cannabis board regulations (often found in the “Licensing Manual” or “Operational Guidelines”). If your license lists “employees” by name, you may need to add the intern as a “trainee” or obtain a supplemental amendment.\n\n---\n\n## 2. Safety & Training Prerequisites\n\n1. **Pre‑entry safety training** (minimum 4 h) covering:  \n   - Hazardous chemicals (solvents, acids, bases)  \n   - Equipment lock‑out/tag‑out (LOTO) procedures  \n   - Emergency response (spill kits, fire extinguishers, eye‑wash stations)  \n   - PPE requirements (chemical‑resistant gloves, goggles, lab coat, respirator if needed)\n\n2. **Written SOP acknowledgment** – Intern must sign that they have read and will follow all standard operating procedures for the extraction area.\n\n3. **Supervision ratio** – One licensed supervisor for every intern (or trainee) present in the extraction suite.\n\n4. **Restricted activities** – Intern may:  \n   - Observe the process from a designated “viewing area” (glass‑partition or separate room with camera feed)  \n   - Ask questions **only** when the supervisor indicates a pause or safe moment  \n   - Never touch solvents, open the extraction vessel, or adjust parameters.\n\n5. **PPE fit‑check** – Verify gloves, goggles, and respirators fit properly before entry.\n\n---\n\n## 3. Documentation Checklist\n\n| Document | Who signs | When |\n|----------|-----------|------|\n| Intern onboarding form (name, DOB, emergency contact) | HR/Manager | First day |\n| Background‑screening clearance | Compliance officer | Prior to entry |\n| Safety training completion certificate | Trainer & intern | After training |\n| NDA / confidentiality agreement | Legal & intern | Prior to entry |\n| Supervisor‑approved “Shadowing Authorization” form (specifies date, time, equipment, supervision) | Licensed supervisor & compliance manager | Day of session |\n| Incident log (blank page for any near‑miss) | Supervisor | Ongoing during session |\n\nRetain all forms for at least the period required by your state (often 3–5 years).\n\n---\n\n## 4. Practical Tips for a Smooth Shadowing Experience\n\n| Tip | Why it matters |\n|-----|\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1173 (173?1000) | Cost: $0.000000*",
      "duration": 13844,
      "grade": "D",
      "score": 62,
      "grading": {
        "accuracy": 19,
        "completeness": 11,
        "relevance": 14,
        "clarity_structure": 10,
        "practical_value": 8,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clearly limits the intern to observation only and emphasizes supervision and safety",
        "Provides actionable safety and training steps (PPE, LOTO, emergency response)",
        "Includes a practical documentation checklist and onboarding considerations",
        "Notes need to verify state rules and potentially add intern as trainee/authorized personnel"
      ],
      "weaknesses": [
        "Misses New York-specific requirements (OCM Part 130) central to the question",
        "Does not state that limited access areas are restricted to employees/authorized personnel and that interns generally must be employees of the licensee in NY",
        "Omits mandatory NY practices such as visitor logs for permitted visitors and ID badge requirements",
        "Does not clearly state age restrictions applicable to NY (e.g., no minors; typically 21+ for adult-use operations)",
        "Overgeneralizes state rules (e.g., 18+ for medical) which may mislead in NY context",
        "Ends with an incomplete section and includes extraneous metadata text, hurting clarity"
      ],
      "feedback": "Your answer offers solid general safety and onboarding guidance for allowing an intern to observe extraction, but it lacks New York-specific regulatory details required for a compliant response. To improve, anchor the guidance to NY OCM Part 130: limited access areas, who may enter (employees/authorized personnel with a business purpose), ID badge and visitor log requirements, prohibition on minors, and the need for the intern to be an employee (or formally authorized) under the license. Clarify NY age requirements, remove generic or conflicting state assumptions, and complete the final section without extraneous text.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "mandatory",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "epa",
        "sop",
        "procedure",
        "standard",
        "operating"
      ],
      "expectedAnswer": "**Generating grading summary** I need to create a summary for a cannabis industry question regarding New York state-specific regulations. This involves an intern shadowing a live extraction session, which falls under employee training and compliance. The summary should be concise, focusing on key requirements, critical regulatory details, and relevant state-specific information. I'll highlight that extraction uses volatile solvents and has strict safety protocols. Also, I'll note that minors are not allowed and that an intern must be an employee of the licensee to access restricted areas.**Reviewing NY OCM regulations** I need to look at New York's OCM regulations, specifically Part 130, which outlines operational requirements. Limited access areas should only be accessed by employees, contractors, vendors, and government officials with a relevant business purpose. It's critical for the licensee to keep visitor logs to ensure compliance. Also, everyone in these areas must wear ID badges for proper identification. I want to make sure all these details are accurate and important for operations!**Summarizing cannabis industry regulations** I need to create a grading summary for a cannabis industry question focusing on New York's specific regulations about allowing interns to shadow an extraction session. The summary should include key facts, regulatory details, and category information related to employee training and compliance. It’s crucial to note that extraction involves vol..."
    },
    {
      "questionNum": 47,
      "question": "Do I need to document breaks if they occur during active batch processing?",
      "category": "employee-training-operational-roles",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Yes – any interruption (or “break”) that occurs while a batch is in active production must be documented.**  \n\nRegulators view a “break” as a deviation from the continuous, controlled state defined in your Standard Operating Procedure (SOP). Failure to record it can be interpreted as a lack of traceability or quality‑control oversight, which may lead to a compliance citation, product hold, or even a license audit finding.\n\n---\n\n### What to Document\n\n| Item | Why It Matters |\n|------|----------------|\n| **Date & Time** (start / stop) | Establishes the exact window of the interruption. |\n| **Reason for the break** (e.g., equipment malfunction, power outage, material shortage, operator shift change, cleaning, safety stop) | Shows it was a legitimate, controllable event. |\n| **Duration** | Determines if the break exceeds any “maximum allowable” limits in your SOP. |\n| **Impact Assessment** (was the product temperature, humidity, pressure, etc., affected?) | Helps decide if the batch remains within specification or needs re‑work. |\n| **Corrective/Preventive Action (CAPA)** | Documents how you restored normal conditions and what you’ll do to avoid recurrence. |\n| **Signature/Initials** of the operator and a supervisor/quality‑assurance (QA) reviewer | Provides accountability and audit trail. |\n| **Reference to SOP/Batch Record Section** | Links the entry to the controlling procedure. |\n\n---\n\n### How to Record It\n\n1. **Batch Log / Manufacturing Record** – Add a line item in the “Interruptions/Deviations” section.  \n2. **Deviation Form (if required)** – For breaks > X minutes or that affect critical parameters, complete a formal deviation report.  \n3. **Electronic Manufacturing System (EMS)** – Most software (e.g., BioTrackTHC, METRC, LeafLogix) has a “Pause/Resume” timestamp feature; use it.  \n4. **Post‑Batch Review** – QA should verify that all breaks were captured before batch release.\n\n---\n\n### Typical Regulatory Guidance (illustrative)\n\n| Jurisdiction | Requirement Highlights |\n|--------------|------------------------|\n| **California (B&C Act)** | Any “interruption of the manufacturing process” must be logged in the batch record with cause and corrective action. |\n| **Massachusetts** | SOPs must define “maximum allowable downtime” and all deviations beyond that must be documented and reviewed by QA. |\n| **Colorado** | Breaks > 15 min must trigger a “process deviation” entry; shorter pauses are acceptable if covered by SOP. |\n| **Ontario (Canada)** | All production pauses must be recorded in the electronic batch record, including temperature excursions. |\n\n*(Always verify the exact language in the state/territorial regulations that apply to your facility.)*\n\n---\n\n### Quick Checklist for Operators\n\n- ☐ Did a break occur?  \n- ☐ Record start/stop times immediately.  \n- ☐ Note the cause and any affected parameters.  \n- ☐ Notify your supervisor/QA as soon as possible.  \n- ☐ Complete the required form (log entry, deviation, EMS pause).  \n- ☐ Obtain required signatures before resuming the batch.\n\n---\n\n## Bottom Line\n**Document every break**—no matter how brief—unless your SOP explicitly states that a specific, pre‑approved pause (e.g., a scheduled 5‑minute equipment check) does not need separate entry. Even in those cases, the SOP itself must be referenced in the batch record to prove the pause was authorized.\n\nDoing so protects product quality, satisfies regulators, and gives you a clear audit trail should any question arise later in the batch lifecycle.\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1072 (132?940) | Cost: $0.000000*",
      "duration": 14104,
      "grade": "A",
      "score": 91.66666666666667,
      "grading": {
        "length": "Pass",
        "keywords": "13/15 matched",
        "noErrors": "Pass",
        "structure": "Pass",
        "relevance": "4/5 key words"
      },
      "strengths": [],
      "weaknesses": [],
      "feedback": "",
      "gradingMethod": "unknown",
      "expectedKeywords": [
        "compliance",
        "regulation",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "massachusetts",
        "metrc",
        "sop",
        "standard"
      ],
      "expectedAnswer": ""
    },
    {
      "questionNum": 48,
      "question": "Can I transfer crude oil to another facility before final testing?",
      "category": "transport-transfer-regulations",
      "agent": "unknown",
      "actualAgent": "formulation",
      "actualAgentName": "Formulation Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** Yes, you can move crude cannabis oil to another licensed facility before the final laboratory test—*provided* you meet all regulatory, safety, and documentation requirements for your jurisdiction.  \n\nBelow is a step‑by‑step checklist you can use to make sure the transfer is compliant and that the oil remains test‑ready.\n\n---\n\n## 1. Verify Licensing & Permissions\n| Action | Why it matters |\n|--------|----------------|\n| **Both facilities must hold a valid state‑issued “Processor/Manufacturer” (or equivalent) license** | Only licensed entities may possess, handle, or transport cannabis material. |\n| **Confirm the receiving facility is authorized to receive crude oil** | Some states differentiate between “extracts” and “finished products.” |\n| **Check any inter‑facility transfer permits** (e.g., “Transfer Manifest” in COA‑tracking systems) | Required in most seed‑to‑sale track‑and‑trace (METRC, BioTrackTHC, etc.). |\n\n---\n\n## 2. Chain‑of‑Custody & Track‑and‑Trace\n1. **Generate a Transfer Manifest** in your state’s seed‑to‑sale system.  \n   - Include: lot number, weight, product type (crude oil), origin license, destination license, and expected delivery date.  \n2. **Assign a unique batch/lot ID** that will stay with the oil through testing, packaging, and final sale.  \n3. **Document every hand‑off** (driver, carrier, receipt sign‑off) with timestamps.  \n4. **Retain a copy of the manifest** for at least the retention period required by the state (often 2–5 years).\n\n---\n\n## 3. Packaging & Labeling Requirements\n| Requirement | Typical Specification |\n|-------------|------------------------|\n| **Closed, tamper‑evident container** (e.g., HDPE or glass vials with child‑resistant caps) | Prevents contamination & diversion. |\n| **Label must include**: lot ID, product type (“Crude Cannabis Oil”), net weight, origin license number, “Not for Sale – Testing Pending” notice | Keeps the product clearly identified as pre‑test material. |\n| **Temperature control** (if required) | Many states require storage ≤ 25 °C for crude oil; if the oil is prone to degradation, use insulated containers or dry‑ice packs. |\n| **Safety labeling** (flammable, hazardous material) | Required for transport under DOT/HAZMAT regulations. |\n\n---\n\n## 4. Transportation Logistics\n- **Licensed carrier** (or driver with a valid “transportation” endorsement on their state cannabis license).  \n- **Vehicle must be inspected** for clean, secure storage of hazardous material.  \n- **Maintain temperature logs** during transit if the oil is temperature‑sensitive.  \n- **Insurance coverage** that includes cannabis product loss/theft.  \n\n---\n\n## 5. Pre‑Testing Considerations\n| Issue | Mitigation |\n|-------|------------|\n| **Degradation of cannabinoids/terpenes** | Keep the oil in a dark, cool environment; limit exposure to air (nitrogen flush if possible). |\n| **Potential contamination** | Use sterile, food‑grade equipment; ensure the receiving facility follows GMP‑level sanitation. |\n| **Variability in sampling** | Agree on a *sampling protocol* with the testing lab (e.g., 5 g from the same lot, homogenized). |\n| **Documentation of “as‑received” condition** | Photo or video of the container at the moment of transfer; include a brief “condition report” on the manifest. |\n\n---\n\n## 6. Lab Acceptance at the Receiving Facility\n1. **Confirm the testing lab can accept samples from the new location** (some labs require a “sample receipt form” signed by the facility that performed the extraction).  \n2.\n\n---\n*Agent: Formulation Agent | Plan: Standard | Tokens: 1190 (190?1000) | Cost: $0.000000*",
      "duration": 3622,
      "grade": "F",
      "score": 55,
      "grading": {
        "accuracy": 17,
        "completeness": 11,
        "relevance": 13,
        "clarity_structure": 7,
        "practical_value": 7,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Provides a clear, step-by-step operational checklist for inter-facility transfers",
        "Emphasizes seed-to-sale manifests and chain-of-custody documentation",
        "Highlights labeling such as “Not for Sale – Testing Pending,” which aligns with common practice"
      ],
      "weaknesses": [
        "Lacks New York-specific regulatory details (OCM rules, track-and-trace platform, quarantine and testing requirements)",
        "Includes questionable or inaccurate claims (e.g., broad DOT/HAZMAT requirements for crude cannabis oil, “many states require storage ≤ 25°C”)",
        "Does not clearly state the prohibition on sale/distribution of untested product beyond a label suggestion",
        "Omits key state restrictions like no interstate transfer and receiving-facility quarantine until testing passes",
        "Section is incomplete and contains extraneous AI/meta text, reducing clarity"
      ],
      "feedback": "Your answer offers a practical, organized checklist but misses the New York-specific focus required. Reference New York OCM regulations directly, specify the state track-and-trace system (e.g., BioTrack in NY), and clearly state that untested crude can be transferred only between licensed entities and must remain quarantined and not for sale until passing required tests. Remove speculative items (like universal HAZMAT handling and temperature requirements) and complete the response without meta artifacts. Including explicit notes on no interstate transfers and documentation retention under NY rules would significantly improve accuracy and completeness.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "epa",
        "sop",
        "procedure",
        "standard",
        "documentation",
        "document",
        "record",
        "log",
        "manifest",
        "testing"
      ],
      "expectedAnswer": "**Summarizing transfer regulations** I need to summarize the answer to the question: \"Can I transfer crude oil to another facility before final testing?\" This involves understanding transport regulations, agent compliance, and New York-specific rules regarding cannabis. I want to capture the main conclusion, key requirements, and critical regulatory details. In many states, transferring untested material is often restricted and must meet certain guidelines, like being quarantined. I’ll specifically reference New York's Office of Cannabis Management for the pertinent regulations.**Evaluating material transfer regulations** I’m considering whether a processor can transfer untested material to another processor for further processing before final testing. Typically, the answer is yes, but there are restrictions. The untested material can’t be sold or distributed to retailers until it passes testing. Additionally, it must be tagged and recorded in the METRC system, though I'm wondering if New York uses BioTrack instead. I need to clarify this point to ensure I'm getting it right.**Summarizing transfer regulations** I need to create a concise summary addressing whether crude oil can be transferred to another facility before final testing, focusing on transport regulations in New York. It'll be vital to note the main conclusions, key requirements, and critical state-specific regulatory details, particularly on cannabis testing. In many states, transferring untested material is rest..."
    },
    {
      "questionNum": 49,
      "question": "Is a licensed cannabis transporter required for in-state product transfers?",
      "category": "transport-transfer-regulations",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** In most U.S. states that have legalized cannabis, **a licensed transporter (or a license‑holder that is authorized to transport) is required for any commercial movement of product—even when the transfer stays entirely within the state’s borders.**  \n\n---\n\n### Why the requirement exists\n1. **Track-and‑trace compliance** – State seed‑to‑sale systems (Metrc, BioTrackTHC, etc.) require every “move” of product to be logged by a registered transporter, allowing regulators to monitor inventory, prevent diversion, and verify that the product stays within the licensed supply chain.  \n2. **Safety and security** – Transporter licenses include background checks, insurance, vehicle‑security standards, and driver‑training requirements that help protect the product from theft or loss.  \n3. **Uniform enforcement** – Requiring a dedicated transporter (or a license‑holder with transport privileges) creates a single point of accountability, simplifying inspections and audits.\n\n---\n\n### How the rule plays out in practice\n\n| State | In‑state transport requirement | Who can transport |\n|-------|-------------------------------|-------------------|\n| **California** | Required. All “moves” must be entered by a **licensed Transporter** or a **cultivation/retail/processor license** that has been granted transport privileges. | Separate transporter license or a cultivator/processor/retailer with transport endorsement. |\n| **Colorado** | Required. Every commercial shipment must be performed by a **licensed Transporter** (or a licensee with a “transport endorsement”). | Separate transporter license; cultivators/retailers can add the endorsement on their own license. |\n| **Oregon** | Required. **Transporter licenses** are mandatory for any movement of cannabis between licensed facilities, even within the same county. | Separate transporter license; a cultivator may apply for a “transport endorsement” on its existing license. |\n| **Michigan** | Required. **Licensed Transporters** must be used for all inter‑business moves; a cultivator/processor can request a transport endorsement on its own license, but it must still be recorded in the state’s tracking system. |\n| **Illinois** | Required. Only **licensed Transporters** may move product; a cultivator/processor can obtain a **transport endorsement** but must still be listed as the transporter in METRC. |\n| **Massachusetts** | Required. **Transporter licenses** are needed for any commercial transfer; a cultivation/processing license can add a transport endorsement, but the move must be logged under that license. |\n| **Washington** | Required. **Transporter licenses** are mandatory; a cultivator/processor can apply for a transport endorsement, but the state’s tracking system still treats it as a distinct transporter activity. |\n| **Other states** (e.g., Arizona, New Mexico, Vermont, etc.) | Generally **required** as well, with similar endorsement options. |\n\n> **Bottom line:** *If you’re moving product between two separate licensed entities (e.g., from a cultivator to a processor, from a processor to a retailer, or even between two retail locations), you need a licensed transporter or an endorsement on the originating license.*  \n\n---\n\n### Exceptions & nuances\n\n| Situation | Typical rule | Why it matters |\n|-----------|--------------|----------------|\n| **Transfers within the same licensed facility** (e.g., moving product from one room to another) | **No transporter needed** – internal “moves” are logged by the facility’s own license. | The product never leaves the premises; the same license handles the inventory. |\n| **Owner‑operator moves** (the same company holds both source and destination licenses) | Many states still **require a transport endorsement** on the operating license, even though the same entity owns both ends. | Regulators want a documented transport event in the seed‑to‑sale system. |\n| **Sample or promotional transfers** (small quantities for testing) | Some states allow **“sample” exemptions** that don’t require a transporter, but the quantity is limited (often ≤ 1 oz) and must still be logged. | Check the state’s rulebook; misuse can lead to violations. |\n| **Medical‑only programs** | Some early‑adopter states (e.g., Maryland before 2022) allowed **licensed dispensaries** to transport directly, but\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1130 (130?1000) | Cost: $0.000000*",
      "duration": 18112,
      "grade": "F",
      "score": 30,
      "grading": {
        "accuracy": 5,
        "completeness": 5,
        "relevance": 5,
        "clarity_structure": 12,
        "practical_value": 3,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Clear structure with rationale and scenarios",
        "Explains compliance reasons (track-and-trace, security) in an understandable way"
      ],
      "weaknesses": [
        "Fails to address New York specifically, which is the core of the expected answer",
        "Contains multiple factual inaccuracies about several states’ transporter requirements (e.g., Oregon, Massachusetts, Michigan, Illinois, Washington)",
        "Conflates or oversimplifies license privileges and endorsements across states",
        "Omits New York’s distribution hierarchy (distributor vs transporter) and who can sell/transport to retail",
        "Provides a generalized table that is misleading and not actionable for NY compliance"
      ],
      "feedback": "The answer is well-organized but misses the mark by not addressing New York, which the question targets. It also includes several state-level inaccuracies and overgeneralizations, making it potentially misleading. Refocus on New York’s adult-use framework: clarify the roles of the Distributor and Transporter licenses, who may move product in-state, whether licensees can self-transport under their own license, and the requirement that distributors sell to retail. Provide precise, NY-specific guidance rather than broad multi-state claims.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "regulatory",
        "requirement",
        "required",
        "mandatory",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "washington",
        "new jersey",
        "massachusetts",
        "michigan",
        "illinois",
        "epa"
      ],
      "expectedAnswer": "**Clarifying cannabis transporter requirements** I need to summarize the requirements for a licensed cannabis transporter in New York, specifically for in-state product transfers. I should focus on New York cannabis regulations regarding adult-use licensed businesses, including cultivators, processors, distributors, and retail dispensaries. In New York, there are different licenses: the \"Cannabis Transporter\" license for third-party logistics and a \"Distributor\" license. Typically, cannabis product movement between licensees must be done by a licensed transporter, although some states allow self-distribution without a separate license. I'll double-check the relevant regulations.**Understanding cannabis distribution hierarchy** I’ve realized that in the cannabis distribution chain, distributors are the only ones allowed to sell directly to retail dispensaries. Processors, on the other hand, sell their products to distributors. Cultivators focus on selling to both processors and distributors. This hierarchy is crucial for understanding how cannabis products move from cultivation through processing to retail. I’m making sure to keep these relationships clear as I work on the summary!**Summarizing cannabis transportation regulations** I need to create a concise summary for grading responses about whether a licensed cannabis transporter is required for in-state product transfers in New York. It’s important to understand NY cannabis regulations, including licensed businesses like c..."
    },
    {
      "questionNum": 50,
      "question": "Do I need to notify the receiving party before sending a partial product shipment?",
      "category": "transport-transfer-regulations",
      "agent": "unknown",
      "actualAgent": "f8_agent",
      "actualAgentName": "F8 Multi-Agent",
      "expectedAgent": "compliance",
      "agentMatch": false,
      "response": "**Short answer:** Yes – you should always notify the receiving party before sending a partial shipment.  In the cannabis industry (and in most regulated wholesale contexts) a partial delivery is considered a change to the original order and can affect compliance, inventory tracking, and payment terms.\n\n---\n\n## Why notification matters\n\n| Reason | What it means for you |\n|--------|----------------------|\n| **Regulatory compliance** | Many state seed‑to‑sale (track‑and‑trace) systems require the receiver to acknowledge each receipt. A partial shipment creates a new “receive event,” and the licensee on the other side must be prepared to log it. |\n| **Inventory & bookkeeping** | Both parties need accurate on‑hand counts for tax reporting, audit trails, and reconciliation. |\n| **Contractual obligations** | Purchase agreements often stipulate that the buyer must be informed of any deviation from the agreed quantity or delivery schedule. |\n| **Logistics & carrier coordination** | Carriers may need a revised bill of lading or manifest; the receiving dock may need to adjust staffing or space allocations. |\n| **Payment & invoicing** | Partial deliveries usually trigger a partial invoice. The buyer must know the exact amount they’re being billed for. |\n| **Risk mitigation** | Unexpected short shipments can lead to disputes, chargebacks, or even a breach of license terms if the buyer cannot legally accept the product. |\n\n---\n\n## Typical steps to follow before a partial shipment\n\n1. **Check the purchase order / contract**  \n   - Verify that the agreement allows partial shipments (most do, but some specify “full shipment only”).  \n2. **Confirm state‑level requirements**  \n   - **California:** The CANNABIS TRACKING SYSTEM (CTS) requires a separate “receive” event for each partial delivery.  \n   - **Colorado:** The METRC system also logs each receipt; the buyer must be ready to record it.  \n   - **Other states:** Look up the specific track‑and‑trace platform (e.g., BioTrackTHC, Leaf Data Systems) – they all need a notification/acknowledgment step.  \n3. **Contact the buyer (preferred method)**  \n   - Email or portal message that includes:  \n     - PO number and line items affected  \n     - Quantity being shipped now vs. remaining quantity  \n     - Reason for the partial shipment (stock shortage, production delay, etc.)  \n     - Expected date of the remaining shipment  \n   - Request written acknowledgment (reply‑all, signed email, or portal approval).  \n4. **Update the manifest / bill of lading**  \n   - Include a note such as “Partial shipment – see PO #XXXX – remaining quantity to be delivered on [date].”  \n5. **Adjust inventory in your seed‑to‑sale system**  \n   - Mark the shipped quantity as “dispatched” and the remaining as “allocated for future shipment.”  \n6. **Issue a partial invoice**  \n   - Align the invoice amount with the quantity shipped; reference the original PO and note “partial delivery.”  \n7. **Document the communication**  \n   - Keep the buyer’s acknowledgment and the updated manifest together in case of an audit.  \n\n---\n\n## What could happen if you skip the notification?\n\n- **Compliance audit flags:** Unexplained inventory reductions can trigger a state audit or license investigation.  \n- **Payment delays or disputes:** The buyer may refuse to pay for a shipment they didn’t expect.  \n- **Carrier refusal:** Some carriers require the consignee’s acceptance before loading a partial load.  \n- **Contract breach:** If the agreement forbids partial shipments, you could be liable for damages.  \n\n---\n\n## Quick checklist for you\n\n- [ ] Does the purchase agreement permit partial shipments?  \n- [ ] Have you checked the state’s track‑and‑trace rules for partial receipts?  \n- [ ] Have you sent a clear notification (email/portal) to the buyer?  \n- [ ] Do you have written acknowledgment from the buyer?  \n- [ ] Is the manifest updated to reflect a partial load?  \n- [ ] Have you entered the shipment into your compliance software?  \n- [ ] Is a partial invoice ready and linked to\n\n---\n*Agent: F8 Multi-Agent | Plan: Standard | Tokens: 1166 (166?1000) | Cost: $0.000000*",
      "duration": 8642,
      "grade": "D",
      "score": 61,
      "grading": {
        "accuracy": 18,
        "completeness": 10,
        "relevance": 14,
        "clarity_structure": 12,
        "practical_value": 7,
        "method": "LLM (GPT-5)"
      },
      "strengths": [
        "Directly answers the question with a clear yes/no position",
        "Explains why notification matters across compliance, logistics, and invoicing",
        "Provides actionable steps and a practical checklist",
        "Emphasizes updating manifests and seed-to-sale inventory records"
      ],
      "weaknesses": [
        "Does not address New York-specific requirements (BioTrack/NYS Cannabis Track-and-Trace) as expected",
        "Omits explicit mention of NY transfer manifests and prior notice/scheduling before arrival",
        "Contains a factual error: California uses METRC, not a system called CTS",
        "Overgeneralizes state rules without citing the NY framework relevant to the question",
        "Includes a truncated checklist item and extraneous agent metadata, reducing polish"
      ],
      "feedback": "While the answer is clear, practical, and directly states that notification is needed, it misses the expected New York-specific context (BioTrack/NYS Track-and-Trace, transfer manifest creation, and prior notice/scheduling). It also contains a factual error about California’s system (it is METRC, not CTS). To improve, anchor the guidance in New York regulations: note that partial shipments must be reflected on a NY transfer manifest in the state system (BioTrack), that receivers need advance notice to accept the partial in the system, and that delivery must be scheduled and documented. Remove the agent footer, finish the checklist, and correct the misstatement about California.",
      "gradingMethod": "LLM (GPT-5)",
      "expectedKeywords": [
        "compliance",
        "regulatory",
        "requirement",
        "required",
        "must",
        "state",
        "california",
        "colorado",
        "oregon",
        "michigan",
        "illinois",
        "epa",
        "metrc",
        "standard",
        "record"
      ],
      "expectedAnswer": "**Summarizing partial shipment notification** I need to create a concise summary addressing whether the receiving party must be notified before sending partial shipments. This involves New York's cannabis regulations for distributors, cultivators, and processors regarding transport and transfer. The idea of \"partial product shipment\" might mean breaking up a purchase order, which likely requires notifying the receiving party. New York uses BioTrack for tracking, and as of 2024, they have the New York State Cannabis Track-and-Trace System in place.**Clarifying transfer requirements** I need to mention that the state requires a transfer manifest to be created. It's important to properly schedule the delivery and provide notice before arrival. This process seems crucial and likely involves notifying all relevant parties to adhere to regulations. Any oversight could cause issues during transport, so I want to make sure these steps are explicitly clear in the summary for anyone involved in the shipping process."
    }
  ],
  "status": "In Progress: 50/438 questions completed"
}